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Fertility care in the Netherlands 
 
Infertility is defined as the failure to achieve a pregnancy after one year of regular 
unprotected sexual intercourse (Zegers-Hochschild et al., 2009) and it affects about 
9-15% of the couples of childbearing age (Boivin et al., 2007). The ultimate 
treatment option is the use of assisted reproductive technology (ART): in vitro 
fertilization (IVF) and intracytoplasmic sperm injection (ICSI). In Europe, 550 296 
ART cycles were performed in 2010 with a clinical pregnancy rate of 29 per cent 
(Kupka et al., 2014). In the Netherlands, about 15,000 cycles of ART are performed 
each year in thirteen licensed clinics, resulting in 1 out of 38 children born after 
ART (www.nvog.nl). Up to three fresh ART cycles per episode are covered by Dutch 
health insurance. 
 
 
Burden in fertility care 
 
In this thesis we will study burden in fertility treatment (figure 1). Burden can lead 
to general distress or diminished fertility-related quality of life (Schmidt, 2006; 
Verhaak et al., 2007a; Boivin et al., 2012; Gameiro et al., 2013). Moreover, burden 
can lead to discontinuation of fertility treatment (Olivius et al., 2004; Smeenk et al., 
2004; Brandes et al., 2009; Domar et al., 2010; Gameiro et al., 2012). Finally, 
burden might influence the outcome of treatment (Smeenk et al., 2001; Boivin et 
al., 2011; Matthiesen et al., 2011; Pasch et al., 2012). Figure 1 shows an integrated 
approach to burden in fertility treatment. 
 
Last years, much more attention has been given to burden in fertility treatment and 
the ways to reduce this burden (Boivin et al., 2012; Gameiro et al., 2013). Since 
this century, important studies were published regarding stress and IVF: the 
evaluation of possible predictors of stress and clinical consequences of stress during 
ART treatment (Verhaak, thesis 2003; Smeenk, thesis 2006, Van den Broeck et al., 
2010). It appears most women could effectively deal with the diagnosis of infertility 
and the stress of the ART treatment (Verhaak et al., 2001). 
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Figure 1: integrated approach to burden in fertility care (based on the concepts of Boivin et al., 2012) 
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However, a substantial part showed subclinical emotional distress (i.e. symptoms of 
anxiety and/or depression) even six months after the last ART cycle. Verhaak et al. 
identified important contributors to this emotional distress, for example, the 
cognitions regarding fertility problems and a lack of social support (Verhaak et al., 
2005). In addition, others studied coping and partner relation and identified these 
factors as contributors to burden in fertility treatment (Boivin et al., 1996; Verhaak 
et al., 2001; Nelson et al., 2008; Chachamovich et al., 2010). Moreover, the physical 
burden of fertility treatment can cause feelings of distress in women (Verhaak et al., 
2007b; Verberg et al., 2008).  
Simultaneously, the relationship between psychosocial factors and dropout of ART 
was studied (Smeenk et al., 2004). Subsequently, many more studies on 
discontinuation on patients’ own initiative were published (Verberg et al., 2008; 
Brandes et al., 2009; Domar et al., 2010; Eisenberg et al., 2010; Gameiro et al., 
2012; Bovin et al., 2012). These studies reveal a variety of reasons or correlates of 
discontinuation of fertility care, which are important in the counselling of patients 
before starting ART treatment.  
Clinicians and counsellors’ aim is to diminish burden in fertility care and to 
optimize personalized psychosocial care in patients undergoing ART. This was 
suggested to achieve by the identification and counselling of women at risk for 
distress, the identification of correlates of discontinuation in ART treatment, and by 
offering women personalized care before, during and after ART treatment (Verhaak 
et al., 2010; Boivin et al., 2012; Van Dongen et al., 2012). 
 
	
Screening of psychosocial risk 
 
A validated instrument to identify women at risk for emotional distress before ART 
treatment was developed and implemented: SCREENIVF (Verhaak et al., 2010). 
SCREENIVF is an instrument based on previously identified risk factors for 
emotional maladjustment, specific for women undergoing ART (Verhaak et al., 
2010). SCREENIVF consists of 14 items assessing anxiety and depression from the 
Hospital Anxiety and Depression Scale (Snaith, 2003), 12 items assessing 
helplessness and lack of acceptance (Evers et al., 2001; Verhaak et al., 2005), and 5 
items assessing perceived social support (Van Dam-Baggen and Kraaimaat, 1992). 
Being able to identify women who are at risk for emotional distress after ART 
treatment, the next step could be to implement this screening in daily clinical care. 
After the evaluation of the implementation, we could focus on ways to prevent this 
distress or on the use of these measures in the counselling of couples.  
 
 
Discontinuation and fertility treatment 
 
Boivin et al. defines discontinuation on patients’ own initiative as patients who opt 
not to proceed with further treatment despite a favourable prognosis and the ability 
to cover the costs of treatment (Boivin et al., 2012). Reasons for discontinuation on 
patients’ own initiative are identified by retrospective studies and can be various. 
They can be related to the couples themselves such as principal or religious issues, 
emotional distress or relational problems. Examples are too much stress or a 
divorce (Olivius et al, 2004; Smeenk et al., 2004; Rajkhowa et al., 2006; Brandes et 
al., 2009; Domar et al., 2010; Eisenberg et al., 2010; Boivin et al., 2012; Gameiro et 
al., 2012, Vassard et al., 2012). Moreover, reasons can be related to the kind of 
treatment for example postponement of treatment (i.e. not starting fertility 
treatment by a good prognosis) or not using a mild stimulation protocol in IVF 
(Verberg et al., 2008; Brandes et al., 2009; Gameiro et al., 2012). Finally, reasons 
can be related to the clinic such as impaired organisation of fertility care or 
diminished management by fertility staff (Huppelschoten et al., 2013). 
Burden seems to be a contributor in discontinuation of fertility care. Therefore, we 
focus on the reasons and correlates of discontinuation in fertility care, which can be 
helpful in the prediction of discontinuation. The next step is to evaluate if 
knowledge about the correlates of discontinuation is helpful in daily clinical care, 
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and to evaluate the feasibility of the implementation of screening on 
discontinuation. 
 
 
Psychosocial care and fertility treatment 
 
In recent years, many studies have focused on the treatment of psychological 
distress in fertility patients. It is known that cognitive behavioural therapy (CBT) 
and educational interventions are most effective in reducing psychosocial distress in 
infertile patients (Boivin, 2003; Faramarzi et al., 2008; Andersson, 2009). However, 
recent reviews and meta-analyses showed mixed results for efficacy of these 
interventions (Boivin, 2003; De Liz and Straus 2005; Haemmerli et al., 2009, 
Frederiksen et al., 2015). These mixed and inconclusive results could be due to 
different factors such as the methodological quality of the studies, a great variety in 
the used interventions and in the duration of these interventions. Moreover, 
definition of the control group is not always clear. Finally, efficacy might be 
influenced by the fact that interventions are not personalized to the patients’ needs 
and preferences, and that interventions are offered to all women and in all different 
phases of fertility treatment. Tailoring psychosocial interventions to specific patient 
groups is possible as has been suggested in recent studies (Domar et al., 2000; Van 
Beugen et al., 2014, Frederiksen et al., 2015), but has not yet been effectuated. 
Moreover, until now no studies are published evaluating psychosocial interventions 
in fertility care, which is tailored to a screening and aimed to prevent distress.  
Although psychological distress is an important factor in fertility care, a limited 
amount of women have access to psychosocial interventions (Boivin et al., 1999; 
Van Dongen et al., 2012; Gameiro et al., 2013). In overcoming barriers such as 
accessibility, an Internet-based therapy could be helpful. Nowadays, Internet-based 
psychological interventions are being developed and tested in chronically ill 
patients, but also in patients undergoing treatment with specific stress moments 
(Van den Berg et al., 2012; Nguyen et al., 2013; Andersson and Titov, 2014; Cotter 
et al., 2014). These studies show promising results. Moreover, a recent review 
reported that most Internet- based interventions were efficacious in improving 
disease-symptoms and control as well as in reducing health-related distress (Beatty 
and Lambert, 2013). Until now, limited data is available concerning Internet-based 
interventions in fertility care (Haemmerli et al., 2010). Studies investigating online 
psychological interventions in fertility care encounter methodological challenges, 
for example high attrition rates, difficulties to assess the intervention dosage or 
	
randomization problems (Cousineau et al., 2008; Frederiksen et al., 2015). This 
makes comparison and pooling of different studies difficult. 
In summary, Internet-based psychosocial interventions could potentially be effective 
in reducing psychosocial distress, and may overcome barriers such as travelling 
distance. Disease-specific screening can be helpful in personalizing care and it can 
determine which patient could benefit most of a specific psychosocial intervention. 
Offering Internet-based therapy can be helpful in overcoming barriers, for example 
travelling distance. Therefore an Internet-based intervention program consisting of 
psycho-education and cognitive behavioural therapy, further on called an e-therapy 
program, in patients undergoing fertility therapy was developed and evaluated in a 
pilot study (Verhaak et al., 2008). In the evaluation of the effects of this e-therapy 
program, general distress in terms of anxiety and depression measures, but also 
fertility related quality of life are important to assess. The next step is to evaluate 
the effects of this e-therapy program in a randomized controlled trial and to 
perform a process evaluation, which can be helpful in identifying barriers and 
facilitators for the clinical implementation on a large scale. 
 
 
Outline of the thesis 
 
In this thesis, we studied several aspects of burden in ART (figure 2). Firstly, we 
studied aspects of discontinuation in fertility treatment. Secondly, we evaluated the 
implementation of screening of emotional distress related to fertility treatment and 
we explored the application of screening and discontinuation. Finally, we studied 
the possibilities of online psychosocial therapy in fertility care. 
In chapter 1 we described the general and fertility-specific context of this thesis. 
In chapter 2, reasons for discontinuation in fertility treatment, especially in 
couples before the start of their treatment, were studied. In chapter 3, we 
described the screening of patients before ART and the experiences of the couples 
undergoing this screening. In chapter 4, we investigated if this screening can 
predict discontinuation during or after ART. Moreover, in chapter 5, we 
investigated if patient-centred care can predict discontinuation in fertility 
treatment. Finally, we focused on online psychosocial therapy in fertility treatment. 
Therefore, the effects of an e-therapy program, which was developed to reduce 
psychosocial distress after the first IVF treatment, are studied in chapter 6. We 
performed a feasibility randomized controlled trial (RCT) to evaluate if it is feasible 
to analyse the effectiveness of this e-therapy program within an RCT. These results 
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undergoing this screening. In chapter 4, we investigated if this screening can 
predict discontinuation during or after ART. Moreover, in chapter 5, we 
investigated if patient-centred care can predict discontinuation in fertility 
treatment. Finally, we focused on online psychosocial therapy in fertility treatment. 
Therefore, the effects of an e-therapy program, which was developed to reduce 
psychosocial distress after the first IVF treatment, are studied in chapter 6. We 
performed a feasibility randomized controlled trial (RCT) to evaluate if it is feasible 
to analyse the effectiveness of this e-therapy program within an RCT. These results 
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could be helpful in introducing e-therapy in day-to-day clinical care and in 
personalizing psychosocial care in fertility treatment. Chapter 7 provided an 
overview of the main findings and their interpretation, a discussion of 
methodological issues, and suggestions for implications for clinical practice and 
future research. 
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Abstract 
 
Objective: To determine the incidence of couples dropping out of the in vitro 
fertilization (IVF) waiting list and to describe couples’ reasons 
Design: Prospective cohort study 
Setting: Fertility centre in an academic hospital 
Patients: 674 women placed consecutively on the IVF waiting list between June 
2000 and July 2003.  
Interventions: none 
Main outcome measures: Number of dropouts and reasons for dropping out 
Results: Follow-up information was collected in 2005 and 2008. Of the 674 
couples on the waiting list, 87% started IVF, and 13% dropped out before starting 
their first IVF cycle. Follow-up data were obtained for 85 of 86 patients (98.8%):  
37% dropped out because of spontaneous pregnancy, 36% due to personal reasons 
(passive censoring), and 27% for medical reasons (active censoring). Most of the 
pregnancies occurred within three months after the patient had been placed on the 
waiting list (30 of 32, 94%). Of the 54 censored couples, four became pregnant. 
Conclusions:  On a 6-month waiting list for IVF, 13% of the couples dropped out 
before starting treatment. The single most important reason for dropout was 
(spontaneous) pregnancy. Most of these pregnancies occur within three months, 
which suggests that psychological factors, such as stress relief after being placed on 
the waiting list might be operative. 
 
 
Keywords: dropout, follow-up, in vitro fertilization, waiting list 
	
Introduction 
 
Since the introduction of in vitro fertilization (IVF) in 1978, the indications to start 
IVF treatment have been widened. In the early days, the main indication for IVF 
was tubal occlusion; nowadays, it is used for almost all categories of subfertility 
diagnoses. However, in vitro fertilization can lead to physical, psychological and 
economical burdens, which is why counselling before starting the treatment is vital. 
Part of the counselling of couples before starting IVF treatment is giving them 
accurate information on success rates. Many studies have described pregnancy rates 
after starting IVF treatment; however, there is also a chance of pregnancy during 
the “waiting list period” (Stolwijk et al., 1996; Olivius et al., 2002; Eijkemans et al., 
2008). Patients should know what to expect in this period. Also, in an intention-to-
treat analysis, dropouts from the waiting list will negatively affect the IVF center’s 
cumulative pregnancy rate. 
A variety of studies have described high dropout rates in IVF treatment (Stolwijk et 
al., 1996; Land et al., 1997; Roest et al., 1998; De Vries et al., 1999; Olivius et al., 
2002; Smeenk et al., 2004; Verhagen et al., 2008), and there is controversy in the 
literature about the reasons for dropout (Roest et al., 1998; De Vries et al., 1999; 
Smeenk et al., 2004). Prognostic factors affecting pregnancy rates can be related to 
general characteristics of patients (such as, e.g. age), or can be related to the results 
of previous IVF treatment. De Vries et al. concluded that there was no selective 
dropout of patients with a poor prognosis (De Vries et al., 1999). These dropouts 
can be actively censored (for medical reasons, as with physician-recommended 
dropouts) or passively censored (as with patient-initiated dropouts). We showed 
that after initiation of IVF treatment the dropout rates for active censoring 
decreased and passive censoring increased during subsequent treatment cycles 
(Verhagen et al., 2008). Dropouts for active or passive censoring may be considered 
an adverse treatment outcome because dropping out deprives a couple of additional 
pregnancy chances by IVF treatment and can influence cumulative success rates per 
completed IVF treatment series or per IVF cycle (Verberg et al., 2008).  
Our study focused is on couples who dropped out before starting IVF, while they 
were still on the waiting list. We investigated the incidence of couples who dropped 
out of the waiting list and their reasons for doing so. A better understanding of why 
couples leave the IVF program before starting treatment allows for tailoring patient 
counselling to the couple’s individual needs and at the same time provides a more 
realistic impression of the program’s overall cumulative pregnancy rate. 
 
39426 Dongen, Angelique.indd   26 14-03-16   12:20
Dropouts from IVF waiting lists
27
2
	
Abstract 
 
Objective: To determine the incidence of couples dropping out of the in vitro 
fertilization (IVF) waiting list and to describe couples’ reasons 
Design: Prospective cohort study 
Setting: Fertility centre in an academic hospital 
Patients: 674 women placed consecutively on the IVF waiting list between June 
2000 and July 2003.  
Interventions: none 
Main outcome measures: Number of dropouts and reasons for dropping out 
Results: Follow-up information was collected in 2005 and 2008. Of the 674 
couples on the waiting list, 87% started IVF, and 13% dropped out before starting 
their first IVF cycle. Follow-up data were obtained for 85 of 86 patients (98.8%):  
37% dropped out because of spontaneous pregnancy, 36% due to personal reasons 
(passive censoring), and 27% for medical reasons (active censoring). Most of the 
pregnancies occurred within three months after the patient had been placed on the 
waiting list (30 of 32, 94%). Of the 54 censored couples, four became pregnant. 
Conclusions:  On a 6-month waiting list for IVF, 13% of the couples dropped out 
before starting treatment. The single most important reason for dropout was 
(spontaneous) pregnancy. Most of these pregnancies occur within three months, 
which suggests that psychological factors, such as stress relief after being placed on 
the waiting list might be operative. 
 
 
Keywords: dropout, follow-up, in vitro fertilization, waiting list 
	
Introduction 
 
Since the introduction of in vitro fertilization (IVF) in 1978, the indications to start 
IVF treatment have been widened. In the early days, the main indication for IVF 
was tubal occlusion; nowadays, it is used for almost all categories of subfertility 
diagnoses. However, in vitro fertilization can lead to physical, psychological and 
economical burdens, which is why counselling before starting the treatment is vital. 
Part of the counselling of couples before starting IVF treatment is giving them 
accurate information on success rates. Many studies have described pregnancy rates 
after starting IVF treatment; however, there is also a chance of pregnancy during 
the “waiting list period” (Stolwijk et al., 1996; Olivius et al., 2002; Eijkemans et al., 
2008). Patients should know what to expect in this period. Also, in an intention-to-
treat analysis, dropouts from the waiting list will negatively affect the IVF center’s 
cumulative pregnancy rate. 
A variety of studies have described high dropout rates in IVF treatment (Stolwijk et 
al., 1996; Land et al., 1997; Roest et al., 1998; De Vries et al., 1999; Olivius et al., 
2002; Smeenk et al., 2004; Verhagen et al., 2008), and there is controversy in the 
literature about the reasons for dropout (Roest et al., 1998; De Vries et al., 1999; 
Smeenk et al., 2004). Prognostic factors affecting pregnancy rates can be related to 
general characteristics of patients (such as, e.g. age), or can be related to the results 
of previous IVF treatment. De Vries et al. concluded that there was no selective 
dropout of patients with a poor prognosis (De Vries et al., 1999). These dropouts 
can be actively censored (for medical reasons, as with physician-recommended 
dropouts) or passively censored (as with patient-initiated dropouts). We showed 
that after initiation of IVF treatment the dropout rates for active censoring 
decreased and passive censoring increased during subsequent treatment cycles 
(Verhagen et al., 2008). Dropouts for active or passive censoring may be considered 
an adverse treatment outcome because dropping out deprives a couple of additional 
pregnancy chances by IVF treatment and can influence cumulative success rates per 
completed IVF treatment series or per IVF cycle (Verberg et al., 2008).  
Our study focused is on couples who dropped out before starting IVF, while they 
were still on the waiting list. We investigated the incidence of couples who dropped 
out of the waiting list and their reasons for doing so. A better understanding of why 
couples leave the IVF program before starting treatment allows for tailoring patient 
counselling to the couple’s individual needs and at the same time provides a more 
realistic impression of the program’s overall cumulative pregnancy rate. 
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Material and methods  
 
The indications for couples to be placed on the IVF waiting list were according to 
the 1998 IVF guidelines of the Dutch Society of Obstetrics and Gynaecology 
(NVOG-Guideline No. 9, Indications for IVF). For tubal blockage, severe 
endometriosis, or severe male subfertility, IVF or intracytoplasmic sperm injection 
(ICSI) can be offered immediately. For unexplained subfertility or mild 
endometriosis, IVF is offered after three years of subfertility, or after two years of 
subfertility when the women’s age is above 36 years. Treatment such as an 
intrauterine insemination must be offered before offering IVF. In case of mild male 
subfertility or cervical factor, IVF is offered after two years of subfertility. For 
hormonal disorders, IVF is offered after twelve cycles of ovulation induction with 
gonadotropins. Depending on the age of the women IVF can be offered earlier. The 
Dutch guidelines are described by Lintsen et al. (Lintsen et al., 2007). 
At the time of our study, the median waiting period before initiating IVF treatment 
at the Maastricht University Medical Centre (MUMC) was six months (range: 1.2 – 
19.2 months). We prospectively collected data for all 674 consecutive patients 
placed on the waiting list for IVF or ICSI treatment in our IVF clinic between June 
2000 and July 2003. Couples using donor gametes or starting IVF for pre-
implantation genetic diagnosis and surgical sperm aspiration were excluded. (These 
indications are not mentioned in the Dutch IVF guidelines.) Patients were observed 
until they started their first IVF cycle, or until the moment of censoring, whichever 
came first. If patients left the program for medical reasons, this was defined as 
active censoring; if patients left the program for personal reasons, this was 
considered passive censoring. Reasons for active censoring included failure to lose 
weight (body mass index > 30 kg/m2), failure to gain weight (body mass index < 
18 kg/m2), or medical conditions such as progressive endometriosis requiring 
surgery, development of azoospermia while on the waiting list, hypertension 
requiring medical treatment, and improved semen quality no longer requiring IVF-
ICSI. Reasons for dropout for passive censoring included financial reasons, 
relational problems, psychological burden, language problems, or continuation of 
treatment elsewhere. 
A pregnancy was defined as a positive urinary pregnancy test at least four weeks 
after the last menstrual period. Follow-up data on dropouts were collected between 
May and December 2005, and between September and November 2008. The data 
were obtained by questionnaires sent to the patients, by contacting the patients’ 
	
family doctor to learn whether the patient had become pregnant, and by chart 
review. 
In counselling couples, cumulative ongoing pregnancies rates or live-birth rates are 
preferred (Min et al., 2004). Our study analysed the dropout on the waiting list and 
the reasons for dropping out, so we decided to take each couple’s first pregnancy 
into account irrespective of its outcome. 
In the Netherlands no ethics review board approval is required for retrospective 
chart review. The local ethics committee approved the collection of data for quality 
monitoring purposes as part of our IVF treatment protocol. Before starting their IVF 
treatment, all couples gave written informed consent for the use of their 
anonymous medical data for research purposes. 
The data were analysed using Microsoft Excel (Redmond, WA) software, and 95% 
confidence intervals were calculated according to Wilson’s method (Wilson, 1927). 
 
 
Results 
 
Between June 2000 and July 2003, 674 couples were placed on the IVF waiting list. 
Eventually, 588 couples (87%, 95%CI: 85 – 90%) started their first cycle in our 
centre. There were 86 dropouts from the waiting list before starting IVF treatment 
(13%, 95%CI: 10 – 15%). The follow-up rate was nearly complete (85 of 86, 
98.8%).  
Analysis of patients’ reasons for dropping out shows that 23 (27%; 95%CI: 19 – 
37%) dropped out for medical reasons (active censoring), 31 (36%; 95%CI: 27 – 
47%) for passive censoring, and 32 for spontaneous pregnancy (37%; 95%CI: 28 – 
48%). Individual reasons for active and passive censoring are summarized in table 
1. 
There were 32 dropouts for spontaneous pregnancy on the waiting list. The 
pregnancy rate in all 674 patients placed on the waiting list before initiating IVF 
was 4.8% (95%CI: 3.4 – 6.6%). The waiting period varied between 1.2 and 19.2 
months, with a median of six months. Ten couples (10 of 588; 1.7%, 95%CI: 1 – 
3%) conceived spontaneously between treatment cycles after they had started IVF 
(Verhagen et al., 2008). 
Of the actively censored couples on the waiting list, two became pregnant 
spontaneously (8.7%), and of the passively censored couples, also two (6.5%). The 
cumulative pregnancy rate in the total follow-up period of 46 months was 42% (36 
of 86; 95%CI: 32 – 52%) in all 86 dropouts from the waiting list. 
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Material and methods  
 
The indications for couples to be placed on the IVF waiting list were according to 
the 1998 IVF guidelines of the Dutch Society of Obstetrics and Gynaecology 
(NVOG-Guideline No. 9, Indications for IVF). For tubal blockage, severe 
endometriosis, or severe male subfertility, IVF or intracytoplasmic sperm injection 
(ICSI) can be offered immediately. For unexplained subfertility or mild 
endometriosis, IVF is offered after three years of subfertility, or after two years of 
subfertility when the women’s age is above 36 years. Treatment such as an 
intrauterine insemination must be offered before offering IVF. In case of mild male 
subfertility or cervical factor, IVF is offered after two years of subfertility. For 
hormonal disorders, IVF is offered after twelve cycles of ovulation induction with 
gonadotropins. Depending on the age of the women IVF can be offered earlier. The 
Dutch guidelines are described by Lintsen et al. (Lintsen et al., 2007). 
At the time of our study, the median waiting period before initiating IVF treatment 
at the Maastricht University Medical Centre (MUMC) was six months (range: 1.2 – 
19.2 months). We prospectively collected data for all 674 consecutive patients 
placed on the waiting list for IVF or ICSI treatment in our IVF clinic between June 
2000 and July 2003. Couples using donor gametes or starting IVF for pre-
implantation genetic diagnosis and surgical sperm aspiration were excluded. (These 
indications are not mentioned in the Dutch IVF guidelines.) Patients were observed 
until they started their first IVF cycle, or until the moment of censoring, whichever 
came first. If patients left the program for medical reasons, this was defined as 
active censoring; if patients left the program for personal reasons, this was 
considered passive censoring. Reasons for active censoring included failure to lose 
weight (body mass index > 30 kg/m2), failure to gain weight (body mass index < 
18 kg/m2), or medical conditions such as progressive endometriosis requiring 
surgery, development of azoospermia while on the waiting list, hypertension 
requiring medical treatment, and improved semen quality no longer requiring IVF-
ICSI. Reasons for dropout for passive censoring included financial reasons, 
relational problems, psychological burden, language problems, or continuation of 
treatment elsewhere. 
A pregnancy was defined as a positive urinary pregnancy test at least four weeks 
after the last menstrual period. Follow-up data on dropouts were collected between 
May and December 2005, and between September and November 2008. The data 
were obtained by questionnaires sent to the patients, by contacting the patients’ 
	
family doctor to learn whether the patient had become pregnant, and by chart 
review. 
In counselling couples, cumulative ongoing pregnancies rates or live-birth rates are 
preferred (Min et al., 2004). Our study analysed the dropout on the waiting list and 
the reasons for dropping out, so we decided to take each couple’s first pregnancy 
into account irrespective of its outcome. 
In the Netherlands no ethics review board approval is required for retrospective 
chart review. The local ethics committee approved the collection of data for quality 
monitoring purposes as part of our IVF treatment protocol. Before starting their IVF 
treatment, all couples gave written informed consent for the use of their 
anonymous medical data for research purposes. 
The data were analysed using Microsoft Excel (Redmond, WA) software, and 95% 
confidence intervals were calculated according to Wilson’s method (Wilson, 1927). 
 
 
Results 
 
Between June 2000 and July 2003, 674 couples were placed on the IVF waiting list. 
Eventually, 588 couples (87%, 95%CI: 85 – 90%) started their first cycle in our 
centre. There were 86 dropouts from the waiting list before starting IVF treatment 
(13%, 95%CI: 10 – 15%). The follow-up rate was nearly complete (85 of 86, 
98.8%).  
Analysis of patients’ reasons for dropping out shows that 23 (27%; 95%CI: 19 – 
37%) dropped out for medical reasons (active censoring), 31 (36%; 95%CI: 27 – 
47%) for passive censoring, and 32 for spontaneous pregnancy (37%; 95%CI: 28 – 
48%). Individual reasons for active and passive censoring are summarized in table 
1. 
There were 32 dropouts for spontaneous pregnancy on the waiting list. The 
pregnancy rate in all 674 patients placed on the waiting list before initiating IVF 
was 4.8% (95%CI: 3.4 – 6.6%). The waiting period varied between 1.2 and 19.2 
months, with a median of six months. Ten couples (10 of 588; 1.7%, 95%CI: 1 – 
3%) conceived spontaneously between treatment cycles after they had started IVF 
(Verhagen et al., 2008). 
Of the actively censored couples on the waiting list, two became pregnant 
spontaneously (8.7%), and of the passively censored couples, also two (6.5%). The 
cumulative pregnancy rate in the total follow-up period of 46 months was 42% (36 
of 86; 95%CI: 32 – 52%) in all 86 dropouts from the waiting list. 
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Table 1: Reasons for dropout in 674 couples on the IVF waiting list 
 
 Patients 95%CI Pregnancies 95%CI 
Pregnancy 32 (37%) 28-48% 32 (100%) 89-100% 
Active censoring 23 (27%) 19-37% 2 (8.7%) 2-27% 
- medical a  12  0  
- failure to correct overweight (BMI > 30 kg/m2) 10  2  
- failure to correct underweight (BMI < 18 kg/m2) 1  0  
Passive censoring 31 (36%) 27-47% 2 (6.5%) 2-21% 
- financial 2  1  
- relational 10  0  
- psychological 7  0  
- language problems 3  0  
- treatment elsewhere 2  1  
- personal 6  0  
- unknown 1  -  
Total dropouts 86 (13%) 10-15% 36 (42%) 32-52% 
Note: BMI = body mass index 
a progressive endometriosis requiring surgery, developing azoospermia, severe hypertension, or improved semen quality 
 
 
Indication 
Dropout rates per indication for IVF treatment were similar. Most of the 
spontaneous pregnancies occurred in the couples with unexplained subfertility 
(67%). In the patients diagnosed with endometriosis, no spontaneous pregnancies 
occurred (table 2). There was no difference in spontaneous pregnancy rates in 
couples diagnosed with primary subfertility or secondary subfertility (38%; 95%CI: 
27 – 51% vs. 48%; 95%CI: 32 – 65%). 
 
 
Table 2: Spontaneous pregnancies per indication for IVF in couples on the waiting list 
 
 
Age 
Mean age in all patients on the waiting list was 32.58 years (standard deviation 
[SD] +/- 3.76 years). Most of the spontaneous pregnancies occurred in patients 
younger than 35 years (83%; 95%CI: 68 – 92%). After 35 years, a decrease in the 
spontaneous pregnancy rate occurred (table 3). 
 
Indication Patients Dropouts 95%CI Pregnancies 95%CI 
Unexplained 183 24 (13%) 9-19% 16 (67%) 47-82% 
Endometriosis 24 3 (13%) 4-31% 0 0-56% 
Male factor 355 44 (12%) 9-16% 17 (39%) 26-54% 
Tubal factor 112 15 (13%) 8-21% 3 (20%) 7-45% 
Total  674 86 (13%) 10-15% 36 (42%) 32-52% 
	
Table 3: Spontaneous pregnancy rate per age group in women on the IVF waiting list 
 
 
Duration 
Thirty of the 32 women (94%; 95%CI: 80 – 98%) who dropped out for pregnancy 
became pregnant within three months after being placed on the waiting list (figure 
1). Eight of these patients subsequently appeared to have been pregnant at the time 
they were placed on the waiting list. Because these patients had effectively been 
placed on the waiting list and there was no reason to suspect pregnancy at that 
time, we included them in our analysis. We observed a rapid increase of pregnancy 
rate in the first three months; after that point, the increase was more gradual.  
 
Figure 1: Crude cumulative pregnancy rate in couples on the IVF waiting list 
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Months 
Pregnancy 
Age (in years) Patients Dropouts 95%CI Pregnancies 95%CI 
20-25 17 1 (6%) 1-27% 1 (100%) 21-100% 
25-30 152 24 (16%) 11-22% 13 (54%) 35-72% 
30-35 320 39 (12%) 9-16% 16 (41%) 27-57% 
35-40 184 22 (12%) 8-17% 6 (27%) 13-48% 
>40 1 0 0-79% 0 - 
Total  674 86 (13%) 10-15% 36 (42%) 32-52% 
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Table 1: Reasons for dropout in 674 couples on the IVF waiting list 
 
 Patients 95%CI Pregnancies 95%CI 
Pregnancy 32 (37%) 28-48% 32 (100%) 89-100% 
Active censoring 23 (27%) 19-37% 2 (8.7%) 2-27% 
- medical a  12  0  
- failure to correct overweight (BMI > 30 kg/m2) 10  2  
- failure to correct underweight (BMI < 18 kg/m2) 1  0  
Passive censoring 31 (36%) 27-47% 2 (6.5%) 2-21% 
- financial 2  1  
- relational 10  0  
- psychological 7  0  
- language problems 3  0  
- treatment elsewhere 2  1  
- personal 6  0  
- unknown 1  -  
Total dropouts 86 (13%) 10-15% 36 (42%) 32-52% 
Note: BMI = body mass index 
a progressive endometriosis requiring surgery, developing azoospermia, severe hypertension, or improved semen quality 
 
 
Indication 
Dropout rates per indication for IVF treatment were similar. Most of the 
spontaneous pregnancies occurred in the couples with unexplained subfertility 
(67%). In the patients diagnosed with endometriosis, no spontaneous pregnancies 
occurred (table 2). There was no difference in spontaneous pregnancy rates in 
couples diagnosed with primary subfertility or secondary subfertility (38%; 95%CI: 
27 – 51% vs. 48%; 95%CI: 32 – 65%). 
 
 
Table 2: Spontaneous pregnancies per indication for IVF in couples on the waiting list 
 
 
Age 
Mean age in all patients on the waiting list was 32.58 years (standard deviation 
[SD] +/- 3.76 years). Most of the spontaneous pregnancies occurred in patients 
younger than 35 years (83%; 95%CI: 68 – 92%). After 35 years, a decrease in the 
spontaneous pregnancy rate occurred (table 3). 
 
Indication Patients Dropouts 95%CI Pregnancies 95%CI 
Unexplained 183 24 (13%) 9-19% 16 (67%) 47-82% 
Endometriosis 24 3 (13%) 4-31% 0 0-56% 
Male factor 355 44 (12%) 9-16% 17 (39%) 26-54% 
Tubal factor 112 15 (13%) 8-21% 3 (20%) 7-45% 
Total  674 86 (13%) 10-15% 36 (42%) 32-52% 
	
Table 3: Spontaneous pregnancy rate per age group in women on the IVF waiting list 
 
 
Duration 
Thirty of the 32 women (94%; 95%CI: 80 – 98%) who dropped out for pregnancy 
became pregnant within three months after being placed on the waiting list (figure 
1). Eight of these patients subsequently appeared to have been pregnant at the time 
they were placed on the waiting list. Because these patients had effectively been 
placed on the waiting list and there was no reason to suspect pregnancy at that 
time, we included them in our analysis. We observed a rapid increase of pregnancy 
rate in the first three months; after that point, the increase was more gradual.  
 
Figure 1: Crude cumulative pregnancy rate in couples on the IVF waiting list 
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Age (in years) Patients Dropouts 95%CI Pregnancies 95%CI 
20-25 17 1 (6%) 1-27% 1 (100%) 21-100% 
25-30 152 24 (16%) 11-22% 13 (54%) 35-72% 
30-35 320 39 (12%) 9-16% 16 (41%) 27-57% 
35-40 184 22 (12%) 8-17% 6 (27%) 13-48% 
>40 1 0 0-79% 0 - 
Total  674 86 (13%) 10-15% 36 (42%) 32-52% 
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Discussion  
 
Our study with almost complete patient follow-up investigated the reasons for 
dropout in 674 women on a waiting list for IVF treatment. An important reason for 
dropout was pregnancy (37%), while 36% of couples dropped out for passive 
censoring and 27% for active censoring. The (spontaneous) pregnancy rate in 
patients being placed on the IVF waiting list was 4.8% before the start of IVF 
treatment. This is comparable with our earlier investigation (Evers et al., 1998), in 
which 5.5% of women achieved a spontaneous pregnancy in the first 12 months on 
the waiting list. Evers et al. investigated treatment-independent pregnancy rates by 
comparing the pregnancy rate of patients on a waiting list for IVF/ICSI with 
pregnancy rates of nested controls after their first IVF/ICSI cycle. The 12-month 
cumulative pregnancy rate of the waiting-list patients was 76 of 1391 (5.5%): 2.4% 
for tubal factor infertility, 5.9% for unexplained subfertility, and 6.6% for male 
factor infertility. More than 75% of the pregnancies in the subgroup of unexplained 
subfertility occurred in the first three months after beging wait-listed. 
Of the 54 couples censored for reasons other than spontaneous pregnancy in our 
study, four became pregnant: two (8.7%) after active censoring and two (6.5%) 
after passive censoring. Actively censored couples are considered to have poorer 
pregnancy chances than passively censored couples (Stolwijk et al., 1996; Olivius et 
al., 2002). An earlier analysis by our centre in couples dropping out after the start 
of IVF treatment could not corroborate this assumption, showing a pregnancy rate 
of 25% (95%CI: 14 – 40%) in actively censored couples and 6% (95%CI: 2 – 18%) 
in passively censored couples (Verhagen et al., 2008). The suggestion was made 
that a reason for the higher pregnancy rate in actively censored couples might be 
our center’s too strict criteria for active censoring. Another reason might be that 
passively censored couples decide to refrain from actively pursuing conception (at 
least for some time) after having left the IVF program (Verhagen et al., 2008). In 
our present study, the pregnancy rate of actively and passively censored patients 
was comparable with our earlier findings (Verhagen et al., 2008). 
The high frequency of pregnancies as a reason for dropout is an especially 
important factor to be considered in counselling couples before placing them on a 
waiting list for IVF. The pregnancies mostly occurred in couples diagnosed with 
unexplained subfertility and in patients younger than 35 years. Most pregnancies 
occurred within three months after the couple was placed on the waiting list. 
Waiting list placement may relieve the couple’s stress, which may play an important 
psychological role in conceiving. Stress relief and its presumed positive influence on 
	
pregnancy chances were suggested by Eijkemans et al. and Evers et al. (Evers et al., 
1998; Eijkemans et al., 2008). Smeenk et al. investigated state anxiety and 
depression scales and concluded that passive dropout was related to psychological 
factors (Smeenk et al., 2004). Better counselling as well as more surveillance and 
support of the couples may influence dropping out for reasons related to 
psychological burdens.  
Our aim is to minimize passive censoring, but at the same time it is important for 
people to put the IVF period actively to an end so that they can cope with eventual 
persisting childlessness (Verhagen et al., 2008). Earlier reports show that it is 
necessary for physicians and counselors to inform and educate the couples on 
success rates because after failed treatment it is a challenge for couples to make 
new decisions (Sydsjö et al., 2005). To patients, IVF treatment might seem to offer 
unlimited treatment possibilities, and this may prevent couples from adopting the 
cognitive coping strategies they need for accepting childlessness. A well-marked 
treatment end point may be an important aspect of a couple’s adaptation process to 
definitive childlessness (Verhaak et al., 2007). Because ours was essentially an 
observational study, we did not evaluate stress and anxiety before and after putting 
a patient on the waiting list. Further research should be focused on the therapeutic 
effect of being put on the waiting list (stress relief), for example, when doing cost-
benefit comparisons for IVF treatment. 
Recently Eijkemans et al. reported on 5962 patients representing all patients on the 
IVF waiting list between January 2002 until December 2003 in the Netherlands 
Eijkemans et al., 2008). Initially, 6221 patients were included, and 259 (4.2%) 
were lost to follow-up observation. For 16% of the patients, values were missing for 
one or more characteristics. At the last date of follow-up evaluation, 718 patients 
had not become pregnant or started IVF, with a median follow-up period of 6.2 
months. Their conclusion was that spontaneous pregnancy chances were low for 
subfertile couples, but that it is possible to identify prognostic factors (e.g. 
unexplained subfertility or young age) for ‘higher chance’ couples. It can be cost-
effective to postpone IVF treatment in these couples (Eijkemans et al., 2008).  
Our study differs from theirs in that ours is based on a smaller group and focuses on 
just one clinic rather than being nationwide. However, our report is based on a 
longer period (between June 2000 and July 2003) and our follow-up duration was 
up to 46 months for the program dropouts. Furthermore, we achieved almost 
complete follow-up with patients who had dropped out, compared with the 
Eijkemans study’s loss to follow-up of 4.2% and up to 16% of patients with missing 
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Discussion  
 
Our study with almost complete patient follow-up investigated the reasons for 
dropout in 674 women on a waiting list for IVF treatment. An important reason for 
dropout was pregnancy (37%), while 36% of couples dropped out for passive 
censoring and 27% for active censoring. The (spontaneous) pregnancy rate in 
patients being placed on the IVF waiting list was 4.8% before the start of IVF 
treatment. This is comparable with our earlier investigation (Evers et al., 1998), in 
which 5.5% of women achieved a spontaneous pregnancy in the first 12 months on 
the waiting list. Evers et al. investigated treatment-independent pregnancy rates by 
comparing the pregnancy rate of patients on a waiting list for IVF/ICSI with 
pregnancy rates of nested controls after their first IVF/ICSI cycle. The 12-month 
cumulative pregnancy rate of the waiting-list patients was 76 of 1391 (5.5%): 2.4% 
for tubal factor infertility, 5.9% for unexplained subfertility, and 6.6% for male 
factor infertility. More than 75% of the pregnancies in the subgroup of unexplained 
subfertility occurred in the first three months after beging wait-listed. 
Of the 54 couples censored for reasons other than spontaneous pregnancy in our 
study, four became pregnant: two (8.7%) after active censoring and two (6.5%) 
after passive censoring. Actively censored couples are considered to have poorer 
pregnancy chances than passively censored couples (Stolwijk et al., 1996; Olivius et 
al., 2002). An earlier analysis by our centre in couples dropping out after the start 
of IVF treatment could not corroborate this assumption, showing a pregnancy rate 
of 25% (95%CI: 14 – 40%) in actively censored couples and 6% (95%CI: 2 – 18%) 
in passively censored couples (Verhagen et al., 2008). The suggestion was made 
that a reason for the higher pregnancy rate in actively censored couples might be 
our center’s too strict criteria for active censoring. Another reason might be that 
passively censored couples decide to refrain from actively pursuing conception (at 
least for some time) after having left the IVF program (Verhagen et al., 2008). In 
our present study, the pregnancy rate of actively and passively censored patients 
was comparable with our earlier findings (Verhagen et al., 2008). 
The high frequency of pregnancies as a reason for dropout is an especially 
important factor to be considered in counselling couples before placing them on a 
waiting list for IVF. The pregnancies mostly occurred in couples diagnosed with 
unexplained subfertility and in patients younger than 35 years. Most pregnancies 
occurred within three months after the couple was placed on the waiting list. 
Waiting list placement may relieve the couple’s stress, which may play an important 
psychological role in conceiving. Stress relief and its presumed positive influence on 
	
pregnancy chances were suggested by Eijkemans et al. and Evers et al. (Evers et al., 
1998; Eijkemans et al., 2008). Smeenk et al. investigated state anxiety and 
depression scales and concluded that passive dropout was related to psychological 
factors (Smeenk et al., 2004). Better counselling as well as more surveillance and 
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psychological burdens.  
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success rates because after failed treatment it is a challenge for couples to make 
new decisions (Sydsjö et al., 2005). To patients, IVF treatment might seem to offer 
unlimited treatment possibilities, and this may prevent couples from adopting the 
cognitive coping strategies they need for accepting childlessness. A well-marked 
treatment end point may be an important aspect of a couple’s adaptation process to 
definitive childlessness (Verhaak et al., 2007). Because ours was essentially an 
observational study, we did not evaluate stress and anxiety before and after putting 
a patient on the waiting list. Further research should be focused on the therapeutic 
effect of being put on the waiting list (stress relief), for example, when doing cost-
benefit comparisons for IVF treatment. 
Recently Eijkemans et al. reported on 5962 patients representing all patients on the 
IVF waiting list between January 2002 until December 2003 in the Netherlands 
Eijkemans et al., 2008). Initially, 6221 patients were included, and 259 (4.2%) 
were lost to follow-up observation. For 16% of the patients, values were missing for 
one or more characteristics. At the last date of follow-up evaluation, 718 patients 
had not become pregnant or started IVF, with a median follow-up period of 6.2 
months. Their conclusion was that spontaneous pregnancy chances were low for 
subfertile couples, but that it is possible to identify prognostic factors (e.g. 
unexplained subfertility or young age) for ‘higher chance’ couples. It can be cost-
effective to postpone IVF treatment in these couples (Eijkemans et al., 2008).  
Our study differs from theirs in that ours is based on a smaller group and focuses on 
just one clinic rather than being nationwide. However, our report is based on a 
longer period (between June 2000 and July 2003) and our follow-up duration was 
up to 46 months for the program dropouts. Furthermore, we achieved almost 
complete follow-up with patients who had dropped out, compared with the 
Eijkemans study’s loss to follow-up of 4.2% and up to 16% of patients with missing 
39426 Dongen, Angelique.indd   33 14-03-16   12:21
34
Chapter 2
	
values. Moreover, we not only took pregnancy rates into account but also analysed 
reasons for dropping off the waiting list. 
Dropout in the IVF program compromises cumulative pregnancy rates (Verberg et 
al., 2008). For the patients’ sake as well, dropping out should be minimized to give 
couples an optimal cumulative chance of conceiving. Verberg et al. concluded that 
reducing the dropout rate is necessary to improve efficacy and cost effectiveness of 
IVF treatment (Verberg et al., 2008). Recognition of factors that cause dropping out 
can help with developing interventions to prevent dropout.  
An important proportion of dropouts on the waiting list for IVF are explained by the 
occurrence of spontaneous pregnancies. A psychological component might play a 
role. Critical reflection on a couple’s indication for IVF before placing them on the 
waiting list will most likely diminish these dropouts. One might consider 
postponing IVF treatment in high chance groups such as patients under 35 years of 
age with unexplained subfertility. Better surveillance and support of couples can 
prevent dropping out for reasons of passive censoring. This can be done by offering 
patients professional support and by developing their cognitive coping strategies. 
Preventing dropout or preventing couples with a high chance of dropping out from 
being put on the waiting list may shorten the waiting list and improve patient flow. 
Furthermore, information about spontaneous pregnancies and patients’ choices 
during the waiting-list period could help clinicians in counselling couples who are 
starting IVF treatment. 
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Abstract 
 
Study question: Is patient screening for emotional risk factors before starting IVF 
treatment feasible? 
Summary answer: Introduction of screening for emotional risk factors by a 
validated instrument (SCREENIVF) in couples treated by IVF or ICSI is feasible, 
indicated by a moderate to high and stable uptake rate, a high acceptance of the 
process of SCREENIVF, and a high acceptability of the presented risk profile by the 
patients. 
What is known already: SCREENIVF is a validated screening tool to identify 
women at risk for emotional maladjustment preceding the start of their IVF/ICSI 
treatment.  
Study design, size and duration: This was a prospective cohort study, 
including data of two cohorts of patients (304 and 342 patients), with duration of 3 
months per cohort. In the first cohort we sent a process evaluation to 210 patients 
that was completed by 91 patients. 
Participants/materials, setting and methods: All 304 patients (male and 
female) that started IVF/ICSI between 1 December 2009 and 28 February 2010 in 
our tertiary IVF clinic were eligible. The uptake rate of SCREENIVF was assessed as 
the response rate to the screening questionnaire. One year later, we re-assessed the 
uptake rate in 342 new patients to assess the stability of the uptake rate. A non-
responder assessment in patients who did not complete SCREENIVF was carried 
out. Finally, patients’ characteristics and their experiences with SCREENIVF as well 
as their subsequent actions were assessed by an additional process evaluation 
questionnaire sent some months later to 210 patients.  
Main results and the role of chance: The uptake rate of SCREENIVF was 
78%-80%. One-third of the responders were found to be at risk for emotional 
maladjustment, which was comparable with previous studies using SCREENIVF. Of 
27 non-responders to SCREENIVF, 41% explained non-response by ‘no actual need 
for psychological help’ and 19% forgot to complete the screening. The response rate 
to the process evaluation was 43% (n=91). Of these, 90% found the screening was 
useful, and almost all patients were positive about the SCREENIVF questionnaire. 
Furthermore, 93% recognized themselves in the risk profile based on SCREENIVF. 
Of the patients at risk, 21% reported planning to seek professional help, but 46% of 
the at-risk patients experienced travelling distance as an obstacle to seek 
psychological help. We concluded that screening patients for emotional risk factors 
	
is feasible. In future, psychosocial care offered by the Internet may be promising in 
meeting the barrier of travelling distance. 
Limitations, reasons for caution: People were asked to fill in SCREENIVF for 
clinical purposes pretreatment. There might be a selection bias in the people who 
did not fill in SCREENIVF, which may be due to already existing psychological 
problems or language problems. The low response rate of the process evaluation 
questionnaire and the mono-centre evaluation may be confounders and may have 
influenced our analysis opportunities.  
Wider implications of the findings: The generalizability of this data is 
unknown with respect to other ethnic groups. Furthermore, more research is 
needed to evaluate psychosocial factors in male partners. Future research should 
also focus on the barriers and facilitators for help-seeking behaviour.  
 
 
Keywords: infertility, assisted reproduction, psychology, process evaluation, 
screening 
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Introduction 
 
Infertility is defined as a disease of the reproductive system resulting in a failure to 
achieve a clinical pregnancy after 12 months or more of regular unprotected sexual 
intercourse (Zegers-Hochschild et al., 2009). Worldwide ~72-80 million people 
suffer from involuntary childlessness (Nachtigall, 2006; Boivin et al., 2007). One of 
the treatment options is in vitro fertilization (IVF); defined as an assisted 
reproductive technology (ART) procedure that involves extracorporeal fertilization 
(Zegers-Hochschild et al., 2009). In 2006 in Europe, 359 110 ART cycles were 
annually performed among a total population of 422.5 million (de Mouzon et al., 
2010). For IVF, the clinical pregnancy rate was on average 29% and for intra 
cytoplasmic sperm injection (ICSI) it was 30% (de Mouzon et al., 2010). 
Since ARTs such as IVF and ICSI are complex, time-consuming and stressful, they 
have been the subjects of many studies investigating emotional distress (Schmidt, 
2006; Verberg et al., 2008; Brandes et al., 2009; Boivin et al., 2011). During 
infertility and fertility treatment, many IVF/ICSI patients report experiencing minor 
to severe emotional distress (Verhaak et al., 2005). Almost 30% of the couples drop 
out of treatment mainly because of psychological burden (Olivius et al., 2004; 
Rajkhowa et al., 2006; Brandes et al., 2009; Domar et al., 2010; Boivin et al., 2011). 
Six months after the last unsuccessful IVF/ICSI treatment, ~20% of women 
experience such severe anxiety or depression that it interferes with daily life 
(Verhaak et al., 2005), indicating that a substantial number suffer from emotional 
maladjustment, although the majority seems to be able to adjust. 
Therefore, it is important to identify patients at risk for emotional problems in time, 
ideally before starting their fertility treatment, which would enable clinicians to 
offer them additional psychosocial care and to anticipate to this emotional 
vulnerability in their consultation. This might prevent emotional problems in 
IVF/ICSI patients, and might be a valuable asset to standard care in fertility 
treatment (Schmidt, 2006; Verhaak et al., 2010). 
Verhaak et al. (2010) developed and validated a short questionnaire consisting of 
34 items, which is named SCREENIVF and is aimed at identifying women at risk for 
emotional maladjustment before the start of their IVF/ICSI treatment. SCREENIVF 
is based on five previously identified risk factors (Verhaak et al., 2005): (i) 
pretreatment anxiety; (ii) pretreatment depression; (iii) helplessness regarding 
fertility problems; (iv) less acceptance regarding fertility problems; (v) lack of social 
support. When patients score above the cut-off for clinically relevant problems on 
one of these risk factors, they were indicated as ‘at risk’. Patients at risk were 
	
invited to seek additional psychosocial support (Verhaak et al., 2010). Earlier 
research investigated to what extent SCREENIVF showed a predictive value for the 
emotional maladjustment of women. This research found that SCREENIVF 
identified 34% of the women as at risk at pretreatment with a sensitivity of 69% 
and a specificity of 77% (Verhaak et al., 2010). 
In September 2009, our tertiary IVF clinic introduced SCREENIVF as a new 
intervention in daily clinical care. By introducing SCREENIVF, we aimed to 
facilitate identification of risk groups for emotional maladjustment in time, and to 
tailor offering of additional psychosocial support to the risk profile of patients. To 
assess the uptake rate of such a new intervention and to give us the opportunity to 
optimize its implementation, a process evaluation can be helpful (Hulscher et al., 
2003). A process evaluation consists of the identification of key processes and 
outcome(s) of an intervention by investigating the actual exposure to the 
intervention and the experiences of the people exposed (Hulscher et al., 2003). A 
subsequent step is the identification of mechanisms by which the intervention will 
lead to improved outcome and the identification of barriers and facilitators for 
application. Finally, these results can give insight into the best achievable 
implementation strategy to improve daily use of this intervention (Campbell et al., 
2007). 
Therefore in this study, we aimed to evaluate the introduction of SCREENIVF by 
assessing its uptake rate, and by performing a process evaluation of the 
administration itself and the results of SCREENIVF. Based on these results, we aim 
to suggest improvement mechanisms by overcoming barriers and using facilitators 
for implementation. 
 
 
Material and Methods 
 
Study design 
In this prospective cohort study we used three ways of collecting data to evaluate 
the implementation of SCREENIVF. 
 
1. Uptake rate 
We analysed the uptake rate of SCREENIVF in a first cohort of patients who started 
their IVF treatment a few months after introducing SCREENIVF (cohort 1). To 
assess the stability of the uptake rate, SCREENIVF was administrated in a second 
cohort a year later (cohort 2). 
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2. Non-responders (cohort I) 
We analysed the characteristics of the non-responders and their reasons for non-
response. 
 
3. Process evaluation (cohort I) 
For the first cohort, we performed a process evaluation. In this process evaluation, 
we described patients’ characteristics, how patients evaluate the administration, the 
results of SCREENIVF and the actions patients undertook following the results of 
SCREENIVF. 
 
SCREENIVF 
For details of the content of SCREENIVF we refer to Verhaak et al. (2010). 
SCREENIVF is a short questionnaire consisting of 34 items aimed at identifying 
women at risk for emotional maladjustment before the start of their IVF/ICSI 
treatment. The SCREENIVF questionnaire consists of 10 items assessing state 
anxiety based on a short version of Spielberger State and Trait Anxiety Inventory 
(Spielberger, 1983); 7 items assessing depression based on the short Beck 
depression Inventory (Beck et al., 1997), 6 items assessing helplessness and 6 items 
assessing lack of acceptance, both from the Illness Cognition Questionnaire for IVF 
patients (Evers et al., 2001; Verhaak et al., 2005); and 5 items assessing perceived 
social support derived from the Inventory of Social Involvement (Van Dam-Baggen 
and Kraaimaat, 1992). Use of SCREENIVF results in an at risk score when the score 
on one of the five risk factors shows clinically relevant problems. The cut-off of the 
depression scale is four or higher. The cut-off for the short version of the STAI was 
based on scores of 1 SD above the mean in a Dutch norm group consisting of 
women: score 24 and above. The cut-off scores for the scores of helplessness, 
acceptance and social support are 14 and above for helplessness, 11 and less for 
acceptance and 15 and less for social support (based on 1 SD above or below the 
mean scores of IVF patients in a previous study; Verhaak et al., 2010). 
 
Setting and participants 
This study was performed at a university hospital (Radboud University Nijmegen 
Medical Centre) in a medium-sized city in the Netherlands. SCREENIVF was 
implemented in daily care from September 2009. In the first cohort, we included all 
patients (male and female) who started their first IVF/ICSI cycle between 1 
December 2009 and 28 February 2010 in our tertiary IVF clinic (n=304). In the 
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2. Non-responders (cohort I) 
We analysed the characteristics of the non-responders and their reasons for non-
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3. Process evaluation (cohort I) 
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we described patients’ characteristics, how patients evaluate the administration, the 
results of SCREENIVF and the actions patients undertook following the results of 
SCREENIVF. 
 
SCREENIVF 
For details of the content of SCREENIVF we refer to Verhaak et al. (2010). 
SCREENIVF is a short questionnaire consisting of 34 items aimed at identifying 
women at risk for emotional maladjustment before the start of their IVF/ICSI 
treatment. The SCREENIVF questionnaire consists of 10 items assessing state 
anxiety based on a short version of Spielberger State and Trait Anxiety Inventory 
(Spielberger, 1983); 7 items assessing depression based on the short Beck 
depression Inventory (Beck et al., 1997), 6 items assessing helplessness and 6 items 
assessing lack of acceptance, both from the Illness Cognition Questionnaire for IVF 
patients (Evers et al., 2001; Verhaak et al., 2005); and 5 items assessing perceived 
social support derived from the Inventory of Social Involvement (Van Dam-Baggen 
and Kraaimaat, 1992). Use of SCREENIVF results in an at risk score when the score 
on one of the five risk factors shows clinically relevant problems. The cut-off of the 
depression scale is four or higher. The cut-off for the short version of the STAI was 
based on scores of 1 SD above the mean in a Dutch norm group consisting of 
women: score 24 and above. The cut-off scores for the scores of helplessness, 
acceptance and social support are 14 and above for helplessness, 11 and less for 
acceptance and 15 and less for social support (based on 1 SD above or below the 
mean scores of IVF patients in a previous study; Verhaak et al., 2010). 
 
Setting and participants 
This study was performed at a university hospital (Radboud University Nijmegen 
Medical Centre) in a medium-sized city in the Netherlands. SCREENIVF was 
implemented in daily care from September 2009. In the first cohort, we included all 
patients (male and female) who started their first IVF/ICSI cycle between 1 
December 2009 and 28 February 2010 in our tertiary IVF clinic (n=304). In the 
second cohort we included all patients who started their first IVF/ICSI cycle 
	
between 1 November 2010 and 31 January 2011 (n=342). Figure I shows a 
timeline to illustrate the chronology. All patients were eligible when they had an 
indication for IVF or ICSI treatment according to the IVF guideline formulated by 
the Dutch Society for Obstetrics and Gynaecology (NVOG, IVF guideline, 
www.nvog.nl), and were about to start their first cycle of a new IVF or ICSI 
treatment. This means that patients had not any IVF/ICSI treatment before, or that 
they were about to start a new IVF/ICSI treatment after achieving a successful 
pregnancy. 
 
 
Figure 1: timeline of the study 
 
September 2009:
introduction of 
SCREENIVF
December 1st 2009 – 
February 28th 2010:
- uptake rate
- process evaluation
- non-responders
November 1st 2010 – 
January 31th 2011:
uptake rate
 
 
As part of their daily care, all patients received the SCREENIVF questionnaire with 
an introduction letter by mail between 1 and 3 months before the start of their 
IVF/ICSI treatment. In this introduction letter, patients were asked to complete 
SCREENIVF for clinical purposes. After returning the completed questionnaire, they 
received their results by mail, and patients at risk were sent an additional letter to 
offer them psychosocial care. 
In the Netherlands, IVF and ICSI are performed in 13 licensed hospitals. Hospitals 
without a licence can initiate and monitor the stimulation phase and refer to a 
licensed hospital for both oocyte retrieval and embryo transfer (satellite clinics) or 
for embryo transfer alone (transport clinics). The costs of the first three fresh IVF or 
ICSI cycles are currently reimbursed by the national healthcare system. In 2010, a 
total of 16 898 IVF and ICSI cycles were performed (Smeenk and Kremer, 2011). 
 
Outcome measures 
1. Uptake rate 
We assessed the uptake rate and the percentage of patients at risk for emotional 
maladjustment according to SCREENIVF in both cohorts, separated by gender. The 
uptake rate was determined as the percentage of patients who returned SCREENIVF 
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of the total of patients who were sent SCREENIVF (i.e. all patients on the IVF 
waiting list). 
 
2. Non-responders (cohort I) 
Among the non-responders, we assessed what their reasons for non-response were 
and what the differences in background characteristics were between patients 
responding and not responding to SCREENIVF. 
 
3. Process evaluation (cohort I) 
For the first cohort, we performed a process evaluation. We assessed how patients 
evaluated the administration of SCREENIVF and the results they received, in terms 
of readability, recognition of the outcome and perceived usefulness of the results. In 
addition, we described the actions patients undertook after getting the results of the 
SCREENIVF questionnaire, who contacted a psychosocial counsellor, and which 
barriers they experienced when seeking psychosocial help.  
 
Data collection 
 
1. Uptake rate 
The uptake rate of SCREENIVF was assessed as the response rate to the screening 
questionnaire by analysing the SCREENIVF database where the results of the 
screening were collected, and comparing this with the list of patients who were sent 
SCREENIVF. All patients, both partners, who were placed on the IVF waiting list 
were sent a SCREENIVF questionnaire. All patients were part of a couple, because 
single parenthood is not supported in our clinic. We assessed the at-risk rate 
according to the cut-off levels defined by Verhaak et al. (2010). Patients who did 
not send back SCREENIVF were considered as the non-responders. In the second 
cohort, a year later, we re-assessed the uptake rate and percentage at risk to 
evaluate if this uptake rate was stable after the introduction of SCREENIVF in daily 
clinical practice in September 2009. 
 
2. Non-responders (cohort I) 
Among the non-responders we performed a telephone survey, in which we 
investigated the same background characteristics as well as the reasons for not 
returning the screening questionnaire. This was a standardized questionnaire 
performed by one interviewer. 
 
	
3. Process evaluation (cohort I) 
Finally, we performed a process evaluation in May 2010 by sending a process 
evaluation questionnaire to all patients who returned SCREENIVF before 30 April 
2010. This questionnaire was divided into three parts. First, we measured 
demographic factors, such as ethnic background, religion and educational level. In 
this part, we also measured fertility-related background characteristics, such as 
indication for IVF/ICSI, duration of fertility problems and if they had had a previous 
child or not. Subsequently, we evaluated patients’ experiences with the counselling 
performed by their clinician and their cognitions with respect to usefulness, 
readability and user friendliness of SCREENIVF. Examples of questions were: “The 
language used in the SCREENIVF questionnaire was… (very easy; easy; normal; 
hard; very hard)” or “the instruction for SCREENIVF was… (very clear; clear; a bit 
clear; unclear; very unclear)”. Finally, we asked a number of questions about 
attitude towards psychosocial help and help seeking behaviour, for examples see 
table 6. Items were scored on a five-point Likert scale (from 1= very often indeed 
to 5= not at all). Using this five-level scale gives a positive or negative response to a 
statement, with the possibility to give nuances and without forcing people to a 
choice. For the analysis we combined the upper two (= agree) and lower two (= 
disagree), and coded the middle answer as neutral (Norman, 2010).  
 
Analysis 
We analysed the data using SPSS 16.0 and performed descriptive statistics, t-tests, 
parametric and non-parametric tests, χ 2 test, McNemar tests and Fisher’s exact test 
where appropriate. A p-value lower than 0.05 was determined as statistically 
significant. 
 
 
Results 
 
1. Uptake rate 
The uptake rate of SCREENIVF in cohort 1 between 1 December 2009 and 28 
February 2010 was 78% (236 out of 304 patients returned the completed screening 
questionnaire), and 78 responders were found at risk (33%, 95% confidence 
interval [CI]: 27 – 39%). In cohort 2, a year later, the uptake rate was 80% (274 
out of 342 patients returned the screening questionnaire), and 81 of the responders 
were at risk for emotional maladjustment (30%; 95%CI: 24 – 35%). The uptake, 
the risk rates and the sub scores of SCREENIVF for cohort 1, can be found in figure 
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of the total of patients who were sent SCREENIVF (i.e. all patients on the IVF 
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hard; very hard)” or “the instruction for SCREENIVF was… (very clear; clear; a bit 
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attitude towards psychosocial help and help seeking behaviour, for examples see 
table 6. Items were scored on a five-point Likert scale (from 1= very often indeed 
to 5= not at all). Using this five-level scale gives a positive or negative response to a 
statement, with the possibility to give nuances and without forcing people to a 
choice. For the analysis we combined the upper two (= agree) and lower two (= 
disagree), and coded the middle answer as neutral (Norman, 2010).  
 
Analysis 
We analysed the data using SPSS 16.0 and performed descriptive statistics, t-tests, 
parametric and non-parametric tests, χ 2 test, McNemar tests and Fisher’s exact test 
where appropriate. A p-value lower than 0.05 was determined as statistically 
significant. 
 
 
Results 
 
1. Uptake rate 
The uptake rate of SCREENIVF in cohort 1 between 1 December 2009 and 28 
February 2010 was 78% (236 out of 304 patients returned the completed screening 
questionnaire), and 78 responders were found at risk (33%, 95% confidence 
interval [CI]: 27 – 39%). In cohort 2, a year later, the uptake rate was 80% (274 
out of 342 patients returned the screening questionnaire), and 81 of the responders 
were at risk for emotional maladjustment (30%; 95%CI: 24 – 35%). The uptake, 
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2. Comparing both cohorts, there were no differences in uptake rate and at-risk rate 
for men and women. In the total group (cohort 1 and cohort 2) as well as in both 
cohorts separately more female than male were at risk (chi-square for total group 
17.6, p<0.001; for cohort 1 chi-square 4.9, p<0.03; for cohort 2 chi-square 12.8, 
p<0.001). The differences in results of SCREENIVF between cohort 1 and cohort 2, 
and separated by gender can be found in table 1. 
 
 
Table 1: differences in frequencies between cohort 1 and cohort 2 in the results of SCREENIVF 
 
 Cohort 1 
(n=304) 
Cohort 2 
(n=342) 
p-value 
(comparing cohort 1 versus 2) 
Male 50% 50% 1.00 
Uptake rate (%) 
Male 
Female 
236 (78%) 
118 (50%) 
118 (50%) 
274 (80.1%) 
137 (50%) 
137 (50%) 
0.44 
 
At risk (%)a 
Male 
Female 
78 (33%) 
31 (26.3%) 
47 (39.8%) 
81 (30%) 
27 (19.7%) 
54 (39.4%) 
0.44 
 
 
Subscores (%) 
- Anxiety 
Male 
Female 
- Depression 
Male 
Female 
- Helplessness 
Male 
Female 
- Less acceptance 
Male 
Female 
- Lack of social support  
Male 
Female 
 
34 (14.4%)b 
8 (6.8%) 
26 (22.0%) 
10 (4.2%) 
3 (2.5%) 
7 (5.9%) 
55 (23.3%)b 
21 (17.8%) 
34 (28.8%) 
13 (5.5%) 
4 (3.4%) 
9 (7.6%) 
21 (8.9%) 
9 (7.6%) 
12 (10.2%) 
 
12 (4.4%)b 
2 (1.5%) 
10 (7.3%) 
1 (0.4%) 
0 (0.0%) 
1 (0.7%) 
62 (22.6%)b 
19 (13.9%) 
43 (31.4%) 
13 (4.7%)b 
2 (1.5%) 
11 (8.0%) 
15 (5.5%) 
8 (5.8%) 
7 (5.5%) 
 
<0.01c 
 
 
<0.01c 
 
 
0.86 
 
 
0.70 
 
 
0.13 
a In total group (n=510) as well as in both cohorts, more female than male are at risk; in total group chi-square = 17.6, 
p<0.001. 
b There were significant differences between male and female in % at risk in this cohort for this risk factor (McNemar 
test). 
c There was a significant difference between cohort 1 and cohort 2 on the % patients at risk (chi-square test). 
  
	
Figure 2: uptake rate for SCREENIVF cohort 1, 2010. The results of the process evaluation are shown in grey. 
 
Cohort 1:
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SCREENIVF
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responders
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26 returned 
SCREENIVF after 
data-analysis
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2. Non-responders (cohort 1) 
The response rate of the telephone survey among non-responders was 40% (27 
patients out of 68 non-responders), 41% of whom explained their non-response by 
claiming there was no actual need for psychological help, while 19% forgot to 
complete the screening (table 2).  
 
	
Table 2: reasons for non-response (all data concerning cohort 1) 
 
Reasons for non-response 
(n=27, non-responders to SCREENIVF) 
percentage 
No need for psychosocial help 40.7 
I forgot 18.5 
I did not receive SCREENIVF 11.1 
Stopped the treatment 11.1 
Already filled in SCREENIVF in another treatment period 7.4 
Questions were too personal 4.2 
Only meant for my partner 4.2 
I did sent it back 4.2 
 
 
39426 Dongen, Angelique.indd   48 14-03-16   12:21
Screening for emotional risk factors before IVF
49
3
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We compared the background characteristics of the 91 responders (out of 210) who 
answered the process evaluation questionnaire with the 27 non-responders of 
SCREENIVF (out of 68) who answered the telephonic review. Compared with 
responders, non-responders significantly more often had had an IVF treatment in a 
previous period (42% versus 21%, p<0.05), had a non-Dutch ethnic background 
(26% versus 9%, p<0.05), were Muslim (15% versus 4%, p=0.05) or had no 
religion (54% versus 30%, p<0.05) and were less likely to be Christian (31% versus 
61%, p<0.05) (table 3). Responders were more likely to be childless than non-
responders (69% versus 44%, p<0.05). 
 
 
Table 3: background characteristics non-responders vs. responders (2010 data; the data concerned cohort a and were 
obtained from the process evaluation) 
 
 Non-responders (n=27) Responders (n=91) p-value 
Median duration of infertility (years) 4.0 3.0 0.07 
Previous IVF/ICSI treatment  11 (40.7%) 19 (20.9%) 0.03 
Non-Dutch ethnic background (%) 7 (25.9%) 8 (8.8%) 0.02 
Level of education 
- Low (%) 
- Medium (%) 
- High (%) 
 
4 (17.4%) 
6 (26.1%) 
13 (56.5%) 
 
22 (26.3%) 
28 (30.8%) 
41 (45.1%) 
 
0.49 
0.66 
0.33 
Religion 
- Christian (%) 
- Muslim (%) 
- No religion (%)  
- Other (%) 
 
8 (30.7%) 
4 (15.4%) 
14 (53.8%) 
0 (0.0%) 
 
55 (61.8%) 
4 (4.5%) 
27 (30.3%) 
3 (3.4%) 
 
0.01 
0.05 
0.03 
0.35 
Childless (%) 12 (44.4%) 63 (69.2%) 0.03 
 
 
3. Process evaluation questionnaire (cohort 1) 
 
Patients’ characteristics 
The process evaluation questionnaire was sent to 210 people who had responded to 
SCREENIVF. There were 26 patients who were not eligible for the process 
evaluation because they sent the SCREENIVF questionnaire back after our mailing 
of the process evaluation questionnaire. Of the 210 patients, 43% completed the 
process evaluation questionnaire (n=91). Comparing the patients’ characteristics 
between those who were and were not at risk, we only found that patients with a 
non-Dutch ethnic background (21% versus 5%, p <0.05), especially those who had 
indicated they had a Muslim religion (17% versus 0%, p <0.05), were significantly 
more at risk for emotional maladjustment (table 4).  
 
	
Table 4: background characteristics responders SCREENIVF (the data concerned cohort 1 and were obtained from the 
process evaluation) 
 
 At risk (n=24) Not at risk (n=67) p-value 
Males (%) 10 (41.7%) 33 (49.3%) 0.41 
Median age in years 
- Male 
- Female 
 
36.5 
31.0 
 
37.0 
34.0 
 
0.81 
0.21 
Median duration of infertility (years) 3.3 3.0 0.32 
Previous IVF/ICSI treatment  5 (20.8%) 14 (20.9%) 1.00 
Non-Dutch ethnic background (%) 5 (20.8%) 3 (4.5%) 0.03 
Level of education 
- Low (%) 
- Medium (%) 
- High (%) 
 
7 (29.2%) 
6 (25.0%) 
11 (45.8%) 
 
15 (22.4%) 
22 (32.8%) 
30 (44.8%) 
 
0.51 
0.48 
0.93 
Religion 
- Christian (%) 
- Muslim (%) 
- No religion (%)  
- Other (%) 
 
12 (50.0%) 
4 (16.0%) 
6 (25.0%) 
2 (8.3%) 
 
43 (64.2%) 
0 (0.0%) 
21 (31.3%) 
1 (1.5%) 
 
0.19 
0.00 
0.53 
0.11 
Childless (%) 18 (75.0%) 45 (67.2%) 0.46 
The bolded values means a p-value < 0.05 
 
 
Evaluation of SCREENIVF questionnaire 
Most people (90%) thought that screening was useful. Even more people (95%) 
reported that filling in SCREENIVF was not unpleasant. The mean time needed to 
fill in SCREENIVF was 10 min and 40 s, which most patients thought was not too 
long. The results concerning the experiences can be found in table 5. A large 
proportion of the patients reported that the result of the screening was not 
explained (68%) to them by their medical clinician. Almost all patients (93%) 
agreed with the results of the screening, the four people who did not were all found 
to be at risk. T-tests for independent samples showed no differences between men 
and women regarding the answers to these questions (t values not presented). 
 
Action of patients 
We assessed barriers for seeking psychological help in all patients, at risk and not at 
risk (table 6 and 7). Five (21%) of the 24 patients at risk reported planning to seek 
professional help; three of them already received psychological help. Of the patients 
at risk, 46% experienced travelling distance as an obstacle to seek psychological 
help. T-tests for independent samples showed differences between men and women 
in planning to seek help; this is indicated in table 6 and 7 (t values not presented). 
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We compared the background characteristics of the 91 responders (out of 210) who 
answered the process evaluation questionnaire with the 27 non-responders of 
SCREENIVF (out of 68) who answered the telephonic review. Compared with 
responders, non-responders significantly more often had had an IVF treatment in a 
previous period (42% versus 21%, p<0.05), had a non-Dutch ethnic background 
(26% versus 9%, p<0.05), were Muslim (15% versus 4%, p=0.05) or had no 
religion (54% versus 30%, p<0.05) and were less likely to be Christian (31% versus 
61%, p<0.05) (table 3). Responders were more likely to be childless than non-
responders (69% versus 44%, p<0.05). 
 
 
Table 3: background characteristics non-responders vs. responders (2010 data; the data concerned cohort a and were 
obtained from the process evaluation) 
 
 Non-responders (n=27) Responders (n=91) p-value 
Median duration of infertility (years) 4.0 3.0 0.07 
Previous IVF/ICSI treatment  11 (40.7%) 19 (20.9%) 0.03 
Non-Dutch ethnic background (%) 7 (25.9%) 8 (8.8%) 0.02 
Level of education 
- Low (%) 
- Medium (%) 
- High (%) 
 
4 (17.4%) 
6 (26.1%) 
13 (56.5%) 
 
22 (26.3%) 
28 (30.8%) 
41 (45.1%) 
 
0.49 
0.66 
0.33 
Religion 
- Christian (%) 
- Muslim (%) 
- No religion (%)  
- Other (%) 
 
8 (30.7%) 
4 (15.4%) 
14 (53.8%) 
0 (0.0%) 
 
55 (61.8%) 
4 (4.5%) 
27 (30.3%) 
3 (3.4%) 
 
0.01 
0.05 
0.03 
0.35 
Childless (%) 12 (44.4%) 63 (69.2%) 0.03 
 
 
3. Process evaluation questionnaire (cohort 1) 
 
Patients’ characteristics 
The process evaluation questionnaire was sent to 210 people who had responded to 
SCREENIVF. There were 26 patients who were not eligible for the process 
evaluation because they sent the SCREENIVF questionnaire back after our mailing 
of the process evaluation questionnaire. Of the 210 patients, 43% completed the 
process evaluation questionnaire (n=91). Comparing the patients’ characteristics 
between those who were and were not at risk, we only found that patients with a 
non-Dutch ethnic background (21% versus 5%, p <0.05), especially those who had 
indicated they had a Muslim religion (17% versus 0%, p <0.05), were significantly 
more at risk for emotional maladjustment (table 4).  
 
	
Table 4: background characteristics responders SCREENIVF (the data concerned cohort 1 and were obtained from the 
process evaluation) 
 
 At risk (n=24) Not at risk (n=67) p-value 
Males (%) 10 (41.7%) 33 (49.3%) 0.41 
Median age in years 
- Male 
- Female 
 
36.5 
31.0 
 
37.0 
34.0 
 
0.81 
0.21 
Median duration of infertility (years) 3.3 3.0 0.32 
Previous IVF/ICSI treatment  5 (20.8%) 14 (20.9%) 1.00 
Non-Dutch ethnic background (%) 5 (20.8%) 3 (4.5%) 0.03 
Level of education 
- Low (%) 
- Medium (%) 
- High (%) 
 
7 (29.2%) 
6 (25.0%) 
11 (45.8%) 
 
15 (22.4%) 
22 (32.8%) 
30 (44.8%) 
 
0.51 
0.48 
0.93 
Religion 
- Christian (%) 
- Muslim (%) 
- No religion (%)  
- Other (%) 
 
12 (50.0%) 
4 (16.0%) 
6 (25.0%) 
2 (8.3%) 
 
43 (64.2%) 
0 (0.0%) 
21 (31.3%) 
1 (1.5%) 
 
0.19 
0.00 
0.53 
0.11 
Childless (%) 18 (75.0%) 45 (67.2%) 0.46 
The bolded values means a p-value < 0.05 
 
 
Evaluation of SCREENIVF questionnaire 
Most people (90%) thought that screening was useful. Even more people (95%) 
reported that filling in SCREENIVF was not unpleasant. The mean time needed to 
fill in SCREENIVF was 10 min and 40 s, which most patients thought was not too 
long. The results concerning the experiences can be found in table 5. A large 
proportion of the patients reported that the result of the screening was not 
explained (68%) to them by their medical clinician. Almost all patients (93%) 
agreed with the results of the screening, the four people who did not were all found 
to be at risk. T-tests for independent samples showed no differences between men 
and women regarding the answers to these questions (t values not presented). 
 
Action of patients 
We assessed barriers for seeking psychological help in all patients, at risk and not at 
risk (table 6 and 7). Five (21%) of the 24 patients at risk reported planning to seek 
professional help; three of them already received psychological help. Of the patients 
at risk, 46% experienced travelling distance as an obstacle to seek psychological 
help. T-tests for independent samples showed differences between men and women 
in planning to seek help; this is indicated in table 6 and 7 (t values not presented). 
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Discussion 
 
In this study, it is shown that the introduction of a validated screening 
questionnaire for emotional maladjustment, performed in women before the start of 
their first IVF treatment, in daily care is feasible. Also in men, for whom 
SCREENIVF is not completely validated yet, administration before start of the IVF 
treatment was feasible. Using SCREENIVF can help to identify patients at risk for 
emotional maladjustment in time to enable clinicians to offer additional 
psychosocial support. In addition, SCREENIVF provides patient feedback on their 
psychosocial risk profile, enabling them to become more aware of their 
maladjustment. This is one of the few studies reporting the implementation of a 
psychosocial intervention integrated in daily clinical practice. 
The response rate of SCREENIVF was around 78-80%, which is satisfactory. A 
screening instrument in cancer patients, the distress thermometer, had an uptake 
rate of ~50% (Tuinman et al., 2008). We found that one-third of the patients who 
filled in SCREENIVF are at risk for emotional maladjustment. This percentage is 
comparable with the results described by Verhaak et al. (2010) earlier. Analysis of 
sub-scores of the risk profile of the patients of cohort 1 and cohort 2 showed 
significant differences in scores on anxiety and depression. However, the total 
percentage of patients at risk in the two cohorts was not statistical different, in both 
cohorts, one-third of the patients. To explain these statistical differences in sub-
scores, we have to focus on differences in background variables and dropout rates 
between the cohorts, but this was beyond the focus of this implementation study. 
The most frequent reasons for non-response to SCREENIVF were “I have no need 
for psychological help” and “I forgot”. We expect to improve the response rate by 
offering better counselling about the aim of the SCREENIVF questionnaire by the 
physician and nurses, by improving our information sheet, and by sending 
reminders. Additional suggestions to facilitate the administration of the 
questionnaire are using the Internet and offering SCREENIVF in different 
languages. 
Our results show that according to SCREENIVF, patients with a non-Dutch ethnic 
background and/or a Muslim religious background are more vulnerable to 
psychosocial problems. Whether this is due to the content of SCREENIVF or to the 
cultural and religious background of this specific patient group is unclear. 
SCREENIVF was developed and validated in a Dutch cohort of subfertile patients; 
their background characteristics were not collected in the validation phase of 
SCREENIVF (Verhaak et al., 2010). Cultural and religious differences in cognitions 
	
about child wishes, parenthood and subfertility might explain the difference 
observed (Husain, 2000). In Islam, to have children is seen as a great blessing 
(Husain, 2000). Depending on the interpretation of the Qur’an, motherhood is 
believed to be the most important role for women and the perceived essence of 
women’s identity in Islamic culture (Husain, 2000). This might explain the higher 
SCREENIVF at risk scores in patients with a non-Dutch ethnic background and 
patients with a Muslim religion. 
The process evaluation questionnaire showed that the majority of patients screened 
as at risk for emotional maladjustment, but did not seek professional help. Only 5 of 
the 24 patients found at risk (21%) said they were planning to seek professional 
help. It is known that infertility patients rely primarily on their partner and family 
when distressed, rather than on formal support such as psychosocial counselling 
(Boivin et al., 1999). In our study, we found that travelling distance can be a barrier 
for seeking professional help. According to Boivin et al. (1999) more distressed 
patients fail to initiate contact with a counsellor because of practical concerns, and 
the focus should be on alternative ways of intervening with infertile people. 
Psychosocial care offered by Internet seems promising in lowering the threshold for 
psychosocial help by meeting the barrier of work or travelling distance (Sexton et 
al., 2010). Sexton et al. evaluated the efficacy of a web-based approach to providing 
a cognitive behavioural intervention. There was a significant decline in general 
stress, but no significant improvement of infertility-specific stress. In addition, in 
2010, Haemmerli et al. (2010) evaluated an Internet-based support tool for infertile 
patients. This intervention showed a significant reduction in the depression level of 
clinically distressed and depressed infertile patients. The treatment was positively 
evaluated by the patients. Based on this, Internet-based interventions seem 
promising in supporting infertile patients especially in patients suffering from 
clinical relevant levels of distress and depression. This is in line with the recent 
discussion about practical interventions to reduce fertility-related burdens to focus 
on the risk groups of patients and to adjust interventions to patient’s risk profiles 
(Boivin et al., 2012). Further research is necessary to find out how to realize a 
better fit between psychosocial vulnerability of patients and the availability of 
additional support, in terms of screening, tailored care and counselling.  
Unfortunately, because of the low response rate of the process evaluation 
questionnaire, differences in the results of the process evaluation between men and 
women could only be interpreted cautiously. 
SCREENIVF is developed and validated in women to identify emotional 
maladjustment before the start of the IVF/ICSI treatment. We administered 
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SCREENIVF in men too, in order to be able to also address the question of 
feasibility in men. Regarding the validation of SCREENIVF, which was not the focus 
of this study, we could say that SCREENIVF consists of five subscales that are 
individually validated for men as well as women (Spielberger, 1983; Van Dam-
Baggen and Kraaimaat, 1992; Beck et al., 1997; Evers et al., 2001; Verhaak et al., 
2005). The men identified as ‘ at risk’ on SCREENIVF showed relevant problems on 
the different subscales, indicating psychosocial vulnerability. However, to date, in 
men before the IVF/ICSI treatment, there is no validation for the total at risk score 
on SCREENIVF. This needs to be addressed in a future study. From the literature, it 
is clear that men and women react differently to the diagnosis and treatment of 
infertility (Wischmann et al., 2009). Also the degree of emotional distress can be 
different. The psychological distress on the part of the women seems to be the 
strongest factor in the decision to seek psychological help (Wischmann et al., 2009). 
Differences in psychological distress and help-seeking behaviour between men and 
women should also be a focus of further research. This could provide information 
about how to design psychosocial care to different needs of both men and women. 
Another limitation of the study is the low response rate of the process evaluation 
questionnaire, 43%. Therefore, we do not know for example what the help-seeking 
behaviour of the 119 non-responders to the process evaluation questionnaire is. 
Despite this response rate, we were able to evaluate our screening instrument and 
to make suggestions for improvement. We did not take the results of the IVF 
treatment into account; there can be a bias when people who did achieve a 
pregnancy were more eligible to return the process evaluation questionnaire, and 
the results of the IVF treatment could have influenced their answers. On the 
contrary, patients who do not achieve a pregnancy could have been more 
vulnerable for emotional maladjustment and could have been more willing to fill in 
the process evaluation questionnaire. The pregnancy rate after treatment should be 
taken into account in future studies. Also, we were not able to evaluate all 
responders due to practical reasons. Furthermore, SCREENIVF was only available in 
Dutch and it is possible that non-Dutch patients did not fill in SCREENIVF. 
Therefore, a selection bias cannot be excluded. We do not know what the size of 
this group is or what percentage of these patients would have been at risk for 
emotional maladjustment. We do not expect this group to be very large and 
influencing our results, because most patients eligible for IVF treatment understand 
the Dutch language. By offering SCREENIVF in other languages, however, we aim 
to respond to this selection bias in future. Finally, we performed the screening in 
only one Dutch centre. We do not know what the international application of this 
	
screening instrument will be; neither do we know how the introduction of 
SCREENIVF in another Dutch centre will go. Our centre offers various fertility 
treatments in a large general population. Therefore, we expect the results to be 
equal in other Dutch, or European, centres. 
One of the aims of the implementation of SCREENIVF was also to provide health 
care professionals with information about the risk profile of the patients. This 
enables them to tailor their interventions to vulnerability of the patients. Highly 
distressed patients could be advised more strongly to seek additional support. In 
daily care, the clinician could be more aware of the patient and their vulnerability, 
which enables them to tailor care. Future research has to point out how physicians 
evaluate the use of a psychosocial screening instrument such as SCREENIVF and 
how they use the results of the screening in their daily clinical practice. 
One strong aspect of this study is the evaluation of the integration process of a 
screening instrument within daily clinical care. Also, the availability of data of a 
large group of screened patients, both men and women, makes it possible to 
evaluate the long-term effects of screening. 
In summary, this study showed the process evaluation of the introduction of 
screening patients for emotional risk factors, and concluded that it is feasible. 
Considering the actions of the patients, travelling distance can be a barrier for 
patients seeking psychological help. Further research is needed to investigate if 
psychosocial care offered by the Internet can meet this barrier of travelling distance 
and diminish symptoms of distress or depression. Internet-based interventions 
should be compared with regular care and vis-a-vis psychosocial therapy to prove 
the effect and to show if these interventions can replace or serve as a supplement to 
usual care. Further research should be focused on barriers and facilitators for help-
seeking behaviour taking differences between ethnic groups and men and women 
into account. This would increase the possibility of tailoring interventions to the 
needs of the individual patients, and their risk profile, their cultural background 
and their gender. 
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Abstract 
 
In this study, we investigated the relationship between psychosocial factors assessed 
pre-treatment and the discontinuation of in vitro fertilisation (IVF) treatment after 
one year. 
A cohort study was performed in a Dutch fertility clinic and included 667 couples. 
Demographic characteristics, scores for psychosocial factors, discontinuation rates, 
reasons for discontinuation and outcome data of the treatment were measured. 
Discontinuation due to personal reasons was differentiated from discontinuation 
because of changing a clinic or physicians’ advice. The results showed that 37.5% of 
the couples became pregnant, while 40 (6%) discontinued IVF treatment because of 
personal reasons. A sample size of 288 women remained for analysis. A longer 
duration of infertility, less perceived social support in women and higher scores on 
acceptance of infertility in both men and women were significantly correlated with 
discontinuation. Multivariate analysis, using these variables including the age of the 
women, showed that these factors could explain 29% of the discontinuation.  
These results point to a differentiation between couples who positively choose to 
discontinue treatment and those discontinuing from a more negative perspective. 
Opportunities to tailor interventions to this second group of couples need to be 
investigated.  
 
 
Keywords: infertility, assisted reproduction, psychology, screening, 
discontinuation 
  
	
Introduction 
 
Worldwide, the prevalence of infertility is about 9% (Boivin et al., 2007). Treatment 
options involving assisted reproductive technologies (ARTs) are in vitro fertilisation 
(IVF) and intracytoplasmic sperm injection (ICSI). In Europe, 399,020 ART cycles 
were performed in 2009 with a clinical pregnancy rate per cycle of 29% (Ferraretti 
et al., 2013). Many couples therefore need multiple cycles to achieve their goal. 
Being involved in fertility treatment is complex, time-consuming and stressful and is 
assumed to be related to a significant discontinuation rate (Brandes et al., 2009; 
Boivin et al., 2011a). Patients discontinue either on their physician’s advice, for 
example in cases of poor response, or on their own initiative (Gameiro et al., 2012). 
Boivin et al. (2012) defined discontinuation on their own initiative as patients with 
a failed cycle who opt not to proceed with further treatment despite a favourable 
prognosis and the ability to cover the costs of treatment. Reasons for 
discontinuation on their own initiative have been identified in retrospective studies 
and include emotional distress and relational problems (Verhagen et al., 2008; 
Brandes et al., 2009). However, predictors for discontinuation are rarely 
investigated. Gameiro et al. showed that in the last twenty years only a few studies 
have focused on predicting dropout rates (Gameiro et al., 2012). Some studies 
focused on pre-treatment psychosocial factors and others showed that pre-existing 
psychological problems and/or depression were associated with higher dropout 
rates (Smeenk et al., 2004; Eisenberg et al., 2010). 
Patients may positively choose to discontinue treatment despite favourable 
prognosis, for instance, with the intention to focus on other life goals. However, it is 
also possible that patients discontinue treatment because they have difficulties in 
coping with the stress of treatment. This last patient group could benefit from 
additional support to alleviate the burden of treatment. Knowledge about predictors 
of discontinuation could shed light on the reasons to discontinue treatment (Van 
den Broeck et al., 2009). Information about the predictors of discontinuation might 
also help to identify obstacles patients encounter and improve counselling and 
patient-centred care (Brandes et al., 2009). The aim of this study was to investigate 
to what extent pre-treatment emotional distress, cognitions regarding fertility 
problems and social support could predict discontinuation of treatment. 
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Materials and Methods 
 
Study design 
A retrospective cohort study was carried out. Couples (women and partners) who 
planned to start IVF/ICSI treatment between 1st November 2009 and 1st November 
2010 were eligible for participation. Informed consent was given before treatment. 
Patients were treated according to a standard protocol and were invited to 
complete a short questionnaire assessing five risk factors for post-treatment 
emotional problems before IVF/ICSI. After one year, we collected the follow-up 
data regarding treatment course.  
 
Setting and participants 
This study was performed at the Radboud University Nijmegen Medical Centre, a 
university hospital in a medium-sized city in the Netherlands. The eligibility of 
patients for IVF or ICSI treatment was determined according to the national 
guideline formulated by the Dutch Society of Obstetrics and Gynaecology (NVOG 
guideline, May 2011, http://www.nvog.nl). Participants were either about to start 
their first cycle of ART treatment, or the first cycle of ART treatment after having 
achieved an ongoing pregnancy after ART. In the Netherlands, the costs of the first 
three fresh ART cycles are reimbursed by the national health care system.  
 
Measures 
Demographics, psychological factors, treatment outcome and discontinuation were 
determined. 
 
Demographics 
Personal data (i.e. age of the women) and infertility related data (i.e. diagnosis and 
duration of infertility) were collected. 
 
Psychological predictors 
Pre-treatment distress, cognitions about infertility and social support were assessed 
by SCREENIVF, a validated instrument based on previously identified risk factors 
for emotional maladjustment (Verhaak et al., 2010). SCREENIVF consists of 14 
items assessing anxiety and depression from the Hospital Anxiety and Depression 
Scale (Snaith, 2003), 12 items assessing helplessness and lack of acceptance taken 
from the Illness Cognition Questionnaire for IVF patients (Evers et al., 2001; 
	
Verhaak et al., 2005), and 5 items assessing perceived social support derived from 
the Inventory of Social Involvement (Van Dam-Baggen & Kraaimaat, 1992).  
 
Treatment outcome 
The outcomes of the initial IVF cycles (e.g. % life birth rate and % miscarriage rate) 
were identified. Next, we determined the follow-up treatment status and divided 
this into five categories, i.e. pregnancy after the first IVF cycle; continuation of 
treatment after the first unsuccessful IVF cycle; advice to stop treatment by the 
medical team (unfavourable prognosis); continuation of treatment in another clinic; 
and discontinuation of treatment.  
 
Discontinuation 
Discontinuation was defined as a patient with a failed cycle who opted not to 
proceed with further treatment despite a favourable prognosis and ability to pay or 
cover the costs of treatment (Boivin et al., 2012). Women who opted not to start 
IVF treatment because of personal reasons despite a favourable prognosis were also 
included in the discontinuation group (Van Den Broeck et al., 2010). A favourable 
prognosis was recorded when there was no physician’s advice to stop treatment. 
The discontinuation one year after the start of the first IVF cycle was assessed. 
 
Data collection 
The uptake rate, results of SCREENIVF and personal data from the local electronic 
registry as well as from the medical health record were collected. In case of 
incomplete data, patients were contacted by telephone.  
 
Statistical analysis 
Data were analysed using SPSS (version 20.0 for Windows*, SPSS Inc., IBM, 
Chicago, IL, USA). Univariate logistic regression analysis was used to discover 
whether demographic factors, pre-treatment anxiety and depression levels, 
cognitions about infertility and social support predicted discontinuation. 
Demographic and psychosocial factors were used as independent variables and 
discontinuation of treatment acted as the dependent variable. Subsequently, 
variables that predicted discontinuation (p-value lower than 0.10) were selected for 
the multivariate logistic regression model (method: enter) to predict 
discontinuation. To control for co-linearity, we determined the correlation of the 
factors in the multivariate model, and used a rho of 0.6 or higher as a cut-off to 
exclude one of the correlated variables. The Hosmer-Lemeshow test was used to 
39426 Dongen, Angelique.indd   64 14-03-16   12:21
Correlates of discontinuation in IVF
65
4
	
Materials and Methods 
 
Study design 
A retrospective cohort study was carried out. Couples (women and partners) who 
planned to start IVF/ICSI treatment between 1st November 2009 and 1st November 
2010 were eligible for participation. Informed consent was given before treatment. 
Patients were treated according to a standard protocol and were invited to 
complete a short questionnaire assessing five risk factors for post-treatment 
emotional problems before IVF/ICSI. After one year, we collected the follow-up 
data regarding treatment course.  
 
Setting and participants 
This study was performed at the Radboud University Nijmegen Medical Centre, a 
university hospital in a medium-sized city in the Netherlands. The eligibility of 
patients for IVF or ICSI treatment was determined according to the national 
guideline formulated by the Dutch Society of Obstetrics and Gynaecology (NVOG 
guideline, May 2011, http://www.nvog.nl). Participants were either about to start 
their first cycle of ART treatment, or the first cycle of ART treatment after having 
achieved an ongoing pregnancy after ART. In the Netherlands, the costs of the first 
three fresh ART cycles are reimbursed by the national health care system.  
 
Measures 
Demographics, psychological factors, treatment outcome and discontinuation were 
determined. 
 
Demographics 
Personal data (i.e. age of the women) and infertility related data (i.e. diagnosis and 
duration of infertility) were collected. 
 
Psychological predictors 
Pre-treatment distress, cognitions about infertility and social support were assessed 
by SCREENIVF, a validated instrument based on previously identified risk factors 
for emotional maladjustment (Verhaak et al., 2010). SCREENIVF consists of 14 
items assessing anxiety and depression from the Hospital Anxiety and Depression 
Scale (Snaith, 2003), 12 items assessing helplessness and lack of acceptance taken 
from the Illness Cognition Questionnaire for IVF patients (Evers et al., 2001; 
	
Verhaak et al., 2005), and 5 items assessing perceived social support derived from 
the Inventory of Social Involvement (Van Dam-Baggen & Kraaimaat, 1992).  
 
Treatment outcome 
The outcomes of the initial IVF cycles (e.g. % life birth rate and % miscarriage rate) 
were identified. Next, we determined the follow-up treatment status and divided 
this into five categories, i.e. pregnancy after the first IVF cycle; continuation of 
treatment after the first unsuccessful IVF cycle; advice to stop treatment by the 
medical team (unfavourable prognosis); continuation of treatment in another clinic; 
and discontinuation of treatment.  
 
Discontinuation 
Discontinuation was defined as a patient with a failed cycle who opted not to 
proceed with further treatment despite a favourable prognosis and ability to pay or 
cover the costs of treatment (Boivin et al., 2012). Women who opted not to start 
IVF treatment because of personal reasons despite a favourable prognosis were also 
included in the discontinuation group (Van Den Broeck et al., 2010). A favourable 
prognosis was recorded when there was no physician’s advice to stop treatment. 
The discontinuation one year after the start of the first IVF cycle was assessed. 
 
Data collection 
The uptake rate, results of SCREENIVF and personal data from the local electronic 
registry as well as from the medical health record were collected. In case of 
incomplete data, patients were contacted by telephone.  
 
Statistical analysis 
Data were analysed using SPSS (version 20.0 for Windows*, SPSS Inc., IBM, 
Chicago, IL, USA). Univariate logistic regression analysis was used to discover 
whether demographic factors, pre-treatment anxiety and depression levels, 
cognitions about infertility and social support predicted discontinuation. 
Demographic and psychosocial factors were used as independent variables and 
discontinuation of treatment acted as the dependent variable. Subsequently, 
variables that predicted discontinuation (p-value lower than 0.10) were selected for 
the multivariate logistic regression model (method: enter) to predict 
discontinuation. To control for co-linearity, we determined the correlation of the 
factors in the multivariate model, and used a rho of 0.6 or higher as a cut-off to 
exclude one of the correlated variables. The Hosmer-Lemeshow test was used to 
39426 Dongen, Angelique.indd   65 14-03-16   12:21
66
Chapter 4
	
indicate goodness of fit for the final logistic regression model. Analyses on the 
couple’s level (demographic and treatment related factors) as well as for women 
and partners separately (psychosocial factors) were performed. The explained 
variance is presented as Nagelkerke R2. 
 
 
Results 
 
During the inclusion period, 679 couples were placed on the waiting list for 
IVF/ICSI treatment. Twelve of them (2%) were excluded for analysis because they 
appeared to be ineligible for IVF/ICSI treatment, resulting in 667 eligible couples 
(figure 1). 
 
IVF/ICSI results 
Overall, after one IVF/ICSI cycle, 37.5% of the 667 couples had achieved an on-
going pregnancy. Of the total, 38 patients achieved a pregnancy spontaneously 
before the start of the treatment (n=27) or after the first unsuccessful treatment 
cycle (n=11).  
 
Discontinuation data 
Of the 667 couples, nine couples (1.3%) went to another clinic, thirty-seven couples 
(5.5%) ended treatment on physician’s advice, mainly because of poor response. 
Forty patients (6.0%) mentioned personal reasons, such as the burden of treatment 
or relational problems, as their main reason for discontinuing IVF/ICSI treatment, 
and met the definition for treatment discontinuation. In total, 331 patients 
continued their treatment after one unsuccessful IVF/ICSI cycle (figure 1). For 
analysis, the data of these two groups (women and their male partners) were 
compared. 
 
Response of psychosocial questionnaire 
For the total of 667 couples, the response rate of the SCREENIVF questionnaire was 
77%. Of the 331 couples that continued treatment after one cycle, 260 women and 
their male partners completed the psychosocial questionnaire pre-treatment. In the 
discontinuation group, this was also the case for 28 women and their male partners 
of the 40 patients who had cited personal reasons. These two groups were 
compared (figure 1).  
 
	
Patient characteristics and discontinuation 
The majority of the demographic and treatment related factors did not predict 
discontinuation of IVF treatment significantly. The discontinuation group had a 
younger female age (p = 0.07) and a significantly longer duration of infertility (p = 
0.03) (table 1). 
 
 
Figure 1: illustration of the patient flow. The bold boxes show the groups that were eligible for analysis. 
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result n=71
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Psychosocial factors and discontinuation 
Univariate logistic regression analysis showed a significant relation between 
women’s social support and discontinuation (table 2). Women experiencing less 
social support pre-treatment were more likely to discontinue (B=0.83; 95%CI: 0.72 
– 0.95). Moreover, a better acceptance of infertility in both men (B=1.25; 95%CI: 
1.10 – 1.42) and women (B=1.13; 95%CI: 1.03 – 1.24) was related to higher 
discontinuation rates. No significant associations were found between 
discontinuation and scores on the other psychosocial factors. 
 
Multivariate analysis 
Based on the univariate analyses, female age, duration of infertility, women’s social 
support scores and both men’s and women’s acceptance scores were selected for 
entry into the multivariate analysis (table 3). None of these variables were strongly 
correlated (i.e. rho’s <0.60) and could therefore all be entered in the multivariate 
model. All five factors included in the multivariate analysis were independently 
related to discontinuation. Moreover, the goodness of fit of the multivariate model, 
the Hosmer-Lemeshow test, gave a p-value of 0.14, implying that this model passed 
the test. Using multivariate analysis, these variables were all independently 
associated with discontinuation and explained 29% of the discontinuation 
(Nagelkerke R2= 0.292). This model was less able to explain discontinuation using 
men’s and women’s psychosocial factors separately. Using male acceptance score 
next to female age and duration of infertility, Nagelkerke R2 was 0.188 (19%) and 
using female acceptance and social support scores next to female age and duration 
of infertility, Nagelkerke R2 was 0.183 (18%). 
 
 
Table 3: Multivariate logistic regression analysis shows the association between female age, duration of infertility, and 
results of the psychosocial factors with discontinuation of care. 
 
Results of multivariate logistic regression analysis, presented as B-value with Odds ratios and 95% CIs and p-values.  
** For example: one point higher score on acceptance in men gives 1.27x more probability for discontinuation of 
treatment (independent of other variables) 
 
 B Odds ratio 95% CI p-value 
Age of the women (years) 
Duration of infertility (months) 
Acceptance (women) 
Social support (women) 
Acceptance (men) ** 
-0.13 
0.02 
0.11 
-0.27 
0.24 
0.88 
1.02 
1.12 
0.76 
1.27 
0.79 – 0.99 
1.01 – 1.04 
0.99 – 1.26 
0.64 – 0.91 
1.09 – 1.49 
0.03 
0.01 
0.07 
0.03 
0.02 
Nagelkerke R2 0.292  (29.2%)   
	
Discussion 
 
In this study, we showed that discontinuation of treatment despite favourable 
prognosis before or after the first IVF cycle could be explained by higher acceptance 
of the fertility problem at pre-treatment in both men and women, and by a lack of 
perceived social support in women. In addition, these factors, next to female age 
and duration of the fertility problem, explained almost 30% of the variance of 
discontinuation. Moreover, a model including both partners’ psychosocial factors 
explained more variance than a model focusing on women or men only. 
The discontinuation due to personal reasons was 6%, which is comparable to results 
of earlier studies (Land et al., 1997; Sharma et al., 2002; Olivius et al., 2004; 
Smeenk et al., 2004; Verberg et al., 2008; Brandes et al., 2009; Boivin et al., 2012). 
Moreover, our results showed that the discontinuation group had a younger female 
age and a longer duration of infertility, which was mentioned earlier as a reason for 
discontinuation of infertility treatment (Van den Broeck et al., 2009). We can only 
speculate why younger women tend to discontinue IVF treatment due to personal 
factors earlier; perhaps it is because they might have more alternatives such as 
adoption or donor insemination. 
In this study, distress, in terms of anxiety and depression, was not related to 
discontinuation, in contrast to what was reported in other studies (Smeenk et al., 
2004; Eisenberg et al., 2010). An explanation for this discrepancy is that our study 
succeeded in obtaining information from a relative large, clearly defined cohort 
which omitted those who went to other clinics and those advised to stop treatment 
because of poor prognosis; indeed, the advice to stop treatment could reveal 
significant negative emotions. Apparently, distress per se is not the main reason to 
stop IVF treatment. Moreover, our results may indicate that, especially in women, 
lack of social support could be an important factor in the decision to discontinue 
IVF treatment. The finding that acceptance of both men and women is related to 
higher levels of discontinuation points to the fact that both partners are important 
in the decision to discontinue treatment. Recently, Vassard et al. showed that 
women with lower levels of family support, especially with regard to infertility, and 
men with lower levels of general family support terminate fertility treatment more 
often. These findings support our results about the importance of a perceived lack 
of social support on the decision to end or continue treatment (Vassard et al., 
2012). 
Both women and men’s greater acceptance of infertility, already apparent pre-
treatment, was related to higher levels of discontinuation. This could point to a 
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explained more variance than a model focusing on women or men only. 
The discontinuation due to personal reasons was 6%, which is comparable to results 
of earlier studies (Land et al., 1997; Sharma et al., 2002; Olivius et al., 2004; 
Smeenk et al., 2004; Verberg et al., 2008; Brandes et al., 2009; Boivin et al., 2012). 
Moreover, our results showed that the discontinuation group had a younger female 
age and a longer duration of infertility, which was mentioned earlier as a reason for 
discontinuation of infertility treatment (Van den Broeck et al., 2009). We can only 
speculate why younger women tend to discontinue IVF treatment due to personal 
factors earlier; perhaps it is because they might have more alternatives such as 
adoption or donor insemination. 
In this study, distress, in terms of anxiety and depression, was not related to 
discontinuation, in contrast to what was reported in other studies (Smeenk et al., 
2004; Eisenberg et al., 2010). An explanation for this discrepancy is that our study 
succeeded in obtaining information from a relative large, clearly defined cohort 
which omitted those who went to other clinics and those advised to stop treatment 
because of poor prognosis; indeed, the advice to stop treatment could reveal 
significant negative emotions. Apparently, distress per se is not the main reason to 
stop IVF treatment. Moreover, our results may indicate that, especially in women, 
lack of social support could be an important factor in the decision to discontinue 
IVF treatment. The finding that acceptance of both men and women is related to 
higher levels of discontinuation points to the fact that both partners are important 
in the decision to discontinue treatment. Recently, Vassard et al. showed that 
women with lower levels of family support, especially with regard to infertility, and 
men with lower levels of general family support terminate fertility treatment more 
often. These findings support our results about the importance of a perceived lack 
of social support on the decision to end or continue treatment (Vassard et al., 
2012). 
Both women and men’s greater acceptance of infertility, already apparent pre-
treatment, was related to higher levels of discontinuation. This could point to a 
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positive choice, based on careful deliberation between different life goals that result 
in a decision to give up further treatment and become resigned to the unfulfilled 
wish for a child (Van den Broeck et al., 2009). 
What are the clinical implications of these findings? It seems as if there are couples 
who discontinue treatment from positive choice, for example after their acceptance 
of childlessness. It is also possible, however, that couples discontinue treatment 
because of lack of social support, which creates in them a negative point of view. 
Such couples could benefit from tailored interventions. The problem is how to 
differentiate between these groups. Couples who make the careful decision to stop 
should not be pushed into interventions to support them in their course through 
treatment. On the other hand, support could be offered to those who feel they 
cannot cope with the burden of treatment, but still are willing to become pregnant. 
These couples could benefit from some additional support, for example an extra 
consultation with their physician or referral to a counsellor (Boivin et al., 2012; 
Gourounti et al., 2012). The problem in differentiating between these types of 
discontinuation has already been discussed (Van den Broeck et al., 2010). Our 
current study reveals some starting points to differentiate between these couples, 
for example actively offering additional support to those who have indicated lack of 
social support. Further research is needed to assess the possible long-term regret in 
reaching the decision to discontinue treatment. 
Several strengths of the study are worth mentioning. They include a complete 
follow-up of patients by telephone when data were missing, as well as 
distinguishing between patients who went to another clinic, were recommended 
they discontinue treatment, who choose themselves to discontinue or who became 
pregnant spontaneously (Gameiro et al., 2013). In addition, the inclusion of data of 
both women and men made it possible to do justice to the fact that discontinuation 
is a couples’ decision. 
The study may also have some limitations. Due to the retrospective study design it 
was not always possible to obtain detailed information about reasons for 
discontinuation. For example, there might have been bias due to poor recollection. 
If the goal was to address personal reasons for discontinuation, future research 
should focus on more structured exit interviews. Second, despite the complete 
follow-up rate, we did not have a complete response rate to the psychosocial 
questionnaires (76%) and were unable to include all couples in the analyses, which 
could have influenced the results. However, it is reassuring that the response rate of 
the screening questionnaire was comparable with earlier studies (Van Dongen et al., 
2012), as were the levels of psychosocial risks (Verhaak et al., 2010; Van Dongen et 
	
al., 2012). Thirdly, we administrated SCREENIVF to men although it is not yet 
validated in men. However, the five subscales that are used in SCREENIVF are 
individually validated in women and in men (Van Dongen et al., 2012). 
Discontinuation of treatment could be a couple’s decision; therefore, we were also 
interested in the psychosocial factors of the men. Finally, this study was performed 
in a single centre. However, since the kind of treatment our centre offers did not 
differ substantially from other European centres, comparable results in other 
centres would be expected. 
Future research should focus on more details concerning psychosocial factors in 
discontinuation rates, for example social and relational aspects, as well as 
infertility-specific quality of life such as that assessed by FertiQoL questionnaire 
(Boivin et al., 2011b). Evaluation of psychosocial factors and discontinuation after 
two or more IVF cycles might also be interesting. Finally, long-term effects of 
discontinuation, and possible regret about the decision, should be evaluated to test 
our hypothesis of positive and negative discontinuation. 
In conclusion, discontinuation of IVF treatment is correlated with a longer duration 
of infertility, less perceived social support in women and a better acceptance of the 
infertility in both men and women. These results seem to point in the direction of a 
differentiation between couples: first, those who viewed their choice to discontinue 
in a positive light, accepting that their wish for a child would be unfulfilled, and 
second, couples who viewed the choice to discontinue treatment negatively and 
experienced less support. By screening for psychosocial vulnerability, interventions 
for couples tending to discontinue treatment could then be focused on those who 
are in the greatest need. 
  
39426 Dongen, Angelique.indd   72 14-03-16   12:21
Correlates of discontinuation in IVF
73
4
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distinguishing between patients who went to another clinic, were recommended 
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pregnant spontaneously (Gameiro et al., 2013). In addition, the inclusion of data of 
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was not always possible to obtain detailed information about reasons for 
discontinuation. For example, there might have been bias due to poor recollection. 
If the goal was to address personal reasons for discontinuation, future research 
should focus on more structured exit interviews. Second, despite the complete 
follow-up rate, we did not have a complete response rate to the psychosocial 
questionnaires (76%) and were unable to include all couples in the analyses, which 
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al., 2012). Thirdly, we administrated SCREENIVF to men although it is not yet 
validated in men. However, the five subscales that are used in SCREENIVF are 
individually validated in women and in men (Van Dongen et al., 2012). 
Discontinuation of treatment could be a couple’s decision; therefore, we were also 
interested in the psychosocial factors of the men. Finally, this study was performed 
in a single centre. However, since the kind of treatment our centre offers did not 
differ substantially from other European centres, comparable results in other 
centres would be expected. 
Future research should focus on more details concerning psychosocial factors in 
discontinuation rates, for example social and relational aspects, as well as 
infertility-specific quality of life such as that assessed by FertiQoL questionnaire 
(Boivin et al., 2011b). Evaluation of psychosocial factors and discontinuation after 
two or more IVF cycles might also be interesting. Finally, long-term effects of 
discontinuation, and possible regret about the decision, should be evaluated to test 
our hypothesis of positive and negative discontinuation. 
In conclusion, discontinuation of IVF treatment is correlated with a longer duration 
of infertility, less perceived social support in women and a better acceptance of the 
infertility in both men and women. These results seem to point in the direction of a 
differentiation between couples: first, those who viewed their choice to discontinue 
in a positive light, accepting that their wish for a child would be unfulfilled, and 
second, couples who viewed the choice to discontinue treatment negatively and 
experienced less support. By screening for psychosocial vulnerability, interventions 
for couples tending to discontinue treatment could then be focused on those who 
are in the greatest need. 
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Abstract 
 
Study question: Are clinic factors, including patients’ experiences with patient-
centred care, associated with dropout in fertility care? 
Summary answer: Clinic factors, including patients’ experiences with patient-
centred care, are not related to dropout. 
What is known already: In fertility care, a significant proportion of patients 
does not achieve pregnancy, because they discontinue treatment prematurely. Many 
studies have tried to identify factors predicting dropout, showing incompatible 
results. However, these studies mainly focus on factors at the treatment and patient 
level, while clinic factors have received little attention. 
Study design, size and duration: This prospective, longitudinal study was 
nested within a large randomized controlled trial (RCT), which aims to improve the 
level of patient-centredness of Dutch fertility care. Of the 1620 infertile women who 
were invited to participate, the baseline measurement of the study (T0) included 
693 women who completed a questionnaire about their experiences with patient-
centred fertility care. The follow-up of the patients was one year (T1). 
Participants, setting and methods: All included women suffered from 
infertility and were undergoing treatment in one of the 32 Dutch clinics involved in 
the trial. Levels of patient-centredness were determined using the Patient-
Centredness Questionnaire-Infertility (PCQ-Infertility) at T0. Meanwhile, a 
professionals’ questionnaire was used to gather additional information on 
characteristics of the clinic (e.g. the number of patients per year or the presence of 
a fertility nurse). After one year, at T1 measurement, patients completed a 
questionnaire on their current status in fertility care, including their main reason for 
discontinuation if applicable. 
Main results and the role of chance: A total of 693 non-pregnant women 
completed the questionnaire set at T0 and 534 women (77.1%) provided consent 
for follow-up. At T1 measurement, 434 women (81.3%) completed the 
questionnaire and 153 women of these women (35.2%) continued treatment while 
76 women (17.5%) dropped out. Another 175 women (40.3%) had achieved 
pregnancy and 30 patients (7.9%) were advised to discontinue treatment for 
medical reasons. Neither levels of patient-centredness nor the additional clinic 
characteristics differed significantly between dropouts and compliers. However, 
patients who did not received assisted reproductive technology (ART) treatment 
(e.g. underwent intrauterine insemination, IUI) before they dropped out had 
significantly lower scores on the PCQ-Infertility subscale ‘Respect for patients’ 
	
values’ than patients who continued their treatment (odds ratio [OR] 0.57; 95% 
confidence interval [CI]: 0.34 – 0.95). Patients who received ART treatment and, 
subsequently, dropped out had higher scores on the PCQ-Infertility subscale ‘Patient 
involvement’ than those receiving non-ART (OR 2.39; 95%CI: 1.02 – 5.59). 
Limitations, reasons for caution: We were not able to follow-up a significant 
proportion (ca. 19%) of the 1620 women who were invited for T0 measurement, 
which might have biased our results. We also excluded patients who were still in 
the diagnostic work-up stage and this might have influenced our results as it is 
known that patients dropout at this stage. As the PCQ-Infertility was validated in 
patients who were already undergoing treatment, we decided to focus on this 
patient group only. 
Wider implications of the findings: The results of this study provide a better 
insight into those factors influencing dropout from the perspective of factors in the 
clinic itself. Although most clinic factors were not related to dropout, clinic factors 
might be of use when predicting dropout for specific patient groups, such as 
patients receiving ART and non-ART. Future research should involve an exploration 
of more specific predictors of dropout at the patient, treatment and clinic levels. 
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Abstract 
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level of patient-centredness of Dutch fertility care. Of the 1620 infertile women who 
were invited to participate, the baseline measurement of the study (T0) included 
693 women who completed a questionnaire about their experiences with patient-
centred fertility care. The follow-up of the patients was one year (T1). 
Participants, setting and methods: All included women suffered from 
infertility and were undergoing treatment in one of the 32 Dutch clinics involved in 
the trial. Levels of patient-centredness were determined using the Patient-
Centredness Questionnaire-Infertility (PCQ-Infertility) at T0. Meanwhile, a 
professionals’ questionnaire was used to gather additional information on 
characteristics of the clinic (e.g. the number of patients per year or the presence of 
a fertility nurse). After one year, at T1 measurement, patients completed a 
questionnaire on their current status in fertility care, including their main reason for 
discontinuation if applicable. 
Main results and the role of chance: A total of 693 non-pregnant women 
completed the questionnaire set at T0 and 534 women (77.1%) provided consent 
for follow-up. At T1 measurement, 434 women (81.3%) completed the 
questionnaire and 153 women of these women (35.2%) continued treatment while 
76 women (17.5%) dropped out. Another 175 women (40.3%) had achieved 
pregnancy and 30 patients (7.9%) were advised to discontinue treatment for 
medical reasons. Neither levels of patient-centredness nor the additional clinic 
characteristics differed significantly between dropouts and compliers. However, 
patients who did not received assisted reproductive technology (ART) treatment 
(e.g. underwent intrauterine insemination, IUI) before they dropped out had 
significantly lower scores on the PCQ-Infertility subscale ‘Respect for patients’ 
	
values’ than patients who continued their treatment (odds ratio [OR] 0.57; 95% 
confidence interval [CI]: 0.34 – 0.95). Patients who received ART treatment and, 
subsequently, dropped out had higher scores on the PCQ-Infertility subscale ‘Patient 
involvement’ than those receiving non-ART (OR 2.39; 95%CI: 1.02 – 5.59). 
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Introduction 
 
A successful fertility treatment is something every infertile couple is striving for. 
Unfortunately, a significant proportion of couples do not achieve pregnancy because 
of medical factors, but also because they discontinue treatment prematurely. The 
exact number of patients dropping out of fertility treatment varies across European 
studies and ranges from 17 to 70% (Olivius et al., 2004; Schröder et al., 2004; 
Rajkhowa, et al., 2006; Verberg et al., 2008; Verhagen et al., 2008; Brandes et al., 
2009; Gameiro et al., 2012). This wide range might be due to the conceptual issues 
around the definition of dropout and the methodological differences between 
studies (Boivin et al., 2012; Gameiro et al., 2012). However, it still indicates that 
treatment dropout concerns many infertile patients. It is worrisome that these 
couples decide to give up their dream of becoming parents, because of the physical 
or psychological burden they encounter during treatment. Therefore, prognostic 
factors for dropping out should be identified to develop interventions, which target 
specifically those burdensome aspects of treatment (Boivin et al., 2012; Gameiro et 
al., 2012). 
When considering the reasons why patients discontinue treatment, one could think 
of reasons related to the patients themselves (e.g. their well-being) or the kind of 
treatments they receive (Boivin et al., 2012). Moreover, it might be expected that 
reasons related to the clinic itself, such as inadequate organization of care or poor 
communication skills of staff, influences patients’ decisions to discontinue fertility 
treatment prematurely. This is supported by the literature where, for example, 
inadequate information provision and coordination of care have been identified as 
reasons for dropout (Haagen et al., 2008). Also a lack of empathy by the staff, poor 
listening skills (Olivius et al., 2004) and negative interactions with staff (Rajkowa et 
al., 2006) have been cited as reasons to discontinue treatment. Apperently, 
numerous clinic factors have been reported in connection with discontinuation 
(Boivin et al., 2012), but whether they could be used as a predictor of dropout has 
never been studied. It would be interesting to investigate this possible relationship 
through longitudincal research, as it shows us to what extent professionals could 
account for these factors in daily practice to prevent dropout. 
To identify clinic factors as potential predictors of dropout, standard clinic 
characteristics could be studied (e.g. clinic size, presence of specialized fertility 
nurses). Furthermore, it would be valuable to ask infertile patients themselves 
about their experiences with fertility care in a clinic to identify relevant and 
predictive clinic factors for dropout. The recently developed and validated Patient-
	
Centredness Questionnaire-Infertility (PCQ-Infertility) could be used for this goal, 
as it measures patient-centredness from the patients’ perspective in seven different 
and concrete dimensions (e.g. accessibility of care, continuity and transition and 
professionals’ competence) (Van Empel et al., 2010a). Van Empel et al. (2011b) 
already showed that patients change clinics because they experience a lack of 
patient-centred care. Whether patients dropout treatment because of a lower level 
of patient-centred fertility care is unknown. 
Therefore, the main aim of this study was to identify clinic factors, including 
patients’ experiences with patient-centredness in their clinic, as potential predictors 
of dropout in fertility care, in a prospective manner. Furthermore, previous studies 
have shown that barriers to the uptake of treatment for dropout are common to all 
types of treatment, while others are type-specific (Brandes et al., 2009; Gameiro et 
al., 2012). Because van Empel et al. (2010b) found a significant association 
between treatment type (i.e. assisted reproductive technology [ART] and non-ART) 
and patient-centred care, we wanted to study the relation between dropout and 
patient-centred care for these subgroups of patients as well.  
 
 
Materials and methods 
 
Study design 
This prospective longitudinal study was nested within a large RCT (Trial 
registration numner: ClinicalTrials.gov NCT01481064)), which aims to improve the 
level of patient-centredness of Dutch fertility care (Huppelschoten, et al., 2012). 
During the baseline measurement of this study (T0), patients completed a 
questionnaire on their experiences with patient-centred care. We used a 
questionnaire for professionals to gather additional clinic characteristics as potential 
predictors of dropout. One year later (T1), patients who gave consent for follow-up 
received a questionnaire on their current status in fertility care. 
 
Setting 
In the Netherlands, fertility care is provided by three different types of clinics based 
on the kind of treatment they offer. Almost all clinics carry out initial fertility 
assessment, ovulation induction (OI) and intrauterine insemination (IUI). A limited 
number of clinics can also start and monitor In Vitro Fertilization (IVF) and Intra-
cytoplasmic Sperm Injection (ICSI) treatments, including the ovum retrieval. The 
laboratory phase of IVF and embryo transfers has to occur in one of the thirteen 
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licensed fertility clinics. Almost all Dutch fertility clinics are funded by the National 
Health Service. Every Dutch citizen has a basic insurance coverage, which covers 
treatment and medication costs for OI, IUI, and a maximum of three cycles of 
IVF/ICSI until couples achieve an ongoing pregnancy.  
 
Study population 
We performed this study in infertile patients, receiving treatment in one of 32 
participating Dutch clinics. All patients who participated underwent at least one 
cycle of Medically Assisted Reproduction (MAR) (e.g., OI, IUIs, IVF and ICSI). We 
only invited the women of the infertile couples to participate in our study as a 
previous study has shown that patients’ experiences with fertility care are 
comparable between infertile women and their partners (Huppelschoten et al., 
2013). Patients who were already pregnant at T0 were excluded from follow-up, as 
our research question did not concern this patient group. 
 
Data collection 
 
T0-measurement 
To include a representative patient group for T0 measurement, clinics were asked 
to extract from their medical recors, the address files of all patients who underwent 
at least one cycle of MAR in their clinis in the previous three months (spring-
summer 2011). From this list of patients, 25 – 75 patients per clinic were randomly 
selected depending on the clinic size. Selected women received a letter in which 
they were invited to complete an online questionnaire set, accessible by a personal 
code. Participation was voluntary and anonymous. Patients received a reminder 
card two weeks after the initial mailing. Another three weeks later, non-responders 
received a reminder with the additional option to complete a paper version of the 
questionnaire (Zuidgeest et al., 2011).  
Per clinic, one gynaecologist (i.e. our contact) received an online questionnaire for 
professionals by e-mail. All 32 gynaecologists received a standard reminder after 
two weeks, and we sent the non-responders an additional reminder three weeks 
later.  
 
T1-measurement 
Only the patients who gave consent to follow-up were invited for the T1-
measurement (summer 2012). The first steps of questionnaire distribution were 
performed in the same way as at T0 measurement. Subsequently, an additional 
	
reminder was sent to the final non-responders to achieve a response rate as high as 
possible. The questionnaire at T1 consisted of questions about patients’ current 
status in fertility care. In cases of dropout, we asked for patients’ most important 
reason for discontinuation. To do so, we provided them with a list of ten different 
options for dropout, which was based on the literature (e.g. poor response, 
emotional reasons, ethical reasons or women’s age) (Brandes et al., 2009; Gameiro 
et al., 2012). In case of no valid options, patients had the possibility to add their 
personal most important reason for discontinuation. Only those patients who 
discontinued their treatment prematurely were identified as dropouts. However, 
patients who ended treatment because they have had the maximum of three 
IVF/ICSI cycles or had no more treatment options were not considered as dropouts. 
The compliers group consisted of patients who were still under treatment in their 
own clinic, or patients who had no more treatment options in their own clinic and, 
therefore, went to another clinic. Patients who went to another clinic, because they 
were unsatisfied with their clinic were excluded from analysis. 
 
Questionnaires at T0-measurement 
 
Patients’ questionnaire 
The questionnaire set for patients consisted of several background questions for 
case-mix adjustment and the PCQ-Infertility questionnaire. The background 
questions were based on both general and fertility care related issues described in 
literature as possibly being linked to dropout and/or patient-centred care (Van 
Empel et al., 2010a and 2011a; Mourad et al., 2010; Nefs et al., 2011; Cho et al., 
2013), including issues related to quality of life (FertiQoL questionnaire) (Boivin et 
al., 2011) and risk factors for emotional maladjustment during treatment 
(SCREENIVF questionnaire) (Verhaak et al., 2010). 
The PCQ-Infertility is a validated instrument measuring patient-centeredness of 
fertility care by asking patients about their experiences with care. This 
questionnaire is composed of 46 questions and contains seven subscales, namely: 
accessibility (two items, Cronbach’s  = 0.64, e.g. ‘Was it a problem for you to 
contact staff if you had any questions?’); information (11 items, Cronbach’s  = 
0.73, e.g. ‘Did you receive an overview of your treatment plan with a time 
schedule?’); communication (seven items, Cronbach’s  = 0.78, e.g. ‘How often did 
your physician take you seriously?’); respect for patients’ values (seven items, 
Cronbach’s  = 0.85, e.g. ‘How often did your physician show an interest in your 
personal situation?’); continuity and transition (seven items, Cronbach’s  = 0.66, 
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e.g. ‘How often did you have an appointment with the same physician?’); patient 
involvement (three items, Cronbach’s  = 0.75, e.g. ‘Was decision-making shared 
with you, if preferred?’); and competence (six items, Cronbach’s  = 0.72; e.g. 
‘How often was your physician well-prepared for an appointment?’). A higher score 
on the total PCQ scale or one of the subscales (range 0 – 3) indicates a higher level 
of experienced patient-centeredness (Van Empel et al., 2010a). 
 
Professionals’ questionnaire 
We used a questionnaire for professionals to gather the remaining clinic 
characteristics as potential predictors of dropout. The representative gynaecologists 
of all 32 participating clinics received a short online questionnaire with eight 
questions about their clinic. The selection of the clinic characteristics was based on 
the literature as possibly being related to patient-centred care (Van Empel et al., 
2010a and 2011b; Mourad et al., 2010), and included the number of 
gynaecologists, the number of new fertility patients per year, presence of a separate 
waiting room for infertile patients (yes/no), a separate room for semen production 
(yes/no), specialized fertility nurse(s) (yes/no), having a psychologist as part of the 
fertility team (yes/no), structured (e.g. weekly) meetings to discuss all (new) 
patients within the team (yes/no) and execution of structured (e.g. yearly) quality 
measurements before the start of this study (yes/no). 
 
Ethical approval 
The institutional ethics committee of Radboud University Nijmegen Medical Centre 
provided ethical approval for this research to proceed (CMO nr 2011/034). A 
written informed consent had been obtained at T0 from all participants. 
 
Data analysis 
We first performed a power analysis using the model of Tosteson (Tosteson et al., 
2003). We considered an odds ratio (OR) of 1.5–2.0 for 1 SD increases in exposure 
as clinically relevant, resulting in a minimum required number of 115 to 317 
patients (alpha = 0.05, beta = 0.80). 
We categorized all patients into five groups, depending on their current status in 
fertility care and compared all background characteristics between these groups. 
The five groups included: 1) patients who had achieved pregnancy between T0 and 
T1; 2) patients who were still under treatment (i.e. compliers); 3) patients who 
dropped out of treatment, 4) patients who ended treatment for medical reasons 
(e.g. having the maximum of three IVF cycles, or poor prognosis); and 5) patients 
	
who were lost to follow-up. We used one-way analysis of variance and chi-quadrate 
tests to compare these groups on continuous and categorical patient characteristics, 
respectively. 
For further analyses, we used the data of groups 2 (i.e. compliers) and 3 (i.e. 
dropouts), as our research question concerned these patients only. Patient 
characteristics that showed significant differences between these two groups were 
taken up as case-mix adjusters in the final analysis. Subsequently, all clinic 
characteristics were included in multiple binary logistic regression analyses to 
evaluate them as a potential predictor for dropout. Compliers and dropouts acted as 
the dependent variable. 
For our additional analysis, we divided our patient group into patients undergoing 
ART and patients undergoing non-ART treatments at T0. Then, we determined to 
what extend the treatment type and PCQ-Infertility total scores were related to each 
other, using linear regression analyses. In case of a significant correlation, we 
performed our previous analyses on these two groups separately. 
Significance for all analyses was set at p < 0.05. Analyses were performed using the 
Statistical Package for the Social Science (version 18.0 for Windows®, SPSS Inc., 
Chicago, IL, USA). 
 
 
Results 
 
At T0 measurement, 1620 women were invited to participate, of which 946 
completed the questionnaire (response rate 58.4%). After excluding 253 pregnant 
women, 693 women were eligible for participation in the follow-up study. Of this 
group, 534 women (77.1%) provided consent for the follow up. At T1 
measurement, 434 women completed the questionnaire (response rate 81.3%). Of 
these women, 175 (40.3%) had achieved pregnancy and 153 women (35.2%) 
continued treatment since T1 measurement. Of these women, 12 (7.8%) changed 
clinics because they were unsatisfied with the care they received in their clinic and 
were, therefore, excluded, leaving 141 patients in the compliers group. Further, a 
total of 76 women (17.5%) dropped out treatment and 30 women (6.9%) had 
stopped because of medical reasons. Figure 1 presents the flowchart of this study. 
From the 76 women who dropped out, 31 women (40.8%) mentioned emotional 
problems as their most important reason and 10 patients (13.2%) stated that they 
had relational problems. Also, female age and increased risk of birth defects (n=10; 
13.2%) and fundamental reasons (e.g. considering IVF as a step too far) (n=5; 
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6.6%) were mentioned as reasons for dropping out. In addition, as we included 217 
patients in our main analysis, it seems we have no remarkable limitations in sample 
size considering our previous power calculation. 
All patient characteristics are presented in table 1, divided according to their 
current status in fertility care. Patients who ended treatment because of medical 
reasons were significantly older and less well educated, had longer experiences in 
fertility care and had undergone ART treatments more often than patients in the 
other groups. Furthermore, patients who dropped out of treatment were 
significantly older than the patients who became pregnant, the compliers or the 
patients lost to follow-up. Female age was, therefore, taken up as a case-mix 
adjuster.  
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6.6%) were mentioned as reasons for dropping out. In addition, as we included 217 
patients in our main analysis, it seems we have no remarkable limitations in sample 
size considering our previous power calculation. 
All patient characteristics are presented in table 1, divided according to their 
current status in fertility care. Patients who ended treatment because of medical 
reasons were significantly older and less well educated, had longer experiences in 
fertility care and had undergone ART treatments more often than patients in the 
other groups. Furthermore, patients who dropped out of treatment were 
significantly older than the patients who became pregnant, the compliers or the 
patients lost to follow-up. Female age was, therefore, taken up as a case-mix 
adjuster.  
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Chapter 5
	
Table 2 presents the results from the PCQ-Infertility, including all median PCQ-
Infertility total and subscale scores. Logistic regression analyses with adjustment for 
age showed that women’s PCQ-Infertility total and subscale scores did not 
significantly differ between dropouts and compliers. Additional analyses on the 
subgroup of patients that went to another clinic because they were unsatisfied 
(n=12) did not show any differences with the compliers group on the PCQ-
Infertility total and subscales (data not shown). Table 3 shows the results from the 
additional clinic characteristics, which also do not differ between dropouts and 
compliers. 
 
 
Table 2: The relation between the level of patient-centredness and dropout 
 
 Compliers 
(n=141) 
Dropout 
(n=76) 
Compliers vs. 
dropout 
 Median (range) Median (range) OR (95%CI) 
PCQ-Infertility (0-3) 
Accessibility of care  
Information provision  
Communication 
Respect for patients’ values 
Continuity and transition 
Patient involvement 
Staff’s competence 
2.24 (1.04 – 2.93) 
2.50 (0.00 – 3.00) 
2.09 (0.60 – 3.00) 
2.57 (0.57 – 3.00) 
2.00 (0.14 – 3.00) 
1.86 (0.67 – 3.00) 
2.33 (0.00 – 3.00) 
2.50 (1.17 – 3.00) 
2.18 (0.67 – 2.95) 
2.50 (0.50 – 3.00) 
2.00 (0.00 – 3.00) 
2.57 (0.14 – 3.00) 
1.80 (0.00 – 3.00) 
1.79 (0.43 – 3.00) 
2.67 (0.33 – 3.00) 
2.50 (0.67 – 3.00) 
0.73 (0.37 – 1.46) 
1.07 (0.71 – 1.61) 
0.79 (0.49 – 1.30) 
0.82 (0.47 – 1.43) 
0.72 (0.49 – 1.05) 
0.87 (0.52 – 1.46) 
1.24 (0.78 – 1.97) 
0.80 (0.40 – 1.62) 
Data presented as OR’s and 95% CI. Binomial logistic regression analysis was used to compare patient under treatment 
with patients who dropped out treatment. The results are adjusted for age. 
 
 
Table 3: The relation between additional clinic characteristics and dropout  
 
Clinic characteristics Compliers 
(n=141) 
Dropout 
(n=76) 
Compliers vs. dropouts 
OR (95%CI) 
Number of patients per clinic 
Median (range) 
444 
(110-2600) 
500 
(110-2600) 
1.00 (1.00 – 1.01) 
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Table 2 presents the results from the PCQ-Infertility, including all median PCQ-
Infertility total and subscale scores. Logistic regression analyses with adjustment for 
age showed that women’s PCQ-Infertility total and subscale scores did not 
significantly differ between dropouts and compliers. Additional analyses on the 
subgroup of patients that went to another clinic because they were unsatisfied 
(n=12) did not show any differences with the compliers group on the PCQ-
Infertility total and subscales (data not shown). Table 3 shows the results from the 
additional clinic characteristics, which also do not differ between dropouts and 
compliers. 
 
 
Table 2: The relation between the level of patient-centredness and dropout 
 
 Compliers 
(n=141) 
Dropout 
(n=76) 
Compliers vs. 
dropout 
 Median (range) Median (range) OR (95%CI) 
PCQ-Infertility (0-3) 
Accessibility of care  
Information provision  
Communication 
Respect for patients’ values 
Continuity and transition 
Patient involvement 
Staff’s competence 
2.24 (1.04 – 2.93) 
2.50 (0.00 – 3.00) 
2.09 (0.60 – 3.00) 
2.57 (0.57 – 3.00) 
2.00 (0.14 – 3.00) 
1.86 (0.67 – 3.00) 
2.33 (0.00 – 3.00) 
2.50 (1.17 – 3.00) 
2.18 (0.67 – 2.95) 
2.50 (0.50 – 3.00) 
2.00 (0.00 – 3.00) 
2.57 (0.14 – 3.00) 
1.80 (0.00 – 3.00) 
1.79 (0.43 – 3.00) 
2.67 (0.33 – 3.00) 
2.50 (0.67 – 3.00) 
0.73 (0.37 – 1.46) 
1.07 (0.71 – 1.61) 
0.79 (0.49 – 1.30) 
0.82 (0.47 – 1.43) 
0.72 (0.49 – 1.05) 
0.87 (0.52 – 1.46) 
1.24 (0.78 – 1.97) 
0.80 (0.40 – 1.62) 
Data presented as OR’s and 95% CI. Binomial logistic regression analysis was used to compare patient under treatment 
with patients who dropped out treatment. The results are adjusted for age. 
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The results from the additional analyses of the non-ART and ART subgroups are 
presented in table 4. It was appropriate to perform these analyses as the PCQ-
Infertility total scores were significantly related to treatment type (Beta= -0.231; 
95%CI= -0.302 – -0.160; p = <0.001). In the non-ART subgroup, a lower score on 
the PCQ subscale ‘Respect for patients’ values’ was significantly related to higher 
dropout (OR 0.57; 95%CI 0.34 – 0.95). In the ART subgroup, a higher score on the 
PCQ subscale ‘Patient Involvement’ was associated with higher dropout (OR 2.39; 
95%CI 1.02 – 5.59). We found no significant differences within both subgroups for 
the additional clinic characteristics.  
 
 
Discussion 
 
This study shows that patients’ experiences with patient-centred fertility care are 
not related to dropout, as the PCQ-Infertility scores did not differ between patients 
who continue and patients who discontinue their fertility treatment. Also the 
additional clinic characteristics were not related to dropout. However, when 
focusing on subgroups of patients, the PCQ-Infertility subscale ‘Respect for patients’ 
values’ negatively predicted dropout in patients receiving non-ART treatments. 
Moreover, the subscale ‘Patient involvement’ was a positive predictor for dropout in 
patients undergoing ART treatments. These are important findings as clinic factors 
have rarely been studied as potential predictors of dropout. Therefore, the results of 
this study provide more insight into fertility clinics’ characteristics that do and do 
not predict dropout and the direction (i.e. positive or negative) in which this 
prediction might be. 
It is remarkable that the level of patient-centredness that patients assign to their 
clinic was not related to dropout, since both qualitative and quantitative studies 
showed that infertile patients consider their clinic’s level of patient-centredness very 
important (Van Empel et al., 2010b and 2011b; Dancet et al., 2011). A study of Van 
Empel et al. also demonstrated that patients were willing to trade of up to a third of 
their pregnancy rate for more patient-centred care (Van Empel et al., 2011b). 
Moreover, a lack of patient-centredness was found as the most common reason for 
patients to change clinics (Malin et al., 2001; Van Empel et al., 2011b). These 
findings notwithstanding, we can now conclude that, in our study setting, patients’ 
experiences with patient-centred care seem to be no optimal predictor for dropout. 
Still, it might be too restrictive to state that clinic factor could never be used as a 
predictor for dropout. Our study was performed within one European country, 
	
while it is known that quality of care varies according to cultural and social settings 
(Grol et al., 1999; Groenewegen et al., 2005; Valentine et al., 2008). Extending our 
study to a more international setting might, therefore, influence the results. 
Moreover, dropout in relation to patient-centred care could be more relevant for 
specific treatment types (Gameiro et al., 2012), as we have shown in our study. 
First, patients who received non-ART treatments had more change of dropping out 
when they scored lower on the ‘respect for patients’ values’ subscale (i.e. a negative 
predictor). It is already known from the literature that non-ART patients are 
generally more dissatisfied with their care than patients receiving ART treatments 
(van Empel et al., 2010a and 2011a; Mourad et al., 2010). This can be better 
understood, knowing that non-ART treatments are generally performed in less 
specialized fertility clinics, by more general gynaecologists compared with the more 
specialized gynaecologists and nurses in fertility centres. Our study showed that 
especially patients undergoing non-ART treatment are sensitive to the respect they 
receive from the professional team. As a result, paying less attention to patients’ 
values led to more dropout, which can be considered a negative effect in fertility 
care. Therefore, professionals treating non-ART patients should give these patients 
the personal attention they need and respect them in their values and needs.  
The second possible predictor for dropout in our additional analyses was ‘Patient 
involvement’. Patients receiving ART treatments were more likely to dropout when 
the level of patient involvement was higher (i.e. a positive predictor). Patients do 
not always know that they also have the option to withdraw from treatment. 
Achieving awareness of this and involving patients in the decision process could 
make this clear to them (Davison et al., 2006). Apparently, patients’ decision to 
discontinue treatment is taken more easily when they are well informed and 
involved in all treatment phases, as we have shown in our study. Other studies in 
fertility care illustrate this as well. For example, Van Peperstraten et al. found that 
empowering infertile patients by giving them a decision aid made them choose to 
replace fewer embryos in IVF (Van Peperstraten et al., 2010). Also, studies from 
other health care areas have shown the relation between patient empowerment and 
a reduction in care consuming (Stacey et al., 2011; Arterburn et al., 2012). From 
this point of view, dropping out or discontinuing treatment might be considered a 
positive choice in fertility care as it is well informed and without decisional conflict. 
This line of thought could shed light on the complex issue of dropout. Dropping out 
of treatment could be a positive, well-informed choice. The decisional process 
seems to be supported by involving patients in their care and by respecting their 
values regarding treatment options. On the other hand, a negative choice to 
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while it is known that quality of care varies according to cultural and social settings 
(Grol et al., 1999; Groenewegen et al., 2005; Valentine et al., 2008). Extending our 
study to a more international setting might, therefore, influence the results. 
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predictor). It is already known from the literature that non-ART patients are 
generally more dissatisfied with their care than patients receiving ART treatments 
(van Empel et al., 2010a and 2011a; Mourad et al., 2010). This can be better 
understood, knowing that non-ART treatments are generally performed in less 
specialized fertility clinics, by more general gynaecologists compared with the more 
specialized gynaecologists and nurses in fertility centres. Our study showed that 
especially patients undergoing non-ART treatment are sensitive to the respect they 
receive from the professional team. As a result, paying less attention to patients’ 
values led to more dropout, which can be considered a negative effect in fertility 
care. Therefore, professionals treating non-ART patients should give these patients 
the personal attention they need and respect them in their values and needs.  
The second possible predictor for dropout in our additional analyses was ‘Patient 
involvement’. Patients receiving ART treatments were more likely to dropout when 
the level of patient involvement was higher (i.e. a positive predictor). Patients do 
not always know that they also have the option to withdraw from treatment. 
Achieving awareness of this and involving patients in the decision process could 
make this clear to them (Davison et al., 2006). Apparently, patients’ decision to 
discontinue treatment is taken more easily when they are well informed and 
involved in all treatment phases, as we have shown in our study. Other studies in 
fertility care illustrate this as well. For example, Van Peperstraten et al. found that 
empowering infertile patients by giving them a decision aid made them choose to 
replace fewer embryos in IVF (Van Peperstraten et al., 2010). Also, studies from 
other health care areas have shown the relation between patient empowerment and 
a reduction in care consuming (Stacey et al., 2011; Arterburn et al., 2012). From 
this point of view, dropping out or discontinuing treatment might be considered a 
positive choice in fertility care as it is well informed and without decisional conflict. 
This line of thought could shed light on the complex issue of dropout. Dropping out 
of treatment could be a positive, well-informed choice. The decisional process 
seems to be supported by involving patients in their care and by respecting their 
values regarding treatment options. On the other hand, a negative choice to 
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dropout could be explained by an inability to continue because of emotional or 
other personal reasons. This is supported by studies indicating stress or emotional 
strain as reasons for dropout. In previous research, dropout is mainly considered as 
a negative decision as patients were unsatisfied with the organization of care or 
mentioned poor communicating skills of the staff as their reasons for 
discontinuation (Olivius et al., 2004; Haagen et al., 2008). The results of our study 
might indicate that patients’ decision to dropout of fertility care is more 
heterogeneous, as their decision was related to negative evaluations of patient-
centred care (i.e. less respect of patients’ values), but also to positive evaluations 
(i.e. more patient involvement). We might, therefore, speak about dropouts as 
following a positive or after a negative choice (Duggan et al., 2006). To underline 
or reject this hypothesis, more research is obviously needed, for example regarding 
the process underlying the decisions that infertile patients make. The results of our 
study could be helpful in the initiation of future research about this topic. 
This study has several strengths. First, we included more than 500 infertile women 
from all areas across the Netherlands, ensuring representativeness of the Dutch 
infertile population. Second, we included patients in different treatment phases, 
while previous studies mainly focused on patients undergoing IVF and/or ICSI 
treatments. By including such a varied group of patients, we were able to evaluate 
predictors of dropout in almost the entire setting of fertility care. Moreover, we 
performed additional analyses, enabling us to draw conclusions on the different 
treatment phases as well. Third, we explored all different elements of ‘clinic factors’ 
by including both ‘standard clinic characteristics’ (e.g. clinic size) and clinic factors 
evaluated by the patients themselves. By including the PCQ-Infertility questionnaire 
we were able to evaluate clinics from the perspective of the patients. Finally, we 
compared various patient characteristics between the dropouts and compliers, 
including patients’ quality of life, and corrected for them if necessary. We also 
added the non-responders to this comparison, showing that their background 
characteristics did not differ significantly from the patients we included in the 
analysis. 
Some limitations of this study should also be discussed. First, we were not able to 
follow up all 534 patients who provided consent for this study at T0, which might 
have biased our results. However, due to the effort of sending additional reminders, 
we managed to reach a response rate of >80% at the T1 measurement. It should, 
however, be noticed that the response rate of T0 was 58.4% and, subsequently, we 
lost 22.9% of patients between T0 and T1, because they were not willing to 
participate in our prospective study. Bias of our results is, therefore, more likely and 
	
should be taken into account when interpreting our results. Second, we only 
included patients who already started treatment for their fertility problem and, 
consequently, left out those patients who dropped out during or even before 
diagnostic fertility workup. Brandes et al. (2009) showed that already at this stage, 
patients dropout. However, the PCQ-Infertility was not validated for this group of 
patients, as they have not visited their clinic enough to evaluate it appropriately. 
Consequently, we decided not to include these patients in our study. Third, we used 
a definition for dropout that might be somewhat different from the definition used 
in several other studies. Generally, dropout is defined as every premature 
discontinuation of treatment in that particular clinic. As we included patients from 
different clinics across the Netherlands and from all different treatment types, our 
study setting was somewhat different. Consequently, patients also ended treatment 
in their clinic, because they needed a treatment in another clinic or simply had no 
more treatment options. Because of this specific situation, we decided to exclude 
these patients from the dropout group. Following the literature, these patients can 
be considered as ‘active censored’ or ‘physician-recommended dropouts’. 
Consequently, we included patients who were ‘passive censored’ or ‘patient-initiated 
dropouts’ (Smeenk et al., 2004; Van Dongen et al., 2010). We also excluded 
patients who went to another clinic because they were unsatisfied with their current 
clinic, as they did not fit our definitions of ‘dropouts’ or ‘compliers’. However, we 
considered this an interesting subgroup of patient and performed additional 
analyses on this group. We found no relation to dropout, but this could very well be 
due to the small sample size (n=12). 
The results of our study led to some recommendations for daily practice and future 
research. 
The fact that we did not find any association between clinic factors and dropouts in 
our entire patient group could imply that this association does not exist at all. If this 
is true, dropouts might be more related to factors at the patient and the treatment 
level and further research should concentrate on these elements. Another 
explanation for the lack of relationship between patient-centredness and dropout is 
the heterogeneity of the sample regarding the center, phase of treatment and 
treatment type. Despite the fact that we controlled for clinical characteristics and 
that we performed separate analyses for patients undergoing ART and non-ART 
treatments, the patients relate their scores on patient-centredness to their 
experience with their own clinic, which could explain the lack of significant 
relationships. In addition, dropout might be explained by a complex interplay of 
clinical, personal and treatment-related factors (Boivin et al., 2012). It is possible 
39426 Dongen, Angelique.indd   92 14-03-16   12:21
Patient-centred fertility care and dropout
93
5
	
dropout could be explained by an inability to continue because of emotional or 
other personal reasons. This is supported by studies indicating stress or emotional 
strain as reasons for dropout. In previous research, dropout is mainly considered as 
a negative decision as patients were unsatisfied with the organization of care or 
mentioned poor communicating skills of the staff as their reasons for 
discontinuation (Olivius et al., 2004; Haagen et al., 2008). The results of our study 
might indicate that patients’ decision to dropout of fertility care is more 
heterogeneous, as their decision was related to negative evaluations of patient-
centred care (i.e. less respect of patients’ values), but also to positive evaluations 
(i.e. more patient involvement). We might, therefore, speak about dropouts as 
following a positive or after a negative choice (Duggan et al., 2006). To underline 
or reject this hypothesis, more research is obviously needed, for example regarding 
the process underlying the decisions that infertile patients make. The results of our 
study could be helpful in the initiation of future research about this topic. 
This study has several strengths. First, we included more than 500 infertile women 
from all areas across the Netherlands, ensuring representativeness of the Dutch 
infertile population. Second, we included patients in different treatment phases, 
while previous studies mainly focused on patients undergoing IVF and/or ICSI 
treatments. By including such a varied group of patients, we were able to evaluate 
predictors of dropout in almost the entire setting of fertility care. Moreover, we 
performed additional analyses, enabling us to draw conclusions on the different 
treatment phases as well. Third, we explored all different elements of ‘clinic factors’ 
by including both ‘standard clinic characteristics’ (e.g. clinic size) and clinic factors 
evaluated by the patients themselves. By including the PCQ-Infertility questionnaire 
we were able to evaluate clinics from the perspective of the patients. Finally, we 
compared various patient characteristics between the dropouts and compliers, 
including patients’ quality of life, and corrected for them if necessary. We also 
added the non-responders to this comparison, showing that their background 
characteristics did not differ significantly from the patients we included in the 
analysis. 
Some limitations of this study should also be discussed. First, we were not able to 
follow up all 534 patients who provided consent for this study at T0, which might 
have biased our results. However, due to the effort of sending additional reminders, 
we managed to reach a response rate of >80% at the T1 measurement. It should, 
however, be noticed that the response rate of T0 was 58.4% and, subsequently, we 
lost 22.9% of patients between T0 and T1, because they were not willing to 
participate in our prospective study. Bias of our results is, therefore, more likely and 
	
should be taken into account when interpreting our results. Second, we only 
included patients who already started treatment for their fertility problem and, 
consequently, left out those patients who dropped out during or even before 
diagnostic fertility workup. Brandes et al. (2009) showed that already at this stage, 
patients dropout. However, the PCQ-Infertility was not validated for this group of 
patients, as they have not visited their clinic enough to evaluate it appropriately. 
Consequently, we decided not to include these patients in our study. Third, we used 
a definition for dropout that might be somewhat different from the definition used 
in several other studies. Generally, dropout is defined as every premature 
discontinuation of treatment in that particular clinic. As we included patients from 
different clinics across the Netherlands and from all different treatment types, our 
study setting was somewhat different. Consequently, patients also ended treatment 
in their clinic, because they needed a treatment in another clinic or simply had no 
more treatment options. Because of this specific situation, we decided to exclude 
these patients from the dropout group. Following the literature, these patients can 
be considered as ‘active censored’ or ‘physician-recommended dropouts’. 
Consequently, we included patients who were ‘passive censored’ or ‘patient-initiated 
dropouts’ (Smeenk et al., 2004; Van Dongen et al., 2010). We also excluded 
patients who went to another clinic because they were unsatisfied with their current 
clinic, as they did not fit our definitions of ‘dropouts’ or ‘compliers’. However, we 
considered this an interesting subgroup of patient and performed additional 
analyses on this group. We found no relation to dropout, but this could very well be 
due to the small sample size (n=12). 
The results of our study led to some recommendations for daily practice and future 
research. 
The fact that we did not find any association between clinic factors and dropouts in 
our entire patient group could imply that this association does not exist at all. If this 
is true, dropouts might be more related to factors at the patient and the treatment 
level and further research should concentrate on these elements. Another 
explanation for the lack of relationship between patient-centredness and dropout is 
the heterogeneity of the sample regarding the center, phase of treatment and 
treatment type. Despite the fact that we controlled for clinical characteristics and 
that we performed separate analyses for patients undergoing ART and non-ART 
treatments, the patients relate their scores on patient-centredness to their 
experience with their own clinic, which could explain the lack of significant 
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that clinical factors play a role in patients who experience a lot of distress. This 
means that the results of this study do not justify the exclusion of clinical factors as 
possible contributors to dropout. More in-depth analyses are warranted to control 
for clinical differences, which will require large samples. Obviously, predicting 
dropout in fertility care is complicated given the number of studies on this subject 
and their conflicting outcomes (De Vries et al., 1999; Sharma et al., 2002; Pelick et 
al., 2007; Verberg et al., 2008; Pearson et al., 2009; Domar et al., 2010; Custers et 
al., 2013). We have made a first initiative to show the relation between clinic 
factors and dropouts in a prospective setting. Future research should concentrate on 
more different patient, treatment and clinic factors and their possible interactions in 
order to identify appropriate predictors of dropout in fertility care. 
In conclusion, patients’ experiences with patient-centred fertility care are not 
related to dropout. However, within two subgroups of patients (i.e. receiving non-
ART and ART treatments) we have collected some clues that clinic factors could be 
used as a predictor for dropout in specific patient groups. In future research, it 
would be interesting to find more predictors of dropout at the patient, treatment 
and clinic levels and explore their possible interactions. Only then, will we gain an 
optimal insight into those factors influencing dropout, making it possible to account 
for them in daily clinical practice. 
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Abstract 
 
Study question: Is it feasible to evaluate a personalized e-therapy program 
(Internet based) for women during fertility treatment aimed to reduce the chance 
of having clinically relevant symptoms of anxiety and/or depression after 
unsuccessful assisted reproductive technology (ART) treatment within a 
randomized controlled trial (RCT)? 
Study answer: The evaluation of a personalized e-therapy program is feasible, 
reflected by good acceptability and integration within current guidelines, but 
adjustments to the e-therapy program and study design of the RCT have to be made 
to enhance demand, practicality and efficacy. 
What is known already: Internet-based interventions are promising in reducing 
psychological distress, especially when treatment is personalized to specific risk 
profiles of patients. However in fertility care, the beneficial effects of personalized 
e-therapy on psychological distress and its implementation in daily clinical care still 
have to be evaluated. 
Study design, size, duration: To evaluate the feasibility of a personalized e-
therapy program, we conducted a two-arm, parallel group, single-blind feasibility 
randomized controlled trial with a 1:1 allocation. Feasibility was assessed in terms 
of demand, acceptability, practicality, implementation, integration, and limited 
efficacy. Women were included between 1 February 2011 and 1 June 2013. Women 
in the control group received care as usual, whereas women in the intervention 
group received in addition to their usual care access to a personalized e-therapy 
program. Women were monitored until three months after the start of their first 
ART cycle. 
Participants, setting, methods: In a university hospital in the Netherlands 
women who were screened as at risk for emotional adjustment problems and 
intended to start their first ART cycle were invited, and of them 120 were 
randomized. Of these women, 48% in the intervention group were compliant to the 
intervention. Outcome measures associated with the feasibility to analyse this e-
therapy program within an RCT were assessed. 
Main results and the role of chance: It is feasible to evaluate a personalized 
e-therapy program within an RCT. The acceptability was good, as was the 
integration within current clinical guidelines and care. However, the demand 
reflected by a participation rate of 44% was low, since most women declined 
participation because they felt no need for support at that moment. The practicality 
of the intervention was moderate illustrated by a relatively high dropout rate (30%) 
	
due to practical concerns. The intervention was effective, showed by a reduction in 
the percentage women having clinically relevant symptoms of anxiety and/or 
depression in the compliant intervention group compared with the control group 
three months after the first ART cycle; risk difference of 24% (95% CI: 2 - 46%; 
p=0.03). 
Limitations, reasons for caution: The large non-participation rate (56%) 
needs further evaluation. This also could have influenced results on limited efficacy. 
Barriers for participation could be assessed more in-depth. Moreover, ~30% 
dropped out. This percentage is comparable with other e-health studies. Finally, this 
is a single-centre study. Generalizability could be enlarged by a multi-centre 
approach. 
Wider implications of the findings: In clinical fertility care, personalizing an 
e-therapy program to the patients’ risk profile is promising and feasible. However, 
in future studies, we recommend modification of the study protocol by for example 
offering the intervention to the preferred moment in the treatment process. 
Moreover, adjustment of the study protocol tailored to the found barriers and 
facilitators is needed. When performing a multicentre consecutive RCT to assess the 
effectiveness of personalized e-therapy in fertility care, the findings of this study, for 
example concerning the preferred timing or reasons for non-participation, could be 
helpful. 
 
 
Keywords: infertility, e-therapy, feasibility, anxiety, depression 
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Introduction 
 
Medical health problems and subsequent treatment can be a significant source of 
psychological distress. Psychological interventions to reduce this psychological 
distress are widely used nowadays and have shown positive effects, e.g., in the 
treatment of Type 1 diabetes or lower back pain (Winkley et al., 2006; Hoffman et 
al., 2007). 
Recently, Internet-based psychological interventions have been developed for and 
tested in chronically ill patients, e.g., in patients with mental disorders, diabetes or 
chronic respiratory diseases (Cuijpers et al., 2008; Nguyen et al., 2013; Andersson 
and Titov, 2014; Cotter et al., 2014). In addition, such kind of e-health programs 
have been developed to reduce psychological distress or to improve patient 
empowerment in patients undergoing treatment with specific stress moments, such 
as breast cancer patients undergoing surgery or chemotherapy (Van den Berg et al., 
2012). Most of these psychological interventions are based on variants of cognitive 
behavioural therapy (CBT), which is flexible, focused and time limited (Winkley et 
al., 2006; Andersson, 2009). 
In fertility treatment, it is known that many couples experience minor to severe 
emotional distress (Connolly et al., 1993; Cousineau and Domar, 2007; Verhaak et 
al., 2007; Volgsten et al., 2008; Boivin et al., 2012; Gameiro et al., 2013). Studies 
showed that 20 – 25% of the women experience severe symptoms of anxiety or 
depression after unsuccessful assisted reproductive technology (ART) treatment, 
which can reduce quality of life but could also have a negative impact on 
continuation of treatment, efficacy and cost-effectiveness of ART treatment 
(Verberg et al., 2008; Verhaak et al., 2010; Gameiro et al., 2013). 
Psycho-educational interventions and CBT are most effective in aiming to reduce 
distress levels of infertile patients (Domar et al., 2000; Boivin 2003; Faramarzi et 
al., 2008; Andersson, 2009). However, recent reviews and meta-analyses showed 
conflicting results for the efficacy of psychological interventions with respect to 
anxiety and depression in infertile patients, varying from a greater reduction in 
symptoms of anxiety than in depression to no efficacy with respect to mental health 
(Boivin 2003; De Liz and Straus, 2005; Haemmerli et al., 2009; Frederiksen et al., 
2015). Studies investigating psychological interventions in fertility care, online as 
well as face-to-face, encounter several methodological challenges comparable to 
studies investigating face-to-face interventions, e.g. high attrition levels, 
disproportionate number of dropouts, randomization problems, the need for 
intention-to-treat analysis and large sample sizes to yield significant results, and 
	
uncertainties around intervention dosage and the recruitment of a homogeneous 
sample to investigate (Domar et al., 2000; Cousineau et al., 2008; Frederiksen et al., 
2015). This causes difficulties in the interpretation and in comparison of the results. 
The adjusted CONSORT criteria could be used to optimize the conducting and 
description of a trial studying an e-health intervention and the methodology of such 
a trial (Baker et al., 2010). To gain insight into all these factors, the feasibility of 
performing a RCT should be studied first. 
Although psychological distress is an important factor in ART treatment, a limited 
number of women have access to psychosocial interventions (Boivin et al., 1999; 
Van Dongen et al., 2012; Gameiro et al., 2013). This seems to be due to logistic and 
financial constraints to get psychotherapy, but also to a lack of knowledge about 
what psychotherapy could offer for a specific individual situation (Boivin et al., 
1999). Furthermore, tailoring interventions to specific patient groups is 
recommended by recent studies and reviews on CBT for patients with chronic 
somatic conditions (Evers et al., 2002; Van Koulil et al., 2011; Van Beugen et al., 
2014, Frederiksen et al., 2015). The efficacy of psychosocial interventions in fertility 
care too might be influenced by the fact that they are offered to patients 
irrespective of their psychosocial vulnerability and to all women in different phases 
of treatment. From this perspective, we developed a personalized e-therapy 
program in fertility care. This e-therapy program is an intensive tailored 
intervention using psycho-education about emotional responses to different aspects 
of infertility and CBT aimed to increase a more adaptive coping behaviour and to 
encourage more helpful cognitions regarding treatment and its outcome. The e-
therapy program is tailored to the specific mental health risks of individual patient 
and follows the course of the ART cycle. 
Therefore, we performed a feasibility RCT, aimed to identify which modifications 
are needed in the study protocol and intervention to test efficacy within an RCT 
(Bowen et al., 2009). The results can be helpful in the design of a consecutive or 
main study investigating the effects of a personalized intervention (Bowen et al., 
2009; Arain et al., 2010; Visser et al., 2015). Moreover, important information 
could be obtained for the implementation of psychological interventions in fertility 
care and for the best way to personalize interventions to specific needs of patients. 
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The adjusted CONSORT criteria could be used to optimize the conducting and 
description of a trial studying an e-health intervention and the methodology of such 
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number of women have access to psychosocial interventions (Boivin et al., 1999; 
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financial constraints to get psychotherapy, but also to a lack of knowledge about 
what psychotherapy could offer for a specific individual situation (Boivin et al., 
1999). Furthermore, tailoring interventions to specific patient groups is 
recommended by recent studies and reviews on CBT for patients with chronic 
somatic conditions (Evers et al., 2002; Van Koulil et al., 2011; Van Beugen et al., 
2014, Frederiksen et al., 2015). The efficacy of psychosocial interventions in fertility 
care too might be influenced by the fact that they are offered to patients 
irrespective of their psychosocial vulnerability and to all women in different phases 
of treatment. From this perspective, we developed a personalized e-therapy 
program in fertility care. This e-therapy program is an intensive tailored 
intervention using psycho-education about emotional responses to different aspects 
of infertility and CBT aimed to increase a more adaptive coping behaviour and to 
encourage more helpful cognitions regarding treatment and its outcome. The e-
therapy program is tailored to the specific mental health risks of individual patient 
and follows the course of the ART cycle. 
Therefore, we performed a feasibility RCT, aimed to identify which modifications 
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Methods 
 
The feasibility approach of Bowen et al. distinguishes several areas of feasibility 
(Bowen et al., 2009). The following outcome measures were applicable in our 
study: demand, acceptability, practicality, implementation, integration and limited 
efficacy. To describe the intervention we used the Template for Intervention 
Description and Replication (TIDieR) checklist (Hoffmann et al., 2014). In addition, 
we used the CONSORT guideline for e-health interventions to describe this research 
(Baker et al., 2010). 
 
Trial 
 
Design 
We analysed the feasibility to determine how the intervention should be tested 
further. Therefore, we carried out a single-centre, two-arm, parallel group, single-
blind feasibility RCT with a 1:1 allocation. The main investigator was blinded for 
the randomization during data collection. Patients and counsellors were of course 
aware of the randomization results. 
Ethical approval was obtained by the Arnhem – Nijmegen ethical committee, the 
Netherlands (CMO Regio Arnhem – Nijmegen; ID number 2009/186 and ABR 
number NL27876.091.09). All patients gave written informed consent before 
participation in this study. The trial was registered at ClinicalTrials.gov, number 
NCT 01283607. 
 
Randomization 
After having obtained written informed consent, randomization took place using 
sealed envelopes. Participants were randomized in a 1:1 allocation. To ensure the 
allocation concealment, an independent collaborator randomly assigned the women 
to the intervention or control group. She opened one of the sealed envelopes 
(containing either a leaflet “control” or “intervention”) and informed the patient of 
the result and the e-therapists when there was a participant for the intervention 
group. The main investigator and the clinical staff of the fertility department were 
blinded for the results of the randomization. The e-therapists, their supervisor and 
the participants were aware of the randomization result. 
 
Participants 
Participants were eligible for participation depending on the results of a 
	
psychosocial screening with SCREENIVF, a psychological screening instrument that 
provides a risk profile for mental health problems. 
 
Psychosocial screening 
We invited women who were at risk for emotional maladjustment according to 
SCREENIVF to participate in this study. SCREENIVF is a validated instrument to 
detect women at risk for emotional maladjustment before the start of an ART 
treatment (Verhaak et al., 2010). The SCREENIVF questionnaire is based on 
previously identified risk factors for emotional maladjustment and therefore 
consists of assessments of symptoms of anxiety and depression, cognitions of 
helplessness and acceptance regarding fertility problems, and perceived social 
support (Verhaak et al., 2010). The use of this screening tool results in a risk 
profile. Patients reporting clinical relevant symptoms on one of the five risk factors 
were considered as at risk for emotional maladjustment. SCREENIVF is 
implemented in daily care in the participating hospital; all patients starting an ART 
treatment are invited to fill out this short questionnaire with a response rate of 78 –  
80% (Van Dongen et al., 2012). 
 
Eligibility criteria for participants 
Women who were about to start their first cycle of ART treatment ever, or their first 
cycle after having achieved an ongoing pregnancy after previous ART, and who 
were at risk for emotional maladjustment according to SCREENIVF were eligible for 
participation in this feasibility study. We included women between 1 February 2011 
and 1 June 2013. We excluded women using donor gametes, having difficulties to 
communicate in Dutch or English language, or having no access to Internet. Based 
on previous reported criteria, patients scoring 13 or higher on one of the Hospital 
Anxiety and Depression Scale (HADS) measurements were directly referred to a 
counsellor and therefore were excluded from this study (Ravazi et al., 1990). 
Finally, women who already had started their ART treatment were also excluded. 
 
Setting 
This study was performed at the Radboud University Nijmegen Medical Centre in 
Nijmegen, a medium-sized city in the Netherlands. Indication for in vitro 
fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment was set 
according to the national clinical guideline formulated by the Dutch Society for 
Obstetrics and Gynaecology (NVOG) (http://www.nvog.nl). In the Netherlands, the 
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participation in this feasibility study. We included women between 1 February 2011 
and 1 June 2013. We excluded women using donor gametes, having difficulties to 
communicate in Dutch or English language, or having no access to Internet. Based 
on previous reported criteria, patients scoring 13 or higher on one of the Hospital 
Anxiety and Depression Scale (HADS) measurements were directly referred to a 
counsellor and therefore were excluded from this study (Ravazi et al., 1990). 
Finally, women who already had started their ART treatment were also excluded. 
 
Setting 
This study was performed at the Radboud University Nijmegen Medical Centre in 
Nijmegen, a medium-sized city in the Netherlands. Indication for in vitro 
fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment was set 
according to the national clinical guideline formulated by the Dutch Society for 
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costs of the first three fresh IVF or ICSI cycles are currently reimbursed by the 
national healthcare system. 
 
Intervention  
The personalized e-therapy program is described according to the guidelines 
developed by Hoffmann et al. (Hoffmann et al., 2014). The e-therapy program was 
aimed to reduce the number of women scoring above the clinically relevant scores 
for anxiety and/or depression after their first unsuccessful ART cycle. Women 
assigned to the control group received care as usual, in terms of access to a 
counsellor or psychologist on request. Women assigned to the e-therapy group 
received access to a personalized e-therapy program, in addition to the usual care.  
The brief name for the e-therapy program was ‘Digicoach’. The e-therapy program 
consisted of digital psycho-education and CBT. Online text providing psycho-
education as well as exercises that were presented as ‘home work’ were offered and 
aimed to support more adaptive coping behaviour and more helpful cognitions 
regarding treatment and its outcome. Content was based on standard CBT 
interventions personalized to the situation of patient undergoing ART treatment, for 
example working with identifying and changing cognitions, relaxation exercises and 
interventions aimed to improve asking for support. In addition, the program 
followed the ART treatment phases e.g., by support the patients in identifying stress 
evoking aspects of the ART treatment as well as planning daily activities adjusted to 
the treatment schedule. Patients could monitor their distress and complete their 
exercises using online forms that could be sent to an e-therapist. The e-therapist 
commented on the exercises on a fixed day every week, using the same online form. 
Patients got access to one session every week. When they completed a session, 
another session was presented to them. A pilot study including five women was 
performed before starting this study to optimize the e-therapy program (Verhaak, et 
al., 2008). The intervention was not modified during this study. 
Before starting the e-therapy an intake meeting took place between the patient and 
e-therapist in which a diagnostic interview was carried out. The results of the at risk 
screening and this intake meeting determined which module was followed. In 
addition, during the intake meeting the e-therapist informed the woman about the 
content of the e-therapy program and how to use it. After this intake meeting, the 
woman started the e-therapy program supported by an e-therapist, who was the 
same person as the one who carried out the intake meeting. The woman followed 
one module during five weeks and was able to start a second module when this was 
possible within the course of the first treatment cycle. 
	
Modules 
Women could be assigned to three different modules in the e-therapy program: 
‘stress management’, ‘depressed mood’ or ‘social support’. In the module ‘stress 
management’ the focus was on relaxation, identifying stress symptoms and 
anticipating on upcoming stressful events, using for example self-monitoring to 
identify stress symptoms or relaxation assignments. The module ‘depressed mood’ 
was focused on identifying automatic thoughts and the relationship between 
thoughts, feelings and behaviour, supported by online forms for indicating these 
thoughts, feelings and behaviour and for formulating alternative thoughts aimed to 
increase positive mood. In the module ‘social support’ the focus was on identifying 
individual needs, communication of the needs with the partner or other important 
people involved, and balancing social expectations and actual social support. 
Examples of tasks in this module are the identification of emotionally loaded 
moments in daily life or writing a letter to your partner or best friend. Two e-
therapists carried out the intake meetings and had weekly contact with the 
participants. Both e-therapists were registered as counsellor specialized in fertility 
care. Weekly, responses of patients were discussed in the psychosocial therapeutic 
team consisting of the two e-therapists and their supervisor (an experienced clinical 
psychologist in fertility care and in e-therapy). Because of the e-health character of 
the intervention, therapeutic interventions could be prepared and discussed within 
the therapeutic team before being sent to the patient. This makes this e-health 
intervention less vulnerable for differences in experience between counsellors.  
Participants logged in at home, weekly, at the time that suited them best. 
Depending on the intake meeting and the available time frame, the women 
followed one or more modules. A module took five weeks to complete. Between 
two modules, there was one week with only e-mail contact with the e-therapist and 
without assignments. The e-therapy program was available during the whole ART 
treatment cycle, including the waiting period after the embryo transfer. 
 
 
Outcomes 
We analysed the feasibility of the evaluation of a personalized e-therapy program in 
daily clinical care according to Bowen et al. (Bowen et al., 2009). 
 
Demand 
We assessed the demand in terms of the percentage of patients agreeing to 
participate compared with the total number of eligible patients. Reasons for non-
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without assignments. The e-therapy program was available during the whole ART 
treatment cycle, including the waiting period after the embryo transfer. 
 
 
Outcomes 
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participation were assessed. The results of the at risk scores according to 
SCREENIVF were compared between participants and non-participants. 
 
Acceptability 
Next, we assessed the acceptability of the personalized e-therapy program. 
Therefore, intent to continued use and satisfaction were assessed. To assess 
continued use of the program we analysed dropout rate and the reasons for 
dropout. 
 
Practicality 
We considered practicality as the time investment of the participants and the 
dropout during the e-therapy program due to practical concerns. Moreover, 
willingness to pay was assessed. Finally, we determined how many women used the 
intervention as we intended. Therefore, we defined three groups: one compliant 
intervention group who used the e-therapy program as intended without additional 
psychosocial support. We assumed that women who completed at least one 
complete module (five weeks) and who had 10 or more logins during this period 
(one login each week to read the comments of the therapist and one login to 
complete the home work exercises) were compliant to the e-therapy program. The 
second group is the control group, who did not receive the e-therapy program nor 
additional psychosocial support. Finally, the residual group consisting of women 
randomized either to the intervention or the control group and who were either not 
compliant to the intervention or received additional face-to-face psychosocial 
support. 
 
Integration and Implementation 
We assessed the perceived fit of the intervention in the current clinical guidelines 
for psychosocial care (Gameiro et al., 2015). In addition, barriers and facilitators for 
implementation in daily clinical care were evaluated. 
 
Limited efficacy 
We assessed the intended effects of the personalized e-therapy limitedly. Therefore, 
we performed a per-protocol analysis in a compliant group of women and an 
intention-to-treat analysis in the whole group to assess the effect in daily clinical 
care. We determined to what extent the intervention worked as expected, i.e. 
showing lower levels of anxiety and depression in those who used the intervention 
as intended compared with the control group without additional psychosocial 
	
support. Moreover, the outcome of the ART treatment was assessed. An ART 
treatment was considered successful when there was an ongoing pregnancy (above 
seven weeks of gestation) determined by a positive heartbeat by ultrasound 
examination. 
We analysed the percentage of women having clinically relevant symptoms of 
anxiety and/or depression according to the HADS (score above 8) both in the 
compliant group versus a control group as well as in all participating women, at the 
different measure points. 
 
Data collection 
Data collection was performed by phone calls and through questionnaires sent to 
the participants by mail. If they did not return the questionnaire within 3 weeks, a 
reminder - and several weeks later a second reminder - was sent. Questionnaires 
were sent at four different time points: directly after randomization (T0); during 
the ART stimulation phase just before retrieval of eggs (T1); two weeks after the 
pregnancy test (T2); and three months after the first ART cycle (T3). The time 
frame of the trial is showed in figure 1. At T2, an additional process evaluation 
questionnaire was sent asking for personal evaluation of the intervention. We 
recorded the reasons for non-response by phone call in the women who were 
eligible for participation in the RCT but declined this. Potential harms of the e-
therapy program were reported by the therapeutic team and were inquired in the 
questionnaires. 
 
Demographics 
We assessed demographic information, e.g., age, duration of infertility and cause of 
infertility. 
 
Psychological data 
We used data obtained by the Hospital Anxiety and Depression Scale (HADS). The 
HADS consists of 14 items assessing anxiety and depression from the Dutch 
translation of the HADS (Snaith, 2003). 
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Figure 1: Time frame of trial and response rate of questionnaires, showed by randomization group (DI is intervention 
group, also called ‘Digicoach’; C is control group). 
 
Screening T0 Egg punctionStart ARTRandomisation T1
T0: 91.7%*
-DI: 95.1%
-C: 86.4%
T1: 75%
-DI: 73.8%
-C: 74.6%
Pregnancy test T2 T3
2 weeks 3 months
T2: 66.7%
-DI: 62.3%
-C: 71.2%
T0: 65.8%
-DI: 59.0%
-C: 71.2%
* response rate in percentages (%) 
 
 
Sample size 
We assessed limited efficacy by analysing intended effects of the e-therapy program. 
Therefore, we calculated which sample size was needed to yield significant results. 
We assumed that by participation in the e-therapy program the percentage of 
women having clinically relevant scores on anxiety and/or depression after an 
unsuccessful ART treatment could be decreased by 28 percentage points, from 48% 
to 20%. This percentage of 48% can be based on earlier research in a comparable 
setting (Verhaak et al., 2010). When using an alpha of 0.05 and a power of 80%, 
we would need 72 non-pregnant women for analysis. Therefore, when performing 
limited efficacy testing within an RCT and assuming a dropout rate of 20% and a 
pregnancy rate after ART of 25%, this corresponds to a total of 120 women who 
should be included: 60 in the intervention and 60 in the control group. 
 
Statistical methods 
We analysed the data using SPSS (version 20.0 for Windows*, SPSS Inc., IBM, 
Chicago, IL, USA). A two-sided p-value lower than 0.05 was considered statistically 
significant. Continuous variables were presented with means and standard 
	
deviations (SDs) and categorical variables with absolute numbers and frequencies. 
Between-group comparisons were performed by means of t-tests (continuous 
variables) or Fisher’s exact tests (categorical or dichotomous variables). 
Data concerning demand, acceptability and practicality were analysed using 
descriptive statistics. Factors affecting integration and implementation were 
described. 
To analyse limited efficacy of the intervention, we compared the results of the 
compliant intervention group with the control group without any psychosocial 
support. We analysed the chance of showing clinically relevant symptoms of anxiety 
and/or depression in the non-pregnant women in the two study groups by means of 
generalized estimating equations (GEEs), using a binomial distribution and an 
identity link, resulting in estimated risk differences at the various time points (Liang 
et al., 1986). A dichotomized HADS score for depression and/or anxiety based on a 
cut-off value of >8 (i.e. yes/no clinically relevant score) was used as dependent 
variable. The HADS score at the time of screening was used as co-variable, and 
other independent variables were treatment group (intervention yes/no), time 
point (T0/T1/T2/T3) and the interaction of time and treatment (time point  
treatment). Use of an exchangeable correlation structure for the repeated measures 
resulted in the best model fit according to the Corrected Quasi-likelihood under 
Independence Model Criterion (QICC criterion). High depression and high anxiety 
scores (>8) were separately analysed with Fisher’s exact tests; here the GEE models 
did not converge. 
In addition, we performed an intention-to-treat analysis to evaluate the effect of the 
intervention in all participation women. Therefore, we analysed the chance of 
showing clinically significant symptoms of anxiety and/or depression in the 
intervention group using the GEEs as described before, and compared this with the 
control group. 
The analyses were based on non-pregnant women, i.e. all women up to T1, and the 
non-pregnant women from T2 onwards. 
 
 
Results 
 
Participant flow 
Overall during the recruitment period of 28 months, 314 women were assessed as 
at risk for emotional maladjustment. We excluded 43 (14%) women, mainly 
because they already had started the ART treatment before their risk assessment   
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Independence Model Criterion (QICC criterion). High depression and high anxiety 
scores (>8) were separately analysed with Fisher’s exact tests; here the GEE models 
did not converge. 
In addition, we performed an intention-to-treat analysis to evaluate the effect of the 
intervention in all participation women. Therefore, we analysed the chance of 
showing clinically significant symptoms of anxiety and/or depression in the 
intervention group using the GEEs as described before, and compared this with the 
control group. 
The analyses were based on non-pregnant women, i.e. all women up to T1, and the 
non-pregnant women from T2 onwards. 
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Figure 2: Trial profile 
 
  Assessed for eligibility (n=314) 
Excluded (n=194) 
- HADS subscale score > 13 (n=4) 
- Spontaneously pregnant (n=4) 
- Language barrier (n=6) 
- No Internet availability (n=3) 
- Already started IVF treatment (n=13)	
	Other reasons (n=13) 
- Declined to participate (n=151) 
Allocated to e-coaching program (n=61) 
- Received e-coaching program (n=58) 
	Withdrew after randomization (n=3)	
Allocated to usual care (n=59) 
- Received usual care (n=51) 
- Withdrew after randomization (n=8) 
	
Allocation 
Randomized (n=120) 
Enrollment 
Analysed at T3, compliant group (n=12) 
- Excluded because of pregnancy (n=11)	
Analysed at T3, compliant group (n=25) 
- Excluded because of pregnancy (n=9)	
	
Lost to follow-up at T2 (withdrew) (n=20)	 Lost to follow-up at T2 (withdrew) (n=9)	
	
Follow-Up 
Analysed at T2, compliant group (n=13) 
- Excluded because of pregnancy (n=13)	
	
Analysed at T2, compliant group (n=24) 
- Excluded because of pregnancy (n=10) 	
Per-protocol analysis 
Analysed at T3 (n=22) 
- Excluded because of pregnancy (n=9)	
Analysed at T3 (n=31) 
- Excluded because of pregnancy (n=11)	
	
Analysed at T2 (n=22) 
- Excluded because of pregnancy (n=16)	
	
Analysed at T2 (n=30) 
- Excluded because of pregnancy (n=12) 
	
Intention-to-treat analysis 
	
was available. Other reasons were a score on anxiety or depression above 13 (n = 
4), a spontaneously achieved pregnancy (n = 4), a language barrier (n=6) or no 
Internet availability (n = 3). Of the 271 eligible women, 120 (44%) consented to 
participate. They were randomly assigned to the intervention group (61) or the 
control group (59) (figure 2). 
 
Recruitment 
We recruited women for participation between 1 February 2011 and 1 June 2013, 
and follow-up data were obtained up to three months after the first ART cycle, until 
January 2014. There were no relevant changes in the e-therapy program or the 
assessment, or in Internet resources or Internet delivery. 
 
Demand 
Of all women who were eligible for participation during the study period, 151 out 
of 271 (56%) declined to participate. Reasons for non-participation could be 
assessed in 51% of them. Most of them (44%) declared they were not interested in 
participation or did not need support at that moment. A minority of them assumed 
language problems (5%) or preferred personal contact (4%). Of all non-
participants, 10% did not start ART. After the first ART cycle the pregnancy rate 
was 28% in the non-responders versus 33% in the responders (p=0.43). 
 
Risk profiles 
The majority of the non-responders scored above the cut-off for clinical forms of 
helplessness (70%) versus 82% of the responders (p=0.03). Of the non-responders 
36% showed clinical relevant symptoms of anxiety versus 35% of the responders 
(p=0.90). A minority of the non-responders showed clinical relevant symptoms of 
depression (6%) versus 8% of the responders (p=0.63). Of the non-responders, 
27% were screened at risk for two or more risk factors compared with 38% of the 
responders (p= 0.07). 
 
Acceptability 
In total, 11 (9%) women declined further participation directly after 
randomization. Two weeks after the pregnancy test, another 29 women (24%) had 
withdrawn participation to the study (Figure 1). Of them, 15% (6 of 40) dropped 
out because of acceptability reasons (i.e. “did not want to continue the study”). In 
total, 55% of the dropouts did not mention their reason to withdrawn to the study. 
Three months after ART treatment, participants evaluated the e-therapy program 
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was available. Other reasons were a score on anxiety or depression above 13 (n = 
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January 2014. There were no relevant changes in the e-therapy program or the 
assessment, or in Internet resources or Internet delivery. 
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of 271 (56%) declined to participate. Reasons for non-participation could be 
assessed in 51% of them. Most of them (44%) declared they were not interested in 
participation or did not need support at that moment. A minority of them assumed 
language problems (5%) or preferred personal contact (4%). Of all non-
participants, 10% did not start ART. After the first ART cycle the pregnancy rate 
was 28% in the non-responders versus 33% in the responders (p=0.43). 
 
Risk profiles 
The majority of the non-responders scored above the cut-off for clinical forms of 
helplessness (70%) versus 82% of the responders (p=0.03). Of the non-responders 
36% showed clinical relevant symptoms of anxiety versus 35% of the responders 
(p=0.90). A minority of the non-responders showed clinical relevant symptoms of 
depression (6%) versus 8% of the responders (p=0.63). Of the non-responders, 
27% were screened at risk for two or more risk factors compared with 38% of the 
responders (p= 0.07). 
 
Acceptability 
In total, 11 (9%) women declined further participation directly after 
randomization. Two weeks after the pregnancy test, another 29 women (24%) had 
withdrawn participation to the study (Figure 1). Of them, 15% (6 of 40) dropped 
out because of acceptability reasons (i.e. “did not want to continue the study”). In 
total, 55% of the dropouts did not mention their reason to withdrawn to the study. 
Three months after ART treatment, participants evaluated the e-therapy program 
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with a mean grade of 6.6 (SD 1.9) out of 10. Women who were compliant to the 
intervention graded the e-therapy program with a 6.7 (SD 1.7) compared with 5.8 
(SD 2.9) in women who were not compliant to the intervention (p=0.31). On 
beforehand, 55% had different expectations of the intervention. In the compliant 
group, 55% indicated that the intervention met their expectations, and 38% 
considered the e-therapy program as a good approach to receive psychosocial 
support during an ART cycle. Women in the compliant group assessed the different 
assignments as the most useful part of the e-therapy. 
 
Practicality 
Overall, the mean duration of participation in the program of women was 5.0 
weeks (SD 2.4; median 5.0) with a median amount of logins of 21.5 (range 2 - 
138), which was in line with the duration of one module. There was no statistically 
significant difference in prevalence of face-to-face psychological support during or 
after the first ART cycle between both study groups (intervention group 5% versus 
control group 19%, p=0.14). Of the participating women, 30% (12 of 40) dropped 
out due to practical concerns, for example achieving a spontaneous pregnancy 
(10%) or not starting ART treatment (20%). In 90% of all participants, there was 
no willingness to pay for this intervention. Finally, we assessed the rate of women 
who followed the study protocol as we intended. Twenty-nine women were 
randomized to the intervention group and used the intervention as intended (48% 
of the total intervention group), further referred as the compliant group. The 
second group consists of women randomized to the control group who did not 
receive additional psychosocial support (n = 51). Forty women did not meet the 
criteria of compliance, of them 8 (14%) in the control group and 32 (52%) in the 
intervention group. 
 
Integration and implementation 
This study fits into current clinical guidelines on psychosocial care in infertility and 
medically assisted reproduction (Gameiro et al., 2015). Barriers for participation 
and intended use are described earlier (demand, acceptability, practicality). 
 
Limited efficacy 
Table 1 shows the baseline characteristics for all randomized women. The results 
for the pregnant and non-pregnant women were similar. After the first ART 
treatment cycle, the pregnancy rate did not differ significantly between the 
intervention group and the control group (respectively, 38% versus 27%; p= 0.22). 
	
Until the time point T2, we were able to analyse data of 80 of the 120 women 
(67%): 38 in the intervention group versus 42 in the control group. Of them, 52 
were non-pregnant: 22 of the 38 women in the intervention group versus 30 of the 
42 women in the control group. Three months after the first ART cycle, data of 78 
of the 120 women (65%) were available: 36 in the intervention group versus 42 in 
the control group. Of them, 53 were non-pregnant: 22 of the 36 women in the 
intervention group versus 31 of the 42 women in the control group. Response rates 
at the different time points are showed in figure 1. 
 
 
Table 1: Baseline characteristics, data of all women in the intervention (Digicoach) group and the control group.  
 
 Digicoach (n=61) Control (n=59) 
Age (mean, SD), in years 32.0 (4.1) 32.4 (4.8) 
Duration of infertility (mean, SD), in months 38.2 (23.2) 36.5 (18.6) 
Pregnancy (n, %) 23 (37.7) 16 (27.1) 
Cause of infertility (n, %) 
- male 
- female 
- both 
- unexplained 
 
25 (43.1) 
9 (15.5) 
7 (12.1) 
17 (29.3) 
 
26 (50.0) 
7 (13.5) 
3 (5.8) 
16 (30.8) 
Primary infertility (n, %) 45 (77.6) 39 (76.5) 
Educational attainment* (n, %) 
- high 
 
25 (43.1) 
 
26 (51.0) 
Ethnicity** (n, %) 
- Dutch 
 
54 (93.1) 
 
42 (80.8) 
Psychological support (n, %) 
- at the moment of inclusion 
- in the past 
 
9 (15.5) 
23 (39.7) 
 
9 (17.3) 
22 (42.3) 
Earlier IVF treatment (n, %) 6 (10.3) 6 (11.8) 
Results for non-pregnant women are similar (data not shown). 
*high = higher professional education or university. Other women were low (primary or lower vocational education) or 
medium (secondary or intermediate vocational education) level educated. 
**For ethnic background the “Statistics Netherlands” classification was used. The Dutch governmental institute 
classifies ethnicity according to citizen’s country of birth and to that of their parents. Immigrants include both those 
who are foreign-born (first generation) and those who have at least one foreign-born parent (second generation). 
Categories were: (1) Dutch, (2) Western (Europe, USA, Canada, Australia, New Zealand, Japan and Israel) or (3) Non-
Western (immigrants from remaining countries, including Morocco, Surinam and Turkey). 
 
 
Per-protocol analysis 
All women were analysed up to T1 (egg retrieval); from T2 onwards only the non-
pregnant women were analysed. Two weeks after the pregnancy test, an estimated 
29% (95% confidence interval [CI]: 14 – 43%) of the women in the compliant 
intervention group had clinically relevant symptoms of anxiety and/or depression 
versus 42% (95%CI: 23 – 61%) of the women in the control group who did not 
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with a mean grade of 6.6 (SD 1.9) out of 10. Women who were compliant to the 
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(SD 2.9) in women who were not compliant to the intervention (p=0.31). On 
beforehand, 55% had different expectations of the intervention. In the compliant 
group, 55% indicated that the intervention met their expectations, and 38% 
considered the e-therapy program as a good approach to receive psychosocial 
support during an ART cycle. Women in the compliant group assessed the different 
assignments as the most useful part of the e-therapy. 
 
Practicality 
Overall, the mean duration of participation in the program of women was 5.0 
weeks (SD 2.4; median 5.0) with a median amount of logins of 21.5 (range 2 - 
138), which was in line with the duration of one module. There was no statistically 
significant difference in prevalence of face-to-face psychological support during or 
after the first ART cycle between both study groups (intervention group 5% versus 
control group 19%, p=0.14). Of the participating women, 30% (12 of 40) dropped 
out due to practical concerns, for example achieving a spontaneous pregnancy 
(10%) or not starting ART treatment (20%). In 90% of all participants, there was 
no willingness to pay for this intervention. Finally, we assessed the rate of women 
who followed the study protocol as we intended. Twenty-nine women were 
randomized to the intervention group and used the intervention as intended (48% 
of the total intervention group), further referred as the compliant group. The 
second group consists of women randomized to the control group who did not 
receive additional psychosocial support (n = 51). Forty women did not meet the 
criteria of compliance, of them 8 (14%) in the control group and 32 (52%) in the 
intervention group. 
 
Integration and implementation 
This study fits into current clinical guidelines on psychosocial care in infertility and 
medically assisted reproduction (Gameiro et al., 2015). Barriers for participation 
and intended use are described earlier (demand, acceptability, practicality). 
 
Limited efficacy 
Table 1 shows the baseline characteristics for all randomized women. The results 
for the pregnant and non-pregnant women were similar. After the first ART 
treatment cycle, the pregnancy rate did not differ significantly between the 
intervention group and the control group (respectively, 38% versus 27%; p= 0.22). 
	
Until the time point T2, we were able to analyse data of 80 of the 120 women 
(67%): 38 in the intervention group versus 42 in the control group. Of them, 52 
were non-pregnant: 22 of the 38 women in the intervention group versus 30 of the 
42 women in the control group. Three months after the first ART cycle, data of 78 
of the 120 women (65%) were available: 36 in the intervention group versus 42 in 
the control group. Of them, 53 were non-pregnant: 22 of the 36 women in the 
intervention group versus 31 of the 42 women in the control group. Response rates 
at the different time points are showed in figure 1. 
 
 
Table 1: Baseline characteristics, data of all women in the intervention (Digicoach) group and the control group.  
 
 Digicoach (n=61) Control (n=59) 
Age (mean, SD), in years 32.0 (4.1) 32.4 (4.8) 
Duration of infertility (mean, SD), in months 38.2 (23.2) 36.5 (18.6) 
Pregnancy (n, %) 23 (37.7) 16 (27.1) 
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- male 
- female 
- both 
- unexplained 
 
25 (43.1) 
9 (15.5) 
7 (12.1) 
17 (29.3) 
 
26 (50.0) 
7 (13.5) 
3 (5.8) 
16 (30.8) 
Primary infertility (n, %) 45 (77.6) 39 (76.5) 
Educational attainment* (n, %) 
- high 
 
25 (43.1) 
 
26 (51.0) 
Ethnicity** (n, %) 
- Dutch 
 
54 (93.1) 
 
42 (80.8) 
Psychological support (n, %) 
- at the moment of inclusion 
- in the past 
 
9 (15.5) 
23 (39.7) 
 
9 (17.3) 
22 (42.3) 
Earlier IVF treatment (n, %) 6 (10.3) 6 (11.8) 
Results for non-pregnant women are similar (data not shown). 
*high = higher professional education or university. Other women were low (primary or lower vocational education) or 
medium (secondary or intermediate vocational education) level educated. 
**For ethnic background the “Statistics Netherlands” classification was used. The Dutch governmental institute 
classifies ethnicity according to citizen’s country of birth and to that of their parents. Immigrants include both those 
who are foreign-born (first generation) and those who have at least one foreign-born parent (second generation). 
Categories were: (1) Dutch, (2) Western (Europe, USA, Canada, Australia, New Zealand, Japan and Israel) or (3) Non-
Western (immigrants from remaining countries, including Morocco, Surinam and Turkey). 
 
 
Per-protocol analysis 
All women were analysed up to T1 (egg retrieval); from T2 onwards only the non-
pregnant women were analysed. Two weeks after the pregnancy test, an estimated 
29% (95% confidence interval [CI]: 14 – 43%) of the women in the compliant 
intervention group had clinically relevant symptoms of anxiety and/or depression 
versus 42% (95%CI: 23 – 61%) of the women in the control group who did not 
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receive additional psychosocial support (risk difference 13% [95%CI: -10 – 36%], 
p=0.26). Three months after ART treatment, the estimated risk difference was 24% 
(95%CI: 2 – 46%); intervention group 24% versus control group 48%, p=0.03 
(table 2), indicating a potential effect of the intervention. 
 
Intention-to-treat analysis 
Two weeks after the pregnancy test, an estimated 30% (95%CI: 17 – 42%) of the 
women in the intervention group had clinically relevant symptoms of anxiety 
and/or depression versus 41% (95%CI: 23 – 58%) of the women in the control 
group (risk difference intervention group versus control group 11% [95%CI: -10 – 
32%], p=0.30). Three months after ART, the estimated risk difference was 19% 
(95%CI: -1% - 38%): intervention group 22% versus control group 40%, p=0.06 
(table 2). Just before the retrieval of eggs, more women assigned to the 
intervention group had clinically relevant scores on anxiety and/or depression, but 
this declined after the pregnancy test and even more three months after the ART 
treatment (figure 3). There were no significant risk differences. 
 
Harms 
No harms or unintended effects of the e-therapy were reported. 
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receive additional psychosocial support (risk difference 13% [95%CI: -10 – 36%], 
p=0.26). Three months after ART treatment, the estimated risk difference was 24% 
(95%CI: 2 – 46%); intervention group 24% versus control group 48%, p=0.03 
(table 2), indicating a potential effect of the intervention. 
 
Intention-to-treat analysis 
Two weeks after the pregnancy test, an estimated 30% (95%CI: 17 – 42%) of the 
women in the intervention group had clinically relevant symptoms of anxiety 
and/or depression versus 41% (95%CI: 23 – 58%) of the women in the control 
group (risk difference intervention group versus control group 11% [95%CI: -10 – 
32%], p=0.30). Three months after ART, the estimated risk difference was 19% 
(95%CI: -1% - 38%): intervention group 22% versus control group 40%, p=0.06 
(table 2). Just before the retrieval of eggs, more women assigned to the 
intervention group had clinically relevant scores on anxiety and/or depression, but 
this declined after the pregnancy test and even more three months after the ART 
treatment (figure 3). There were no significant risk differences. 
 
Harms 
No harms or unintended effects of the e-therapy were reported. 
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Figure 3: Estimated percentages of women showing clinically relevant scores for depression and/or anxiety in the 
control and the intervention (Digicoach) group. Graphic presentation of results of generalized estimating equations 
analysis based on non-pregnant women, i.e. all women up to T1, and the non-pregnant women from T2 onwards. 
 
 
 
Discussion 
 
This study shows that evaluation of personalized e-therapy in daily clinical fertility 
care within an RCT is feasible. Personalizing psychosocial interventions to 
vulnerabilities of patients is frequently recommended (Van Beugen et al., 2014; 
Frederiksen et al., 2015). However, the implementation of a personalized e-therapy 
program in clinical fertility practice is new. The findings of this study can be helpful 
in the modification of the study protocol and the adjustments to the proposed 
procedure we should make when performing a consecutive study. Firstly, we should 
adapt the timing of including patients to their needs and preferences. Next, 
methods to increase participation rate and compliancy to the e-therapy program 
should be investigated. Also, we should identify which improvements could be 
made to the modules and performance of the personalized e-therapy program itself. 
In addition, we should calculate an appropriate sample size. And finally, we should 
	
evaluate the long-term effects from this e-therapy according to an intention-to-treat 
approach and by extending the follow up period. 
We evaluated the feasibility structurally according to Bowen et al. assessing 
acceptability, demand, practicality, implementation, integration and limited efficacy 
(Bowen et al., 2009). We concluded that it is feasible to offer personalized 
psychosocial care to patients at risk for psychosocial maladjustment before start of 
their first ART cycle in about half of the patients. However, before proving the 
effectiveness of this e-therapy program within an RCT, several concerns have to be 
addressed. Suggestions for modifications to the study protocol as well as to the 
intervention will be made. One of the strengths of the study is the use of this 
structured approach. In addition, we used a theoretical frame which is based on 
previous prospective studies investigating emotional impact of ART as well as 
characteristics of patients vulnerable to emotional adjustment problems. These 
studies were based on stress vulnerability models frequently used in psychological 
studies in patients with medical health problems (Verhaak et al., 2005). To actually 
prevent the occurrence of adjustment problems or to prevent deterioration of 
already existing mental health problems the intervention was offered during ART 
treatment. This structured approach to evaluate this personalized e-therapy 
program is necessary according to Campbell et al. when evaluating a complex 
intervention (Campbell et al., 2000, Arain et al., 2010). This e-therapy program is a 
complex innovative intervention, since it uses multiple interacting components 
during a short, intense medical ART treatment cycle. We structured the evaluation 
of this intervention by starting with a theoretical phase, in which first the 
components of the interventions and second the trial and intervention design were 
defined. Experiences of a earlier studies were assessed and used in the design of 
this study (Verhaak et al., 2008; Verhaak et al., 2010). We evaluated the feasibility 
to evaluate effectiveness of this e-therapy program in this feasibility RCT. The next 
steps are the addressing of found barriers and facilitators to conduct a consecutive 
trial on effectiveness (Campbell et al., 2000). This study reveals important 
information how evaluation and implementation of a complex intervention could be 
optimized. As is indicated by Campbell et al. the evaluation of complex 
interventions is challenging (Campbell et al., 2007). Several important steps have 
been made (developing the intervention, identifying patients in need for the 
intervention and documenting the process of screening and intervention), however, 
defining the optimal way to personalize the intervention to the assessed 
psychosocial vulnerability and to the patients’ needs and wishes is still a challenge. 
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Figure 3: Estimated percentages of women showing clinically relevant scores for depression and/or anxiety in the 
control and the intervention (Digicoach) group. Graphic presentation of results of generalized estimating equations 
analysis based on non-pregnant women, i.e. all women up to T1, and the non-pregnant women from T2 onwards. 
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methods to increase participation rate and compliancy to the e-therapy program 
should be investigated. Also, we should identify which improvements could be 
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In addition, we should calculate an appropriate sample size. And finally, we should 
	
evaluate the long-term effects from this e-therapy according to an intention-to-treat 
approach and by extending the follow up period. 
We evaluated the feasibility structurally according to Bowen et al. assessing 
acceptability, demand, practicality, implementation, integration and limited efficacy 
(Bowen et al., 2009). We concluded that it is feasible to offer personalized 
psychosocial care to patients at risk for psychosocial maladjustment before start of 
their first ART cycle in about half of the patients. However, before proving the 
effectiveness of this e-therapy program within an RCT, several concerns have to be 
addressed. Suggestions for modifications to the study protocol as well as to the 
intervention will be made. One of the strengths of the study is the use of this 
structured approach. In addition, we used a theoretical frame which is based on 
previous prospective studies investigating emotional impact of ART as well as 
characteristics of patients vulnerable to emotional adjustment problems. These 
studies were based on stress vulnerability models frequently used in psychological 
studies in patients with medical health problems (Verhaak et al., 2005). To actually 
prevent the occurrence of adjustment problems or to prevent deterioration of 
already existing mental health problems the intervention was offered during ART 
treatment. This structured approach to evaluate this personalized e-therapy 
program is necessary according to Campbell et al. when evaluating a complex 
intervention (Campbell et al., 2000, Arain et al., 2010). This e-therapy program is a 
complex innovative intervention, since it uses multiple interacting components 
during a short, intense medical ART treatment cycle. We structured the evaluation 
of this intervention by starting with a theoretical phase, in which first the 
components of the interventions and second the trial and intervention design were 
defined. Experiences of a earlier studies were assessed and used in the design of 
this study (Verhaak et al., 2008; Verhaak et al., 2010). We evaluated the feasibility 
to evaluate effectiveness of this e-therapy program in this feasibility RCT. The next 
steps are the addressing of found barriers and facilitators to conduct a consecutive 
trial on effectiveness (Campbell et al., 2000). This study reveals important 
information how evaluation and implementation of a complex intervention could be 
optimized. As is indicated by Campbell et al. the evaluation of complex 
interventions is challenging (Campbell et al., 2007). Several important steps have 
been made (developing the intervention, identifying patients in need for the 
intervention and documenting the process of screening and intervention), however, 
defining the optimal way to personalize the intervention to the assessed 
psychosocial vulnerability and to the patients’ needs and wishes is still a challenge. 
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Next, a strength of the study is the use of a general (HADS) outcome measure. This 
measure was used as the primary outcome measure when evaluating the limited 
efficacy of the e-therapy program. This general outcome measures enhances 
generalizability and therefore, we could be able to assess the potential effects of the 
intervention on general symptoms of psychopathology or psychosocial distress. 
In this feasibility RCT, a total of 151 women declined to participate; most of them 
did so because they felt they did not need support at that moment. Our earlier 
study indicated only 8% of the patients at risk for emotional maladjustment 
planned to seek psychosocial support (Van Dongen et al., 2012). In the present 
study, 45% agreed to participate in a feasibility study regarding a psychosocial 
intervention. This suggests they are potentially interested in achieving psychosocial 
support. Still, a considerable group of women did want to participate. Several 
reasons could explain this lack of interest. We offered the intervention already at 
pretreatment and parallel to the ART treatment, from the perspective of prevention 
of increase of distress during and after ART treatment. A considerable group of 
patients indicated they did not need psychosocial support at that moment. We 
suggest that, from the perspective of personalized health care, interest in the e-
therapy program could be improved by personalizing it to the patients’ expectations 
and preferences regarding timing and phase in fertility treatment. In this way, the 
applicability of the e-therapy program could be enlarged by offering it to those who 
request psychosocial support independently of the phase in ART treatment. 
Personalizing psychological support not only to individual needs and risk profile, 
but also to the perceived appropriate moment in the treatment, could help in the 
provision of timely and appropriately personalized psychosocial support. 
In the study of Cousineau et al. all female fertility patients were eligible to 
participate; in that study there was a high participation rate (Cousineau et al., 
2008). In our study, on the contrary, only women at risk for emotional 
maladjustment were eligible to participate, and the e-therapy program was tailored 
to their specific risk profile. More recent meta-analyses also recommend this 
tailored care (Haemmerli et al., 2009; Frederiksen et al., 2015). 
Approximately 30% of the women dropped out during the study period, of them 
15% because they did not want to continue the study. This could have influenced 
the results, depending on their potential to benefit from the e-therapy program. 
Factors related to the course of the ART treatment cycle (e.g. non-optimal 
fertilization) could have de-motivated some participants and made them drop out 
(Frederiksen et al., 2015). Dropout rates are comparable with other intervention 
studies, e.g. a median of 29% in the intervention group in a recent meta-analytic 
	
review regarding internet-based CBT (Van Beugen et al., 2014). In future research 
the suggestion to explore and compare characteristics of dropouts and completers, 
was made (Frederiksen et al., 2015). However, the impact of adherence to 
psychological programs on outcome appears to vary, and showed no positive 
association within e-health interventions (Donkin et al., 2011). It is important to 
understand factors influencing dropout in order to prevent the offering of costly 
interventions to patients who will not benefit from its potential, e.g. because of 
limited usage. In fertility care, psychological interventions focusing on the stressors 
of the treatment cycle have to deal with unexpected course of fertility treatment 
and a limited attention of patients to the psychological treatment compared with 
their invasive fertility treatment. Tailoring the intervention more to patients’ needs 
could increase their commitment to complete the program. This is supported by the 
process evaluation showing that only a small majority (55%) declared that the 
intervention met their expectations. We assume that offering the e-therapy program 
within a fixed protocol and without adaptation to the ART cycle of the women can 
be an explanation of this. In future, expectations of the program should be 
managed beforehand, for example offering more information in the intake meeting 
or handout an information leaflet before participation. 
In the current study, several aspects were difficult to control for, e.g. a considerable 
group of women in the control group had access to general psychosocial support. A 
possibility is to focus on a homogeneous group of women who did not receive 
additional psychosocial support. However, this would hamper the translation of 
intervention process to daily clinical fertility care. In addition, we could not control 
for factors related to the course of the ART treatment cycle, such as the number of 
fertilized eggs or side effects of the medication. Most psychological interventions in 
patients with chronic conditions are offered and evaluated during relatively stable 
disease periods. The e-therapeutic intervention in this study was offered during the 
first ART cycle. It is valuable to further investigate how to implement personalized 
psychosocial support to patients in fertility treatment as is in line with other studies 
(Gameiro et al., 2013; Frederiksen et al., 2015). 
Of the participating women, 20% did not start ART treatment and 10% conceived 
spontaneously. This suggests that fitting participants in a fixed protocol following 
the phases in treatment is difficult due to personal differences in the treatment 
course. 
Detecting and addressing the psychosocial need patients experience is 
recommended in the recently published ESHRE guideline (Gameiro et al., 2015). 
This e-therapy program was especially designed for this group of patients. The next 
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Next, a strength of the study is the use of a general (HADS) outcome measure. This 
measure was used as the primary outcome measure when evaluating the limited 
efficacy of the e-therapy program. This general outcome measures enhances 
generalizability and therefore, we could be able to assess the potential effects of the 
intervention on general symptoms of psychopathology or psychosocial distress. 
In this feasibility RCT, a total of 151 women declined to participate; most of them 
did so because they felt they did not need support at that moment. Our earlier 
study indicated only 8% of the patients at risk for emotional maladjustment 
planned to seek psychosocial support (Van Dongen et al., 2012). In the present 
study, 45% agreed to participate in a feasibility study regarding a psychosocial 
intervention. This suggests they are potentially interested in achieving psychosocial 
support. Still, a considerable group of women did want to participate. Several 
reasons could explain this lack of interest. We offered the intervention already at 
pretreatment and parallel to the ART treatment, from the perspective of prevention 
of increase of distress during and after ART treatment. A considerable group of 
patients indicated they did not need psychosocial support at that moment. We 
suggest that, from the perspective of personalized health care, interest in the e-
therapy program could be improved by personalizing it to the patients’ expectations 
and preferences regarding timing and phase in fertility treatment. In this way, the 
applicability of the e-therapy program could be enlarged by offering it to those who 
request psychosocial support independently of the phase in ART treatment. 
Personalizing psychological support not only to individual needs and risk profile, 
but also to the perceived appropriate moment in the treatment, could help in the 
provision of timely and appropriately personalized psychosocial support. 
In the study of Cousineau et al. all female fertility patients were eligible to 
participate; in that study there was a high participation rate (Cousineau et al., 
2008). In our study, on the contrary, only women at risk for emotional 
maladjustment were eligible to participate, and the e-therapy program was tailored 
to their specific risk profile. More recent meta-analyses also recommend this 
tailored care (Haemmerli et al., 2009; Frederiksen et al., 2015). 
Approximately 30% of the women dropped out during the study period, of them 
15% because they did not want to continue the study. This could have influenced 
the results, depending on their potential to benefit from the e-therapy program. 
Factors related to the course of the ART treatment cycle (e.g. non-optimal 
fertilization) could have de-motivated some participants and made them drop out 
(Frederiksen et al., 2015). Dropout rates are comparable with other intervention 
studies, e.g. a median of 29% in the intervention group in a recent meta-analytic 
	
review regarding internet-based CBT (Van Beugen et al., 2014). In future research 
the suggestion to explore and compare characteristics of dropouts and completers, 
was made (Frederiksen et al., 2015). However, the impact of adherence to 
psychological programs on outcome appears to vary, and showed no positive 
association within e-health interventions (Donkin et al., 2011). It is important to 
understand factors influencing dropout in order to prevent the offering of costly 
interventions to patients who will not benefit from its potential, e.g. because of 
limited usage. In fertility care, psychological interventions focusing on the stressors 
of the treatment cycle have to deal with unexpected course of fertility treatment 
and a limited attention of patients to the psychological treatment compared with 
their invasive fertility treatment. Tailoring the intervention more to patients’ needs 
could increase their commitment to complete the program. This is supported by the 
process evaluation showing that only a small majority (55%) declared that the 
intervention met their expectations. We assume that offering the e-therapy program 
within a fixed protocol and without adaptation to the ART cycle of the women can 
be an explanation of this. In future, expectations of the program should be 
managed beforehand, for example offering more information in the intake meeting 
or handout an information leaflet before participation. 
In the current study, several aspects were difficult to control for, e.g. a considerable 
group of women in the control group had access to general psychosocial support. A 
possibility is to focus on a homogeneous group of women who did not receive 
additional psychosocial support. However, this would hamper the translation of 
intervention process to daily clinical fertility care. In addition, we could not control 
for factors related to the course of the ART treatment cycle, such as the number of 
fertilized eggs or side effects of the medication. Most psychological interventions in 
patients with chronic conditions are offered and evaluated during relatively stable 
disease periods. The e-therapeutic intervention in this study was offered during the 
first ART cycle. It is valuable to further investigate how to implement personalized 
psychosocial support to patients in fertility treatment as is in line with other studies 
(Gameiro et al., 2013; Frederiksen et al., 2015). 
Of the participating women, 20% did not start ART treatment and 10% conceived 
spontaneously. This suggests that fitting participants in a fixed protocol following 
the phases in treatment is difficult due to personal differences in the treatment 
course. 
Detecting and addressing the psychosocial need patients experience is 
recommended in the recently published ESHRE guideline (Gameiro et al., 2015). 
This e-therapy program was especially designed for this group of patients. The next 
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step is to evaluate the effectiveness of this e-therapy program. In addition, 
information assessed in this feasibility study can be helpful to enhance 
implementation. Finally, generalizability could be enlarged by introducing this e-
therapy program to other centres. By performing a multi-centre RCT, we will be 
able to increase participation and to achieve generalizability by being able to 
control for different practices regarding psychosocial care as usual in different 
centres. 
A strength of the study is the evaluation of limited efficacy by performing both a 
per-protocol analysis and an intention-to-treat analysis. The per-protocol-analysis 
showed a potential efficacy of the intervention, the intention-to-treat analysis 
showed the importance to improve the study protocol and intervention. According 
to Bowen et al., in a feasibility study limited efficacy testing can be helpful and may 
be conducted with shorter follow-up periods or with limited statistical power 
(Bowen et al., 2009). These analyses showed that this unique personalized e-
therapy program, based on CBT and psycho-education and completed with 
coaching by a specially trained e-therapist in fertility care, has potential. The next 
step is to perform a well-designed and structurally evaluated RCT to analyse the 
short- and long-term effects of personalized e-therapy in fertility care. Assessing 
accurate power in personalized therapy studies is difficult. In this study, the power 
was limited because based on earlier research, we made the assumption that 48% 
of the women would have clinically relevant symptoms of anxiety and/or 
depression after the first unsuccessful ART treatment without intervention (Verhaak 
et al., 2010). However, we found a percentage of only 40% in our research 
population. An elucidation for this lower percentage could be the exclusion of 
women scoring above 13 on HADS for participation in this study. We offered them 
direct access to usual psychological care, according to good clinical practice. 
However, these women could just be the ones who benefit most from the e-therapy 
program. Excluding them from participation can lower the potential effect of the 
intervention in a RCT. 
The findings of this study show that evaluating personalized e-therapy in fertility 
care is feasible and promising, but should be further modified and evaluated.. The 
findings of this study according demand, acceptability and practicality can be 
helpful in the modification of the study protocol when performing an RCT. Tackling 
burden in ART is important and should lead to improved outcomes, in terms of 
better quality of life during and after fertility treatment and lower discontinuation 
rates (Boivin et al., 2012). 
Meta-analyses are inconclusive regarding which participants should be the primary 
	
focus: only women, men and women, or couples (Boivin et al., 2012)? At this 
moment, RCTs comparing these groups are lacking, as well as RCTs comparing 
group versus individual interventions. Moreover, many studies that included both 
members of the infertile couple found differences between them in psychosocial 
responses to infertility and its treatment (Wischmann et al., 2009; Chachamovich et 
al., 2010; Huppelschoten et al., 2013). A next step could be the tailoring of e-
therapy to the specific psychosocial needs of the couple. This study indicates that 
tailoring an intervention to the risk profile of the patient is feasible. This is an 
important result as most psychosocial interventions are focused on women both 
with and without relevant distress levels (Boivin et al., 2011). However, one could 
question if tailoring to the risk profile at a specific moment in fertility treatment is 
the best method compared with tailoring it also to the individual needs of the 
patients regarding moment (before, during or after fertility treatment) and 
participation (women only, men only or couple-based) (Gameiro et al., 2015). 
Regarding the attrition rate, paying participants to complete the study could be an 
option to increase completion rates (Domar et al., 2011). However, the effects of 
this on the generalizability of the results are not clear. 
Next, it is important to control for the phase in ART treatment. Tailored 
psychosocial treatment should be flexible according to the different phases in ART 
(Boivin et al., 2011). This presented study was designed to follow the ART cycle. 
Future studies should be able to be tailored to the treatment phase by providing 
intervention on how to cope with treatment, in addition to how to cope with 
treatment failure and how to decide about treatment continuation. This had also 
been recommended in the recently published guideline on psychosocial care in 
infertility and medically assisted reproduction (Gameiro et al., 2015). 
As was suggested earlier, exploration of dropouts and completers as well as of 
responders and non-responders is important (Frederiksen et al., 2015). Sample size 
could be enlarged by expanding the evaluation of personalized e-therapy to other 
centres. To enhance clinical implementation of e-therapy in fertility care, we should 
evaluate which modifications can be made for example in time points of offering 
the e-therapy program or the ideal duration of the e-therapy program, aimed to 
enhance personalized health care. A consecutive study could shed more light on 
how to optimize timing and intensity of e-therapy to patients’ needs. 
In summary, this study showed that it is feasible to evaluate a personalized e-
therapy program designed for women at risk for emotional maladjustment 
undergoing ART treatment within an RCT. There was a moderate to good 
acceptability to the study protocol and intervention and the study fitted within 
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step is to evaluate the effectiveness of this e-therapy program. In addition, 
information assessed in this feasibility study can be helpful to enhance 
implementation. Finally, generalizability could be enlarged by introducing this e-
therapy program to other centres. By performing a multi-centre RCT, we will be 
able to increase participation and to achieve generalizability by being able to 
control for different practices regarding psychosocial care as usual in different 
centres. 
A strength of the study is the evaluation of limited efficacy by performing both a 
per-protocol analysis and an intention-to-treat analysis. The per-protocol-analysis 
showed a potential efficacy of the intervention, the intention-to-treat analysis 
showed the importance to improve the study protocol and intervention. According 
to Bowen et al., in a feasibility study limited efficacy testing can be helpful and may 
be conducted with shorter follow-up periods or with limited statistical power 
(Bowen et al., 2009). These analyses showed that this unique personalized e-
therapy program, based on CBT and psycho-education and completed with 
coaching by a specially trained e-therapist in fertility care, has potential. The next 
step is to perform a well-designed and structurally evaluated RCT to analyse the 
short- and long-term effects of personalized e-therapy in fertility care. Assessing 
accurate power in personalized therapy studies is difficult. In this study, the power 
was limited because based on earlier research, we made the assumption that 48% 
of the women would have clinically relevant symptoms of anxiety and/or 
depression after the first unsuccessful ART treatment without intervention (Verhaak 
et al., 2010). However, we found a percentage of only 40% in our research 
population. An elucidation for this lower percentage could be the exclusion of 
women scoring above 13 on HADS for participation in this study. We offered them 
direct access to usual psychological care, according to good clinical practice. 
However, these women could just be the ones who benefit most from the e-therapy 
program. Excluding them from participation can lower the potential effect of the 
intervention in a RCT. 
The findings of this study show that evaluating personalized e-therapy in fertility 
care is feasible and promising, but should be further modified and evaluated.. The 
findings of this study according demand, acceptability and practicality can be 
helpful in the modification of the study protocol when performing an RCT. Tackling 
burden in ART is important and should lead to improved outcomes, in terms of 
better quality of life during and after fertility treatment and lower discontinuation 
rates (Boivin et al., 2012). 
Meta-analyses are inconclusive regarding which participants should be the primary 
	
focus: only women, men and women, or couples (Boivin et al., 2012)? At this 
moment, RCTs comparing these groups are lacking, as well as RCTs comparing 
group versus individual interventions. Moreover, many studies that included both 
members of the infertile couple found differences between them in psychosocial 
responses to infertility and its treatment (Wischmann et al., 2009; Chachamovich et 
al., 2010; Huppelschoten et al., 2013). A next step could be the tailoring of e-
therapy to the specific psychosocial needs of the couple. This study indicates that 
tailoring an intervention to the risk profile of the patient is feasible. This is an 
important result as most psychosocial interventions are focused on women both 
with and without relevant distress levels (Boivin et al., 2011). However, one could 
question if tailoring to the risk profile at a specific moment in fertility treatment is 
the best method compared with tailoring it also to the individual needs of the 
patients regarding moment (before, during or after fertility treatment) and 
participation (women only, men only or couple-based) (Gameiro et al., 2015). 
Regarding the attrition rate, paying participants to complete the study could be an 
option to increase completion rates (Domar et al., 2011). However, the effects of 
this on the generalizability of the results are not clear. 
Next, it is important to control for the phase in ART treatment. Tailored 
psychosocial treatment should be flexible according to the different phases in ART 
(Boivin et al., 2011). This presented study was designed to follow the ART cycle. 
Future studies should be able to be tailored to the treatment phase by providing 
intervention on how to cope with treatment, in addition to how to cope with 
treatment failure and how to decide about treatment continuation. This had also 
been recommended in the recently published guideline on psychosocial care in 
infertility and medically assisted reproduction (Gameiro et al., 2015). 
As was suggested earlier, exploration of dropouts and completers as well as of 
responders and non-responders is important (Frederiksen et al., 2015). Sample size 
could be enlarged by expanding the evaluation of personalized e-therapy to other 
centres. To enhance clinical implementation of e-therapy in fertility care, we should 
evaluate which modifications can be made for example in time points of offering 
the e-therapy program or the ideal duration of the e-therapy program, aimed to 
enhance personalized health care. A consecutive study could shed more light on 
how to optimize timing and intensity of e-therapy to patients’ needs. 
In summary, this study showed that it is feasible to evaluate a personalized e-
therapy program designed for women at risk for emotional maladjustment 
undergoing ART treatment within an RCT. There was a moderate to good 
acceptability to the study protocol and intervention and the study fitted within 
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current clinical guidelines. In the future, we should focus on demand and on 
practicality. The following suggestions were made: offering more information 
beforehand, tailoring the timing of the protocol to the women’s needs and 
preferences (e.g. offering the intervention after the first unsuccessful ART cycle), 
exploring the possibility of modification of the modules according to the 
suggestions of the participants and evaluating the intervention multicentre to 
enhance participation rate and generalizability. As a part of evaluating the 
feasibility, we demonstrated the effectiveness of the e-therapy program in the 
women who were compliant to the treatment protocol but could not support this in 
an intention-to-treat approach. A consecutive study is necessary to investigate 
whether this personalized e-therapy program for women undergoing ART could 
reduce the number of women suffering from psychological distress shortly after 
ART treatment with specific focus on improving the fit with patients needs at 
different phases in ART treatment and increasing adherence to the intervention for 
those agreeing to participate. 
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current clinical guidelines. In the future, we should focus on demand and on 
practicality. The following suggestions were made: offering more information 
beforehand, tailoring the timing of the protocol to the women’s needs and 
preferences (e.g. offering the intervention after the first unsuccessful ART cycle), 
exploring the possibility of modification of the modules according to the 
suggestions of the participants and evaluating the intervention multicentre to 
enhance participation rate and generalizability. As a part of evaluating the 
feasibility, we demonstrated the effectiveness of the e-therapy program in the 
women who were compliant to the treatment protocol but could not support this in 
an intention-to-treat approach. A consecutive study is necessary to investigate 
whether this personalized e-therapy program for women undergoing ART could 
reduce the number of women suffering from psychological distress shortly after 
ART treatment with specific focus on improving the fit with patients needs at 
different phases in ART treatment and increasing adherence to the intervention for 
those agreeing to participate. 
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Tackling burden in fertility treatment is an important issue. Nijmegen has a long 
tradition in studying this field and many questions have been addressed. The 
insights we have gained, gave us the ability to situate burden within fertility 
treatment (Figure 1). However, these insights also have raised new questions. For 
example, how does burden influence treatment continuation? And, how can we 
reduce burden before or during fertility treatment? 
 
Figure 1: graphical outline of this thesis 
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Burden in fertility treatment can lead to emotional distress or diminished fertility-
related quality of life (Schmidt, 2006; Boivin et al., 2012; Gameiro et al., 2013; 
Domar et al., 2015). Moreover, this burden can result in discontinuation of fertility 
treatment (Olivius et al., 2004; Smeenk et al., 2004; Brandes et al., 2009; Domar et 
al., 2010; Gameiro et al., 2012).  
In our clinic, clinicians and counsellors aim to alleviate or to prevent burden in 
fertility treatment and to optimize personalized psychosocial care in patients 
undergoing artificial reproductive technologies (ART) treatment. We try to prevent 
burden by the identification and counselling of women at risk for distress, the 
identification of correlates of discontinuation in ART treatment, and by offering 
women personalized care before, during and after ART treatment (Verhaak et al., 
2005, Verhaak et al., 2010, Boivin et al., 2012; Gameiro et al., 2013; Gameiro et al., 
2015). 
In this thesis we studied several aspects of reducing burden in fertility treatment 
(figure 1), focusing on: discontinuation of ART treatment (chapter 2, 4 and 5), 
implementation of psychosocial screening of patients before starting ART (chapter 
3), and the prevention of distress using psychosocial e-therapy (chapter 6). In this 
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general discussion, we discussed the main findings of the different studies and point 
out some clinical and methodological considerations. Finally, we end with 
recommendations for future clinical care and future research in this field. 
 
 
Main findings 
• A large proportion of the patients that were put on a waiting list for ART 
treatment discontinued treatment due to personal reasons possible related to 
distress. Therefore, counselling of these patients could be important before 
actually starting ART treatment (chapter 2). 
• A substantial part of the women on this waiting list for ART treatment conceived 
spontaneously (chapter 2). 
• Screening patients before ART treatment to identify women at risk for emotional 
maladjustment using a validated screening instrument, named SCREENIVF, is 
feasible (chapter 3). 
• We identified barriers for help-seeking behaviour in patients at risk for 
emotional maladjustment, such as travelling distance or uncertainty whether 
costs are reimbursed by insurance (chapter 3). 
• We were not able to predict discontinuation of treatment using a screening 
instrument based on risk predictors for emotional maladjustment, SCREENIVF. 
However, additional analyses showed that both women and men with a higher 
level of acceptance of their fertility problem, and women who perceived a lack 
of social support discontinued ART treatment more often (chapter 4). 
• We were not able to predict discontinuation of treatment using a measure of 
patient-centredness of care, the PCQ-Infertility. However, additional analyses 
showed that non-ART patients, who experience less respect of patient values 
(e.g. ‘how often did your physician show an interest in your personal 
situation?’), tend to discontinue treatment more often. On the contrary, patients 
undergoing ART were more likely to discontinue when they experience a higher 
level of patient involvement. This might suggest that discontinuation of 
treatment is a deliberate decision of these patients (chapter 5). 
• It is feasible to evaluate the effects of a personalized e-therapy program in 
fertility care within an RCT setting. Women who were compliant in their use of 
the e-therapy program versus a control group show a reduction of clinically 
relevant symptoms of distress after unsuccessful ART. However, adjustments to 
the e-therapy program have to be made before it can be implemented in daily 
clinical care (chapter 6). 
	
Interpretation of the main findings 
 
Discontinuation of fertility care due to personal reasons is an important factor in 
fertility treatment and was studied extensively (Smeenk et al., 2004; Verberg et al., 
2008; Verhagen et al., 2008; Brandes et al., 2009; Eisenberg et al., 2010; Boivin et 
al., 2011; Boivin et al., 2012; Gameiro et al., 2012). The large proportion of our 
patients, who discontinued fertility care due to personal reasons (i.e. relationship 
problems or psychological burden) before actually starting ART treatment, could 
reflect the need to gain more insight in the possibility of distress related factors as 
predictors of dropout (chapter 2). Other studies also showed high discontinuation 
rates before ART, even before starting fertility treatment at all (Eijkemans et al., 
2008; Brandes et al., 2009). This suggests we could focus on the counselling even 
before starting ART treatment, depending on the couples’ needs. In our waiting list 
study (chapter 2) we did not measure distress in women being placed on the ART 
waiting list. Therefore, it was not possible to correlate experienced distress to 
discontinuation of treatment in this group of women. In chapter 4, however, we 
tried to correlate distress measured before starting ART treatment to 
discontinuation of treatment. In the recent ESHRE guideline it is recommended to 
detect and address the psychosocial need patients experience before, during and 
after treatment (Gameiro et al., 2015). We found that a substantial part of women 
on the ART waiting list conceived spontaneously, which might reflect the effect of 
stress relief by only being placed on this waiting list. Until now, no studies have 
been performed to evaluate the effect on distress by being placed on a waiting list 
for ART. In other medical health care areas however, there are several studies 
studying the spontaneous remission of psychological symptomatology over a 
waiting period (Posternak and Miller, 2001; Hesser et al., 2011). These studies 
mainly focused on short term changing in symptomatology of depression or tinnitus 
distress without medication to estimate the placebo effect in trials. In patients 
suffering from infertility, we still wonder what process evokes this stress relief. Or, 
do we place patients on the ART waiting list too soon, and could they have 
benefitted from tailored expectant management (TEM)? In couples with a good or 
intermediate prognosis to conceive spontaneously (i.e. more than 30% chance to 
conceive spontaneously the next year, Hunault et al., 2004), TEM can lead to the 
prevention of unnecessary treatment, complications, costs and physical and 
psychological burden, although this has been debated internationally (Steures et al., 
2006; Van den Boogaard et al., 2011; Custers et al., 2012; Kamphuis et al., 2014, 
Kersten et al., 2015). 
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Screening patients for emotional maladjustment is feasible (chapter 3). We are able 
to implement screening in daily clinical care. To enhance generalizibility, the next 
step can be to extend implementation of screening to all fertility patients, including 
men, or to other clinics and maybe other countries with other kinds of patients and 
other kinds of care (Lopes et al., 2014). Based on the barriers identified (e.g. 
travelling distance or not planning to seek professional help), we could consider the 
possibilities of introducing online screening and self-management tools. Recently, 
an exploratory randomized trial was published on the effect of a brief self-
administered psychological intervention, which led to an improved psychological 
status measured using Fertility Quality of Life, but not to a lower discontinuation 
rate or higher pregnancy rate (Domar et al., 2015). Next, screening can be extended 
to other time points, or to a longer follow-up period. It is known that women report 
more anxiety during the time period in which they are waiting for the outcome of 
an ART cycle (Lancastle and Boivin, 2008; Ockhuijsen et al., 2014). A randomized 
controlled trial examining the impact of a self-administered coping intervention in 
this period did not found a significant effect on anxiety (Ockhuijsen et al., 2014). 
Such self-administered interventions can be important in overcoming barriers for 
help-seeking behaviour such as travelling distance. Future research should focus on 
the effectiveness of these forms of psychosocial care and counselling. 
SCREENIVF could not predict discontinuation of treatment, although additional 
analyses indicated that both women and men with a higher level of acceptance of 
the fertility problem, and women who perceived a lack of social support 
discontinued ART treatment more often (chapter 4). This reveals that the 
discontinuation of fertility treatment is a complex process and could be influenced 
by choices from a positive as well as from a negative perspective (Duggan et al., 
2006). An example of a positive perspective could be couples who discontinue 
treatment and have a higher level of acceptance of the fertility problem. An 
example of a negative perspective could be a woman experiencing lack of social 
support and therefore decides to discontinue ART treatment. It is interesting to 
study long-term psychosocial burden and coping strategies used by the couple, and 
the correlation with their choice to discontinue treatment. Can we differentiate 
between couples with a positive perspective who are more open towards their 
alternatives for child wish and couples with a negative perspective who are not 
considering alternatives yet (Van den Broeck et al., 2009)? And what is the role of 
the partner in the social support experienced? Knowing more about these different 
perspectives can influence psychosocial fertility care, in supporting informed 
decision making and preventing decisional regret. 
	
Also, experience of patient-centredness of care could not predict discontinuation of 
fertility treatment (chapter 5). However, when focusing on specific patient groups 
(ART and non-ART patients) and on different subscales of the PCQ-Infertility (such 
as accessibility or respect for patient values), we had some interesting results. This 
also underlines the complexity of the decision to discontinue treatment. ART 
patients who experience more involvement in their treatment were more likely to 
discontinue treatment, which could be explained from a positive perspective. Non-
ART patients who experienced less respect for patient values were more likely to 
discontinue, and this discontinuation could be explained from a negative 
perspective. Future research should focus on patients’ perspectives and their needs 
when offering counselling after the end-of-treatment decision. Are there other 
determinants that can predict discontinuation in fertility care? Moreover, the role of 
the partner and family in the decision to discontinue treatment should be 
investigated. The ESHRE guideline on psychosocial care recommends offering 
patients who are at risk for infertility-specific psychosocial distress additional 
psychosocial care after unsuccessful treatment; however the recommendations after 
unsuccessful treatment in this guideline are not evidence-based (Gameiro et al., 
2015). Future research should gain more evidence-based support for these 
recommendations. 
Finally, we showed that is it feasible to evaluate a personalized e-therapy program 
within an RCT. We demonstrated the potential effectiveness of this e-therapy 
program in women who were compliant to the treatment protocol (chapter 6). The 
e-therapy program was tailored to the risk profile of the women, which was 
assessed before starting ART treatment using SCREENIVF. The feasibility RCT 
reveals some interesting points about compliancy and adherence to the program. 
For example, we experienced a large proportion of women declining to participate 
as well as a high percentage of dropouts. Difficulties in willingness to participate 
were also seen in the randomized controlled trial evaluating the effects of a self-
administered coping and relaxation intervention (Domar et al., 2015). Of all eligible 
patients in this RCT, 385 declined to participate and 166 were randomized, 
although patients were paid to complete this study. Moreover, in this trial using a 
self-administered intervention only 77% responded to this intervention, although 
women received a gift certificate when completing the last survey (Domar et al., 
2015). Patients were invited to participate without baseline risk screening in 
contrary to our study, which might explain a high non-participation rate and high 
dropout rate. In other studies attrition rates of 20-35% were described (Lancastle 
and Boivin, 2008; Ockhuijsen et al., 2014). The importance of addressing an 
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to implement screening in daily clinical care. To enhance generalizibility, the next 
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men, or to other clinics and maybe other countries with other kinds of patients and 
other kinds of care (Lopes et al., 2014). Based on the barriers identified (e.g. 
travelling distance or not planning to seek professional help), we could consider the 
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the effectiveness of these forms of psychosocial care and counselling. 
SCREENIVF could not predict discontinuation of treatment, although additional 
analyses indicated that both women and men with a higher level of acceptance of 
the fertility problem, and women who perceived a lack of social support 
discontinued ART treatment more often (chapter 4). This reveals that the 
discontinuation of fertility treatment is a complex process and could be influenced 
by choices from a positive as well as from a negative perspective (Duggan et al., 
2006). An example of a positive perspective could be couples who discontinue 
treatment and have a higher level of acceptance of the fertility problem. An 
example of a negative perspective could be a woman experiencing lack of social 
support and therefore decides to discontinue ART treatment. It is interesting to 
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the correlation with their choice to discontinue treatment. Can we differentiate 
between couples with a positive perspective who are more open towards their 
alternatives for child wish and couples with a negative perspective who are not 
considering alternatives yet (Van den Broeck et al., 2009)? And what is the role of 
the partner in the social support experienced? Knowing more about these different 
perspectives can influence psychosocial fertility care, in supporting informed 
decision making and preventing decisional regret. 
	
Also, experience of patient-centredness of care could not predict discontinuation of 
fertility treatment (chapter 5). However, when focusing on specific patient groups 
(ART and non-ART patients) and on different subscales of the PCQ-Infertility (such 
as accessibility or respect for patient values), we had some interesting results. This 
also underlines the complexity of the decision to discontinue treatment. ART 
patients who experience more involvement in their treatment were more likely to 
discontinue treatment, which could be explained from a positive perspective. Non-
ART patients who experienced less respect for patient values were more likely to 
discontinue, and this discontinuation could be explained from a negative 
perspective. Future research should focus on patients’ perspectives and their needs 
when offering counselling after the end-of-treatment decision. Are there other 
determinants that can predict discontinuation in fertility care? Moreover, the role of 
the partner and family in the decision to discontinue treatment should be 
investigated. The ESHRE guideline on psychosocial care recommends offering 
patients who are at risk for infertility-specific psychosocial distress additional 
psychosocial care after unsuccessful treatment; however the recommendations after 
unsuccessful treatment in this guideline are not evidence-based (Gameiro et al., 
2015). Future research should gain more evidence-based support for these 
recommendations. 
Finally, we showed that is it feasible to evaluate a personalized e-therapy program 
within an RCT. We demonstrated the potential effectiveness of this e-therapy 
program in women who were compliant to the treatment protocol (chapter 6). The 
e-therapy program was tailored to the risk profile of the women, which was 
assessed before starting ART treatment using SCREENIVF. The feasibility RCT 
reveals some interesting points about compliancy and adherence to the program. 
For example, we experienced a large proportion of women declining to participate 
as well as a high percentage of dropouts. Difficulties in willingness to participate 
were also seen in the randomized controlled trial evaluating the effects of a self-
administered coping and relaxation intervention (Domar et al., 2015). Of all eligible 
patients in this RCT, 385 declined to participate and 166 were randomized, 
although patients were paid to complete this study. Moreover, in this trial using a 
self-administered intervention only 77% responded to this intervention, although 
women received a gift certificate when completing the last survey (Domar et al., 
2015). Patients were invited to participate without baseline risk screening in 
contrary to our study, which might explain a high non-participation rate and high 
dropout rate. In other studies attrition rates of 20-35% were described (Lancastle 
and Boivin, 2008; Ockhuijsen et al., 2014). The importance of addressing an 
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intervention consistently across participants was mentioned in relation to these 
attrition rates. Moreover, a lower frequency of use of the intervention could have 
impact on the effect (Ockhuijsen et al., 2014). Screening patients beforehand, and 
providing them structured information about the results of this screening, might 
facilitate their involvement in interventions aimed to improve psychosocial care. 
 
 
Methodological issues 
 
The findings described in this thesis underline the complexity of studying burden in 
couples undergoing ART. We addressed methodological issues one could encounter 
when studying psychosocial care during intense medical treatment. Strengths of the 
different studies in this thesis are the almost complete follow-up rates and the 
completeness of the information obtained by using medical charts and phone calls 
with patients. Concerning the limitations, we will focus on the methodological 
issues when evaluating discontinuation of fertility care, and when performing a 
process evaluation as well as a randomized controlled trial. Investigating 
discontinuation in fertility care starts with a clear definition of this term. Boivin 
defined discontinuation of fertility treatment as the decision to opt out of (further) 
treatment despite a favourable prognosis and the ability to cover the costs of 
treatment (Boivin et al., 2012). This should be distinguished from medical reasons 
to discontinue treatment (formerly known as active censoring). To distinguish 
between medical and personal reasons can be difficult. In addition, we should 
define when to assess the discontinuation of care: after the first ART cycle or 
continuously (Gameiro et al., 2012). A longer follow-up period, ideally after the 
final decision has been made, is preferable. In this follow-up period, perspectives of 
both members of the couple should be taken into account. Finally, prospective 
studies are needed to get information about the informed decisions to discontinue 
treatment from both patients as physicians. 
In the feasibility RCT a large proportion of the women who were eligible to 
participate declined participation, mostly because they felt they did not need the 
support at that moment. Identification of barriers for participation is needed. For 
example, it could be that women with a very strong focus on child wish do not 
recognize this wish as a risk for later emotional distress. Being unable to include 
these women, who may have benefitted from support according to their risk profile, 
in the analyses could potentially lower the assessed effect of the e-therapy program. 
To enhance completing the study until the last questionnaire, we should focus on 
	
the provision of information about the psychosocial screening, the determined risk 
profile, but also about the possibilities to have access to psychosocial care. Next, we 
should investigate in what form and at which time point care could be offered, 
independently of the phase of the fertility treatment. These factors should be taken 
into account in the design and analyses when performing a (multicentre) 
consecutive trial. Methods to enlarge participating and response rates, for example 
offering a gift after completing the final survey, could be considered (Edwards et 
al., 2009; Domar et al., 2015). 
In the feasibility study, we found that a considerable part of the women dropped 
out during the study period, and were not compliant to the e-therapy program. 
These women could have had a potential to benefit from the e-therapy program. 
We should identify methods to enlarge compliancy and to reduce dropout rate. 
Researchers should ground their studies on decision-making and compliancy 
theories (Gameiro et al., 2012). We know that psychological distress can fluctuate 
over time during fertility care, for example, more feelings of anxiety just before the 
egg collection or the pregnancy test, or other coping problems after several failed 
IVF cycles. A stepped-care approach could potentially be valuable in this population 
(Frederiksen et al., 2015). In stepped care the least intensive intervention that is 
appropriate for a person is typically provided first, and people can step up or down 
the pathway according to changing needs and in response to treatment (NICE 
guideline, 2011). The design and analyses of a consecutive study could be adjusted 
to a stepped-care approach of psychosocial counselling and care and to the 
compliancy of the intervention that is offered. For example, we could firstly offer 
patients a self-management program, and depending on the needs of the patient or 
responses to the program we could offer them e-therapy supported by a coach or 
even face-to-face counselling and support. 
Finally, we should determine when we consider the effect of e-therapy as relevant 
or significant and adjust the study design to this. Besides focusing on effectiveness 
in terms of less distress, one could also consider other outcome measures as 
relevant such as perceived patient-centred care, patient compliancy with the 
program, or economic measures. 
 
To address methodological issues before conducting a RCT, which investigates a 
complex innovative intervention, a structured approach can be helpful (Campbell et 
al., 2000). As is suggested by this structured approach, we started with a theoretical 
framework for the methodology based on previous prospective studies in this field 
(Verhaak et al., 2005). Moreover, we used the experiences of a small pilot study 
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issues when evaluating discontinuation of fertility care, and when performing a 
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defined discontinuation of fertility treatment as the decision to opt out of (further) 
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example, it could be that women with a very strong focus on child wish do not 
recognize this wish as a risk for later emotional distress. Being unable to include 
these women, who may have benefitted from support according to their risk profile, 
in the analyses could potentially lower the assessed effect of the e-therapy program. 
To enhance completing the study until the last questionnaire, we should focus on 
	
the provision of information about the psychosocial screening, the determined risk 
profile, but also about the possibilities to have access to psychosocial care. Next, we 
should investigate in what form and at which time point care could be offered, 
independently of the phase of the fertility treatment. These factors should be taken 
into account in the design and analyses when performing a (multicentre) 
consecutive trial. Methods to enlarge participating and response rates, for example 
offering a gift after completing the final survey, could be considered (Edwards et 
al., 2009; Domar et al., 2015). 
In the feasibility study, we found that a considerable part of the women dropped 
out during the study period, and were not compliant to the e-therapy program. 
These women could have had a potential to benefit from the e-therapy program. 
We should identify methods to enlarge compliancy and to reduce dropout rate. 
Researchers should ground their studies on decision-making and compliancy 
theories (Gameiro et al., 2012). We know that psychological distress can fluctuate 
over time during fertility care, for example, more feelings of anxiety just before the 
egg collection or the pregnancy test, or other coping problems after several failed 
IVF cycles. A stepped-care approach could potentially be valuable in this population 
(Frederiksen et al., 2015). In stepped care the least intensive intervention that is 
appropriate for a person is typically provided first, and people can step up or down 
the pathway according to changing needs and in response to treatment (NICE 
guideline, 2011). The design and analyses of a consecutive study could be adjusted 
to a stepped-care approach of psychosocial counselling and care and to the 
compliancy of the intervention that is offered. For example, we could firstly offer 
patients a self-management program, and depending on the needs of the patient or 
responses to the program we could offer them e-therapy supported by a coach or 
even face-to-face counselling and support. 
Finally, we should determine when we consider the effect of e-therapy as relevant 
or significant and adjust the study design to this. Besides focusing on effectiveness 
in terms of less distress, one could also consider other outcome measures as 
relevant such as perceived patient-centred care, patient compliancy with the 
program, or economic measures. 
 
To address methodological issues before conducting a RCT, which investigates a 
complex innovative intervention, a structured approach can be helpful (Campbell et 
al., 2000). As is suggested by this structured approach, we started with a theoretical 
framework for the methodology based on previous prospective studies in this field 
(Verhaak et al., 2005). Moreover, we used the experiences of a small pilot study 
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(Verhaak et al., 2008). We plead to adjust the methodology to the trial, and 
critically concern which outcome measures in which patients are the best suitable to 
assess the potential of the intervention one would like to investigate. Concerning 
this, a RCT with a fixed roadmap and fixed evaluation points and with less 
possibilities to deviate from the protocol, might not be the best way to determine 
the effects of a personalized e-therapy program in fertility care. Adjustment of the 
evaluation of the e-therapy programs, for example using different measure points 
and personalized goals, could show effectiveness of this e-therapy program. As is 
already known, comparing the outcomes of multiple interventions under various 
conditions is a well-known challenge in experimental research (Trietsch et al., 
2014). Also in this study, non participation was mentioned as a limitation. 
Alternatively, a plan-do-study-act (PDSA) method, in which a structure for iterative 
development and testing of improvements in complex healthcare system is 
provided, could be considered as method to evaluate a complex innovative 
intervention (Taylor et al., 2014). Although a theoretical framework for the PDSA 
method exists, it appears to be complex to implement and a systematic review 
demonstrated poor compliance to the key principles of the PDSA method (Taylor et 
al., 2014). When using a PDSA method, it will be possible to continuously evaluate 
the intervention and to adjust the intervention to this evaluation. As an alternative, 
a structurally performed process evaluation has the potential to demonstrate the 
feasibility of the implementation of an innovation in daily clinical care (Hulscher et 
al., 2003; Campbell et al., 2007). As we showed in Chapter 3, such a process 
evaluation might also help to gain insight into potential facilitators and barriers of 
participation and compliancy. We suggest that these alternatives, for example the 
use of a structured process evaluation or a PDSA-method in which it is possible to 
test changes in complex systems, will be used to evaluate the possible effects of 
innovative complex interventions such as an e-therapy program in fertility care. 
 
 
Implications for clinical practice 
 
This thesis highlighted several points that are important in daily clinical practice. 
Firstly, the awareness of the whole care-team for the psychosocial aspects of 
infertility and fertility treatment should be enlarged. Clinicians can ask questions 
about the feelings and concerns of a patient and her partner, and they can 
emphasize the stressful periods during or after treatment. It can be helpful to 
develop a guide for clinicians which they can use in clinical practice, including tools 
	
to identify high-risk patients. Moreover, clinicians can refer to a counsellor when 
necessary. We should encourage protective coping strategies, such as social support, 
and identify couples who are at risk for using non-adaptive coping strategies and 
developing long-term distress (Rockliff et al., 2014). We should focus on the factors 
which can be influenced by psychosocial support and counselling, and can provide 
effective stress reduction (Rockliff et al., 2014). 
The next step is to introduce and implement counselling and psychosocial care in 
daily clinical practice- where possible- delivered by nurses and physicians. 
Information on the psychosocial needs that patients experience during their 
treatment pathway, and on how clinical staff can detect and address these needs, 
available in the recently published ESHRE guideline on psychosocial care in 
infertility and medically assisted reproduction, can be helpful (Gameiro et al., 
2015). 
As was assessed in chapter 4 and 5, discontinuation of infertility treatment could be 
the result of a positive or a negative point of view. Other studies also have 
addressed these different perspectives of discontinuation of treatment (Van den 
Broeck et al., 2010). Results obtained from SCREENIVF or PCQ-I can help the 
clinician in the counselling of patients and in the provision of psychosocial support, 
if necessary in collaboration with a psychosocial team. Moreover, knowing the 
perspective of discontinuation can be helpful in improving quality of fertility care, 
and might help counsellors to adjust their care to the specific needs of the couple. 
They can, for example, encourage couples in their acceptance of childlessness, or 
secure social support mechanisms of the couple (Rockliff et al., 2014). 
At this moment it is not clear which interventions are most effective in psychosocial 
support and counselling in fertility care (Boivin et al., 2012; Galhardo et al., 2013; 
Sherratt and Lunn, 2013; Ockhuijsen et al., 2014; Domar et al., 2015; Frederiksen 
et al., 2015). Concerning the e-therapy program, which was investigated in chapter 
6, we concluded that has to be modified before it can be implemented in daily 
clinical practice. 
 
 
Implications for future research 
 
Having attention for psychosocial needs is important in couples, who are about to 
start ART treatment (chapter 2). In this group who are about to start ART 
treatment, it would be interesting to identify those who can benefit from TEM. 
Nowadays there is no consensus on the best treatment strategy for couples with 
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if necessary in collaboration with a psychosocial team. Moreover, knowing the 
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and might help counsellors to adjust their care to the specific needs of the couple. 
They can, for example, encourage couples in their acceptance of childlessness, or 
secure social support mechanisms of the couple (Rockliff et al., 2014). 
At this moment it is not clear which interventions are most effective in psychosocial 
support and counselling in fertility care (Boivin et al., 2012; Galhardo et al., 2013; 
Sherratt and Lunn, 2013; Ockhuijsen et al., 2014; Domar et al., 2015; Frederiksen 
et al., 2015). Concerning the e-therapy program, which was investigated in chapter 
6, we concluded that has to be modified before it can be implemented in daily 
clinical practice. 
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Having attention for psychosocial needs is important in couples, who are about to 
start ART treatment (chapter 2). In this group who are about to start ART 
treatment, it would be interesting to identify those who can benefit from TEM. 
Nowadays there is no consensus on the best treatment strategy for couples with 
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unexplained or mild male infertility (van den Boogaard et al., 2014). Although 
guideline recommendation on TEM is developed and published, there is still 
overtreatment in couples who were eligible for an expectant management (Kersten 
et al., 2015). We should not only focus on implementation of guideline 
recommendations, but also on the identification of couples that could benefit from 
TEM. An additional step can be the development of prognostic models for these 
patients using not only the medical parameters but also the experienced distress, 
using among others the information from the waiting list study (chapter 2). 
It is feasible to screen women at risk for emotional maladjustment after fertility 
treatment. Knowing who is at risk can be helpful in tailored care. The next step is to 
develop this tailored care, and develop and evaluate new programs for patients. 
Programs to enhance stress relief in fertility patients, for example using mindfulness 
exercises, could be introduced and evaluated (Galhardo et al., 2013; Sherratt and 
Lunn, 2013). Patient involvement should be applied more often in the development 
of such studies and programs, and will also be helpful in the implementation of 
psychosocial care in fertility care. Patient involvement can also be helpful in 
determining whether screening should become routine standard care before starting 
ART treatment, and what would be the best timing to screen. 
Future research should also focus on the time-point to offer an intervention. A good 
evaluation in a multicentre randomized controlled trial is needed. We could, for 
example, offer all patients at risk e-therapy in every phase of their ART treatment, 
meaning in the waiting list period, during ART cycles, and several months after 
ART. Next, we could assess effectiveness comparing the results on distress and 
quality of life questionnaires. 
We are convinced that in psychosocial fertility care more attention should be given 
to the partner and the social environment of the couple. Earlier studies showed that 
patients rely primarily on their partner and family when being distressed rather 
than on formal support (Boivin et al., 1999). The couples’ experiences and decisions 
regarding fertility care should be assessed. Also, the role and needs of the partner 
have to be thoroughly investigated. Although several studies have indicated that 
women suffer more seriously from involuntary childlessness than their male 
partners, men also can show symptoms of distress (Wright et al., 1991; Pook et al., 
2000; Wischmann et al., 2001; Wischmann et al., 2009). In addition, both partners 
play an important role to support each other and difficulties in partner 
communication predict fertility problem stress (Schmidt et al., 2005; Peterson et al., 
2011). Screening of both partners of the couple can be helpful to identify those at 
risk for emotional maladjustment. We plead to focus in future research on the 
	
screening of the partner, and the external validation of this (couple) screening. 
Moreover, more attention should be given to marital distress and coping strategies 
of both women and men. Coping strategies that are used by patients to deal with 
their infertility have been explored, and the next step should be to empower 
patients who are at risk for distress using protective coping strategies such as social 
support or marital satisfaction (Rockliff et al., 2014). Furthermore, we should 
explore whether interventions could provide effective ways to reduce distress in the 
clinical population (Rockliff et al., 2014). Nowadays, most intervention programs 
focus only on the women who undergo the fertility treatment. Counselling 
programs should be adjusted to the needs of the partners as well. In addition, 
adjustment to final childlessness in relation to the results of screening before 
fertility treatment has to be assessed. A longitudinal cohort study showed that 
parity after fertility evaluation may be an important component in the quality if the 
relationship of couples with previous infertility (Kjaer et al., 2014). However, in this 
study marital quality of relational well being of couples was not assessed before or 
during fertility evaluation and treatment (Kjaer et al., 2014). Other longitudinal 
retrospective cohort studies showed an association between being unsuccessful in 
giving birth after fertility evaluation and risk for suicide or hospitalisation for 
psychiatric disorders (Kjaer et al., 2011; Baldur-Felskov et al., 2013). Also in these 
studies, psychosocial risk factors were not assessed before fertility evaluation (Kjaer 
et al., 2011; Baldur-Felskov et al., 2013). When identifying psychosocial risk factors 
before fertility evaluation and being able to associate these with long term outcome 
of couples, psychosocial care can be tailored even better before, during and even 
long time after ART treatment. 
Finally, exploration why women decline to participate or to complete this e-therapy 
program is needed. The per-protocol analyses in the feasibility RCT (chapter 6) 
indicate that women could benefit from the e-therapy program, depending on their 
willingness to participate. Exploration of women’s preferences and needs is 
important, for example the duration of the e-therapy, the role of the counsellor and 
the time point of offering the e-therapy (Haemmerli et al., 2009; Frederiksen et al., 
2015). The suggestion was made to explore and to compare dropouts and 
completers, as well as non-responders and responders to enlarge response rates 
(Frederiksen et al., 2015). The suggestions made by our participants can be helpful 
in adjustments to the e-therapy program, for example offering e-therapy at different 
time points or the possibility to participate without an e-coach. Next, the 
effectiveness, efficiency and accessibility should be investigated structurally. 
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Patients themselves should be involved in these developments and improvements of 
e-therapy programs and the systematic evaluation of these programs. 
 
 
Epilogue 
 
In this thesis, we tried to unravel the complexity of discontinuation of care and 
quality of life in relation to the burden of fertility treatment. Knowing more about 
the underlying distress and motivations of the couple, particularly before starting 
treatment, can be helpful in tailoring psychosocial care. A first step was made to 
evaluate an e-therapy program in women undergoing fertility treatment. We hope 
that our results will be helpful in counselling and treating infertile patients, and in 
the evaluation of the efficacy of personalized psychosocial interventions. 
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In this thesis we studied several aspects of burden in fertility treatment, focused on 
discontinuation in assisted reproductive technology (ART) treatment, 
implementation of psychosocial screening of patients before ART, prediction of 
discontinuation and the prevention of distress through psychosocial e-therapy. 
Chapter 1 describes the outline and rationale of this thesis. 
 
 
Discontinuation in ART 
 
Earlier studies concluded that the reduction of discontinuation rate in ART is 
necessary to improve the (cost-) effectiveness of ART treatment. Many studies 
focused on discontinuation during ART treatment. In chapter 2 we focused on 
discontinuation before starting ART treatment, i.e. the discontinuation of couples 
with an indication to start ART treatment and waiting to actually start medication 
and their first ART cycle. It appears that 13% of the couples on the waiting list 
dropped out before the start of ART treatment, most of them achieving a 
spontaneous pregnancy. This could be an important message in counselling couples 
who have an indication to start ART. 
Stress relief and its presumed positive influence on the chance of conceiving 
spontaneously could be an underlying mechanism, as was suggested in earlier 
literature. Consequently, focusing on stress relief by psychosocial counselling might 
be operative. In addition, to diminish discontinuation due to personal reasons, 
better surveillance and counselling is needed.  
 
 
Implementation of psychosocial screening before ART 
 
Although psychosocial factors are important in discontinuation and/or developing 
long-term distress, most women could deal effectively with the diagnosis of 
infertility and the stress of the ART treatment. In order to deliver personalized care, 
it is important to identify those women who are at risk for emotional 
maladjustment. In chapter 3, it is shown that the introduction of the validated 
screening instrument SCREENIVF in daily clinical care was feasible and acceptable. 
We found a high uptake rate (approximately 80%) and we showed by process 
evaluation that a substantial number of patients screened as at risk did not seek 
professional help. Travelling distance was identified as an important barrier for 
seeking professional help. In addition, this screening instrument could provide 
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health care professionals information about the risk profile of the patient, which 
enables clinicians to tailor psychosocial care and interventions. 
 
 
Prediction of discontinuation in ART 
 
Psychosocial screening 
In chapter 4, we determined whether risk factors for emotional maladjustment 
could predict discontinuation in ART. We showed that discontinuation of ART 
treatment despite a favourable prognosis could be explained by higher acceptance 
of the fertility problem at pre-treatment in both men and women, as well as by a 
lack of perceived social support in women. We stated that it seems as if there are 
couples that discontinue ART treatment from a positive choice, for example the 
acceptance of their childlessness. However, there are also couples who discontinue 
from a negative choice, for example a perceived lack of social support. It is 
important to differentiate between these two types of discontinuation. 
SCREENIVF could be helpful to make this differentiation. In addition, the results of 
this screening could help to tailor couples’ psychosocial care. Long-term follow up, 
for example to assess possible regret regarding the decision to discontinue 
treatment, is needed. 
 
Patient-centred care 
In addition to chapter 4, we also related patients’ experiences with aspects of 
patient-centred fertility care to discontinuation of fertility treatment (chapter 5). In 
a different subset, derived from a large randomized controlled trial aimed at 
improving the level of patient-centredness in fertility care, we investigated the 
scores of the Patient-Centredness Questionnaire (PCQ)-Infertility in relation to 
discontinuation of fertility care. The results showed no significant relation between 
the experienced level of patient-centred fertility care and discontinuation. However, 
significant associations were found when focusing on specific patient groups. 
Firstly, patients undergoing non-ART treatment (e.g. ovulation induction or intra-
uterine insemination) had a bigger chance of discontinuation when they scored 
lower on the PCQ-Infertility subscale ‘respect for patients’ (i.e. a negative 
predictor). Secondly, patients receiving ART treatment were more likely to 
discontinue treatment when the level of ‘patient involvement’ was higher (i.e. a 
positive predictor). 
	
The associations found in the additional analyses underline that the decision to end 
fertility treatment is complex, and can again be driven by a negative or positive 
direction of the choice. These findings, combined with the findings of the previous 
chapter, can be helpful in the counselling of patients and the provision of 
personalized care to them who need it most. Future research has to point out to 
what extend experienced patient-centredness or other factors, such as lack of social 
support, can be used to predict discontinuation. This could result in the 
development if a personalized intervention to prevent the discontinuation from a 
negative choice. 
 
 
e-Therapy in fertility care 
 
In chapter 6, we focus on the prevention of emotional maladjustment using a 
personalized e-therapy program, combining psycho-education by online cognitive 
behavioural therapy with coaching by specially trained e-therapists. We performed 
a feasibility randomized controlled trial (RCT) aimed to determine if it is feasible to 
evaluate this e-therapy program within an RCT. Feasibility was evaluated according 
to a structured approach and the following outcome measures were assessed: 
demand, acceptability, practicality, implementation and integration and limited 
efficacy. A large proportion of the eligible women did not want to participate (56%) 
in this study, mostly because they did not feel the need for support at that moment. 
This is an interesting finding which might show the need of modification of the 
study protocol or intervention, for example providing more information beforehand 
or adjust the timing of the provision of the e-therapy. Furthermore, we found that 
15% dropped out due to acceptability reasons. A large proportion of the 
participants stated they had different expectations of the intervention (55%), 30% 
of the participants dropped out due to practical concerns e.g. achieving a 
spontaneously pregnancy. We showed that the intervention is effective in a 
compliant group of women (n=29), reflected by a reduction in the percentage 
women having clinically relevant symptoms of anxiety and/or depression compared 
to the control group (n=51) at three months after the first ART cycle; risk 
difference 24% (95% CI: 2 – 46%; p =0.03). 
All in all, we concluded that evaluation of the e-therapy program within an RCT is 
feasible and suggestions for study protocol and intervention improvement were 
made focusing on adherence and compliancy. 
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General discussion 
 
Burden in fertility treatment can lead to emotional distress, diminished fertility-
related quality of life or discontinuation of fertility treatment. Therefore, 
minimising this burden is important.  
In the final chapter (chapter 7) we discussed some major points regarding burden 
in fertility treatment. Regarding the dropout during the waiting list period, could it 
be that patients were placed on the waiting list for ART treatment too soon? Maybe 
they could have benefitted from tailored expectant management. Does stress relief 
play a role? We previously found it is possible to screen patients for emotional 
maladjustment. We found this is feasible, and the next step is to modify the 
screening instrument, for example introducing on-line screening or integrating self-
management tools, to enhance acceptance. In this thesis, we evaluated whether the 
results of this validated screening instrument and the perceived patient-centredness 
could predict discontinuation. Although we found that discontinuation of ART 
could be influenced by a choice from a positive or from a negative perspective, 
much of the underlying mechanism stays unclear. More research is needed to 
unravel the complex process of the choice to discontinue fertility care. One of the 
suggestions we made is to focus on personalized psychosocial support in fertility 
care. We found it is feasible to evaluate a personalized e-therapy program in 
fertility care within an RCT, although modifications to the study protocol and to the 
intervention have to be made. 
In this thesis, we tried to unravel the complexity of burden in fertility treatment. We 
explored the underlying distress of patients undergoing fertility treatment aimed to 
tailor the psychosocial care. Being able to support patients before and during their 
fertility treatment with tailored care adjusted to the patients’ needs and preferences 
will help in diminishing burden in fertility treatment. 
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In dit proefschrift beschrijven we het onderzoek naar psychosociale kwetsbaarheid 
bij fertiliteitsbehandeling, waarbij we de focus hebben gelegd op de uitval vooraf en 
tijdens IVF/ICSI behandelingen en het voorspellen van deze uitval, het 
implementeren van screening naar psychosociale kwetsbaarheid van patiënten 
vooraf aan hun IVF/ICSI behandeling en de haalbaarheid van een internet 
interventie om psychosociale stress tijdens IVF/ICSI behandeling te voorkomen. In 
hoofdstuk 1 beschrijven we de achtergrondinformatie en de vraagstelling van dit 
proefschrift. 
 
 
Uitval bij IVF/ICSI behandelingen 
 
Eerdere studies laten zien dat het terugdringen van vroegtijdige uitval tijdens 
IVF/ICSI behandelingen belangrijk is om de (kosten)effectiviteit van deze 
behandelingen te verbeteren. Veel van deze studies hebben alleen de uitval tijdens 
IVF/ICSI behandelingen onderzocht. In hoofdstuk 2 hebben we gekeken naar de 
uitval van paren vooraf aan het starten van hun eerste IVF/ICSI behandeling. Dit 
betrof paren die een indicatie hadden om te starten met IVF/ICSI en hiervoor op de 
wachtlijst waren geplaatst. We konden concluderen dat 13% van de paren uitviel 
voordat hun behandeling daadwerkelijk startte en dat het optreden van een 
spontane zwangerschap de belangrijkste reden voor deze uitval was. Daarnaast gaf 
een groot deel aan te stoppen wegens persoonlijke redenen. Deze informatie kan 
gebruikt worden bij de counseling van paren die een indicatie hebben om een 
IVF/ICSI behandeling te starten. 
Afname van stress en de hierbij behorende positieve invloed op de spontane 
zwangerschapskans zou een rol kunnen spelen. Ook deze informatie kan mee-
genomen worden in de counseling van paren. In dit hoofdstuk suggereren we 
tevens dat er meer aandacht zou moeten komen voor de paren die vroegtijdig de 
behandeling stoppen om persoonlijke redenen. 
 
 
Implementatie van psychosociale screening vooraf aan IVF/ICSI 
behandeling 
 
Ondanks de rol van psychosociale factoren bij uitval van IVF/ICSI behandeling 
en/of bij het ontwikkelen van emotionele kwetsbaarheid op lange termijn blijkt dat 
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de meeste vrouwen de diagnose verminderde vruchtbaarheid en de stress 
behorende bij een IVF/ICSI behandeling goed kunnen verwerken. Het is belangrijk 
om de vrouwen te identificeren die wel een verhoogd risico hebben op problemen 
op de lange termijn, idealiter vooraf aan het starten van de IVF/ICSI behandeling 
omdat er dan al de mogelijkheid is om hen persoonlijke psychosociale zorg aan te 
bieden. In hoofdstuk 3 hebben we laten zien dat het haalbaar is om een 
gevalideerde screeningsvragenlijst in te voeren in de dagelijkse praktijk. We zagen 
dat veel paren de vragenlijst invulden (ongeveer 80%). Ook hebben we de paren 
gevraagd naar hun ervaringen met de vragenlijst. Hieruit bleek dat een groot deel 
van de personen die een verhoogd risico op stress lieten zien aangaf geen 
professionele hulp te gaan zoeken. Reisafstand is hierbij een belemmerende factor. 
De uitkomsten van deze vragenlijst geven niet alleen de patiënten inzicht, maar 
kunnen ook professionals helpen om gepersonaliseerde psychosociale counseling en 
interventies aan te bieden. 
 
 
Voorspelling van uitval bij IVF/ICSI behandelingen 
 
Psychosociale screening 
In hoofdstuk 4 hebben we onderzocht of het hebben van risicofactoren voor 
emotionele stress ook voorspellend kan zijn voor uitval tijdens IVF/ICSI 
behandeling. We vonden hierbij dat uitval bij IVF/ICSI behandeling ondanks een 
gunstige prognose voorspeld kan worden door een hogere acceptatie van het 
vruchtbaarheidsprobleem bij zowel mannen als vrouwen en door het ervaren van 
minder sociale steun bij vrouwen. Er lijken paren te zijn die stoppen met IVF/ICSI 
behandeling vanuit een positieve keuze, zoals het al hebben geaccepteerd van het 
vruchtbaarheidsprobleem. Daarnaast zijn er paren zijn die stoppen vanuit een meer 
negatieve keuze, zoals het ervaren gebrek aan sociale steun. Het is belangrijk om bij 
paren na te gaan vanuit welke optiek zij hun keuze tot stoppen met behandelingen 
maken. 
Het resultaat van de screeningsvragenlijst zou ook behulpzaam kunnen zijn om na 
te gaan vanuit welke keuze patiënten stoppen met IVF/ICSI behandelingen, en kan 
helpen om vervolgens gepersonaliseerde psychosociale zorg aan te bieden. Het is 
belangrijk om de keuze van paren, maar ook de spijt van hun gemaakte keuze, na 
te gaan in vervolgonderzoek. 
 
 
	
Patiëntgerichte zorg 
In hoofdstuk 5 hebben we onderzocht in hoeverre de ervaren patiëntgerichtheid 
van zorg voorspellend kan zijn bij het stoppen van vruchtbaarheidsbehandelingen. 
Binnen een andere onderzoeksgroep, die verkregen werd uit een grote 
gerandomiseerde studie met als doel de zorg meer patiëntgericht te maken, is 
gekeken naar de uitkomsten van een patiëntgerichtheids-vragenlijst en de uitval bij 
vruchtbaarheidsbehandelingen. De door de patiënt ervaren patiëntgerichtheid kon 
de uitval bij vruchtbaarheidsbehandelingen niet voorspellen. We vonden wel 
associaties bij specifieke patiëntengroepen. Zo hadden vrouwen die ovulatie-
inductie of inseminatie behandelingen kregen een grotere kans om uit te vallen als 
zij het ‘respect voor de patiënten’ als laag hadden ervaren. Vrouwen die een 
IVF/ICSI behandeling kregen, vielen vaker uit als zij een hoog niveau van 
‘betrokkenheid van de patiënt bij de behandeling’ hadden ervaren. 
De beslissing om te stoppen met vruchtbaarheidsbehandeling is complex, wat ook 
blijkt uit deze associaties. Het lijkt erop dat de uitval uit de behandeling vanuit een 
positieve keuze (zoals het al geaccepteerd hebben van het vruchtbaarheids-
probleem, of het ervaren van betrokkenheid van de patiënten bij de behandeling) 
maar ook vanuit een negatieve keuze (zoals het ervaren van gebrek aan sociale 
steun of het ervaren van weinig respect voor de patiënten) gemaakt kan worden. 
Bovenstaande gegevens, samen met de uitkomsten uit hoofdstuk 4, zijn belangrijk 
bij de counseling en zorg van paren voorafgaand aan hun vruchtbaarheids-
behandeling. Verder onderzoek zal nog moeten uitwijzen hoe paren hun keuze om 
te stoppen met vruchtbaarheidsbehandeling maken en hoe ze op deze keuze 
terugkijken, en of we deze keuze kunnen voorspellen. 
 
 
Internettherapie in de fertiliteitszorg 
 
In hoofdstuk 6 hebben we onderzocht of het haalbaar is om gepersonaliseerde 
internettherapie in te zetten met als doel psychosociale stress te voorkomen. In deze 
internettherapie wordt psycho-educatie gecombineerd met online cognitieve 
gedragstherapie, ondersteund door speciaal hiervoor getrainde therapeuten. We 
hebben een haalbaarheidsonderzoek verricht waarbij we binnen een 
gerandomiseerde studie (RCT) gekeken hebben of het haalbaar is om deze 
internettherapie te evalueren in een RCT. De haalbaarheid werd gestructureerd 
onderzocht. Hierbij is gekeken naar de vraag van patiënten om deel te nemen aan 
deze internettherapie, de acceptatie van het programma, de praktische uitvoerbaar-
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heid van zowel de RCT als het programma, de implementatie en integratie van het 
programma binnen de huidige zorg en dagelijkse praktijk en tenslotte de 
effectiviteit van het programma. Het bleek dat een groot deel van de vrouwen die in 
aanmerking kwam voor deelname, niet deel wilde nemen aan de studie naar 
haalbaarheid van de internettherapie (56%), waarbij de meeste vrouwen aangaven 
geen behoefte aan psychosociale steun te hebben op dat moment. Een aanpassing 
van het studieprotocol en van de interventie is nodig om vrouwen beter te kunnen 
motiveren om deel te nemen, bijvoorbeeld door meer informatie vooraf te geven of 
door het aanpassen van het tijdstip waarop vrouwen de internettherapie krijgen 
aangeboden. Vijftien procent van de vrouwen stopte met de studie wegens 
acceptatieredenen, vooral omdat de internettherapie niet aan hun verwachtingen 
voldeed (55%). Dertig procent van de deelnemers viel uit wegens praktische 
redenen zoals het optreden van een spontane zwangerschap. We zijn nagegaan of 
het programma effectief kan zijn door een therapietrouwe groep te vergelijken met 
een controle groep. In de therapietrouwe groep (n=29) zagen we een vermindering 
van het percentage vrouwen dat klinisch relevante symptomen van angst en/of 
depressie liet zien drie maanden na de 1e IVF/ICSI behandeling vergeleken met de 
controle groep (n=51). Het risico verschil tussen beide groepen was 24% (95% BI: 
2 – 46%, p=0.03). 
We hebben uit dit hoofdstuk geconcludeerd dat het haalbaar is om deze ge-
personaliseerde internettherapie te evalueren in een RCT. Daarnaast hebben we 
suggesties gegeven voor aanpassing van het studieprotocol en van de interventie 
om zo de deelname en het volbrengen van het programma te verbeteren. 
 
 
Algemene discussie 
 
Kwetsbaarheid bij fertiliteitsbehandelingen kan leiden tot emotionele stress, 
verminderde kwaliteit van leven en vroegtijdige uitval uit vruchtbaarheids-
behandelingen. Dit is een reden om deze kwetsbaarheid te verminderen. 
In het laatste hoofdstuk van dit proefschrift (hoofdstuk 7) gaan we in op enkele 
punten die belangrijk zijn bij deze kwetsbaarheid. We zagen uitval van paren 
tijdens de wachtlijstperiode voorafgaand aan de IVF/ICSI behandeling. Wellicht 
worden paren te vroeg op een IVF wachtlijst geplaatst. Hadden ze nog kunnen 
profiteren van een afwachtend beleid, met een relatief grote kans op een spontane 
zwangerschap? Wat is de rol van stress en stressreductie hierbij? We zagen dat het 
haalbaar is om paren te screenen op hun risico voor psychosociale stress. Mogelijk 
	
kan de screeningsvragenlijst nog verbeterd worden, bijvoorbeeld door deze online 
aan te bieden of door de vragenlijst te integreren in zelfmanagement-tools, met als 
doel de acceptatie van deze vragenlijst te verbeteren. We hebben onderzocht of 
deze vragenlijst en een vragenlijst naar ervaringen van paren met patiëntgerichte 
zorg kunnen helpen bij de voorspelling van vroegtijdige uitval tijdens IVF/ICSI 
behandelingen. Het lijkt erop dat het stoppen van behandelingen te maken heeft 
met een positieve of negatieve keuze, maar hoe paren tot deze keuze komen blijft 
onduidelijk. Het is belangrijk om meer onderzoek te doen naar deze complexe 
beslissing tot het stoppen van vruchtbaarheidsbehandelingen. We suggereren dat er 
meer aandacht moet komen voor gepersonaliseerde psychosociale zorg in de 
voortplantingsgeneeskunde. In dit proefschrift laten we zien dat het haalbaar is om 
gepersonaliseerde internettherapie te evalueren in een RCT, hoewel aanpassingen 
aan het studieprotocol en de interventie wenselijk zijn. 
In dit proefschrift hebben we geprobeerd meer inzicht te krijgen in de complexiteit 
van kwetsbaarheid van paren bij fertiliteitsbehandelingen. We hebben gekeken naar 
de onderliggende emotionele stress bij paren die vruchtbaarheidsbehandelingen 
ondergaan en de mogelijkheden om gepersonaliseerde zorg te geven. Als we paren 
vooraf en tijdens de vruchtbaarheidsbehandeling goed kunnen ondersteunen op 
psychosociaal gebied en deze steun kunnen aanpassen aan de wensen en behoeften 
van de patiënten, kan dit helpen om de kwetsbaarheid van paren tijdens 
vruchtbaarheidsbehandeling te verminderen. 
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Dankwoord 
 
Hooggeleerde prof. J.A.M. Kremer, beste Jan: Toen ik eind 2010 tijdens mijn 
sollicitatiegesprek voor een fellowship voortplantingsgeneeskunde op jouw afdeling 
vroeg of ik “ook iets aan onderzoek kon doen zodat ik misschien een artikel zou 
kunnen schrijven”, had ik niet verwacht dat het een heel manuscript zou worden. 
Maar met jouw onuitputtelijke stroom ideeën, je tomeloze energie, je vlotte 
beoordelingen van stukken en jouw inspiratie kan alles! Vaak kwam ik met meer 
vragen dan antwoorden naar buiten na onze promotiegesprekken. Hoe jij de 
gezondheidszorg wilt verbeteren en vernieuwen is voor velen en ook voor mij 
inspirerend en ik hoop nog veel langer samen met jou aan dit soort projecten te 
mogen werken! 
 
Weledelgeleerde dr. C.M. Verhaak, lieve Chris: Je lijkt wel 1001 dingen op een dag 
te kunnen doen, en je blijft altijd goed gehumeurd. Het is fijn om met jou samen te 
mogen werken. Ik heb veel van je geleerd over psychologie en statistiek, maar ook 
over het combineren van werk, privé, wetenschap en allerlei andere zaken. Ik 
bewonder het hoe jij de psychosociale zorg voor fertiliteitspatiënten wereldwijd op 
de kaart zet! Ik hoop nog lang samen met jou deze zorg te verbeteren! 
 
Weledelgeleerde dr. W.L.D.M. Nelen, lieve Willianne: Wat is het fijn om iemand 
zoals jij in je promotieteam te hebben. Je bent niet alleen kritisch op mijn artikelen 
(die ik soms meer rood dan wit terug kreeg), maar ook een fantastische steun op 
het persoonlijke vlak. Je wist me altijd weer op te peppen als ik het even niet zag 
zitten. Je maakt altijd tijd om even samen naar dit of dat te kijken, terwijl je toch 
heel wat promovendi onder je hoede hebt. Dankjewel voor al je tijd, je luisterende 
oor en je hulp. Ik heb er veel vertrouwen in dat we samen nog veel onderzoek doen 
op de afdeling gynaecologie/voortplantingsgeneeskunde. En ik heb er zin in! 
 
Hooggeleerde prof. dr. Speckens, hooggeleerde prof. dr. Assendelft en 
hooggeleerde prof. dr. Evers, leden van de manuscriptcommissie: Bedankt voor 
jullie kritische beoordeling van mijn manuscript. 
 
Alle patiënten die hebben meegewerkt aan dit onderzoek wil ik bedanken. Zonder 
jullie kunnen we niet onderzoeken hoe we psychosociale zorg kunnen veranderen 
en verbeteren. Dank voor het meedoen aan Digicoach, dank voor het invullen van 
vragenlijsten en dank voor het beantwoorden van telefonische enquêtes. 
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Lieve collega’s van de pijler voortplantingsgeneeskunde Radboudumc, lieve Didi, 
Ina en Kathrin: Wat fijn dat jullie mij, na mijn opleiding helemaal in het zuiden van 
het land, wilden opleiden tot subspecialist en vervolgens het vertrouwen hebben 
gegeven om deel uit te maken van de staf vpg. Ik heb veel van jullie geleerd en ik 
leer nog iedere dag bij. Ik heb er veel zin in om samen hard te werken om de 
voortplantingsgeneeskunde binnen het Radboudumc naar een nog hoger plan te 
tillen! Dankjulliewel. 
 
Collega’s van de pijlers algemene gynaecologie, obstetrie en oncologie: Ik heb me 
vanaf de allereerste dag thuis gevoeld in het Radboudumc en dat zegt 
waarschijnlijk wel genoeg. Ik kan altijd bij iedereen terecht voor een vraag, voor 
een gezellig praatje of wat dan ook. Ik ben blij dat ik deel mag uit maken van dit 
geweldige team! 
 
Lieve dames van het secretariaat (Kiki, Lisette, Marlies en Miranda): dankzij jullie 
kreeg iedereen een uitnodigingsbrief en werd er gerandomiseerd. Dank voor al 
jullie hulp bij het onderzoek. Kiki, wat fijn dat jij onze stafsecretaresse bent 
geworden. 
 
Lieve IVF artsen en verpleegkundig specialisten (Ellen, Jolieneke, Bea, Lobke, 
Marloes, Martje, Gwendolyn, Corine, Ellen, Greet, Fleur, Aukje, Ouijdane en Ellen 
Marie): Met een aantal werk ik nog met veel plezier samen en een aantal heeft 
reeds een andere werkplek. Bea en Gwendolyn: ik heb van jullie de puncties en 
terugplaatsingen geleerd maar ook dat er naast werk en promoveren nóg een leven 
bestaat. Lieve medewerkers van de poli: Het is altijd gezellig en ontspannen bij 
jullie; jullie laten jullie waardering voor mij merken, maar bij deze: heel veel 
waardering voor jullie! Ik vind het super hoe jullie de afdeling draaien! Liliana, 
Alex, Hans en alle andere medewerkers van het lab: Wat werken jullie hard en 
zorgvuldig. We zijn niet voor niets (vrijwel) de beste van het land. Super om deel 
uit te mogen maken van dit team. 
 
Gerry en Emiel: Zonder jullie zou de hele RCT niet zijn uitgevoerd. En daarmee doe 
ik jullie misschien nog wel te kort. Wat een energie en tijd hebben jullie gestoken in 
het digitaal begeleiden en coachen van dames die aan hun eerste IVF behandeling 
begonnen. En wat een mooi programma is het geworden dankzij jullie. 
Dankjulliewel voor al jullie tijd en energie. Gerry: geniet van je vrije tijd; en Emiel: 
ik ben benieuwd naar jouw boekje! 
	
Emiel, Sanne, Maartje, Sylvia, en de rest van ESC: Van begin af aan mocht ik 
aansluiten bij jullie e-health club. Ik heb bewondering voor hoe jullie dit toch 
uitdagende onderwerp oppakken en op de kaart zetten en ik ben trots op onze 
samenwerking. Ik heb veel van jullie geleerd. 
 
Mede-auteurs, dank voor alle hulp bij het schrijven van de artikelen. Dana, wat een 
top-onderzoeker en top-gynaecoloog in opleiding ben je. Dank voor je hulp bij de 
statistiek, en dank voor het meeschrijven en –denken. Gezellig dat je nu in het 
Nijmeegse zit: nu hoop ik jou van alles te kunnen leren! Nelleke, het begon met het 
uitwerken van jouw scriptie, en daarmee het eerste artikel in Nijmegen. Tamara, 
dank dat je me op weg geholpen hebt met mijn eerste stappen in de wetenschap, 
destijds nog in Maastricht! 
 
Mede-onderzoekers: Wat een fantastisch wetenschappelijk inspirerende sfeer heerst 
er in de ‘tuin’. Tom, dank dat je me vaak een nuttig linkje stuurde. Lobke, dank voor 
de gezelligheid samen op de congressen en ook nu nog! Annemijn, Dana, Tom, 
Lobke en Anika, jullie gingen me voor met top-werk. Marloes, Fleur, Aukje, Elvira, 
Özlem, Helga, Eva, Ellen Marie, Sebastian, jullie zijn hierna aan de beurt, succes! 
Kirsten en Marit, bedankt voor de data-invoer en de hulp bij de follow-up studie. 
 
Leslie: bedankt voor de correcties in de Engelse teksten, fijn om van een ‘native 
speaker’ gebruik te kunnen maken! Sylvia: bedankt, de kaft is prachtig geworden! 
 
Ook een woord van dank aan alle aios. In de diensten kan ik af en toe heerlijk bij 
jullie klagen als het weer eens niet opschoot. Jullie zijn een fantastisch hard-
werkende groep, het is heerlijk om met jullie samen te werken! 
 
Lieve vrienden en vriendinnen: Wat fijn dat jullie voor afleiding, ontspanning, 
inspanning en gezelligheid zorgen. 
 
Dames van mijn jaarclub (Femke, Desiré, Fiona, Geke, Imke, Marije, Martien, 
Nathalie en Suus): Al wonen we niet meer met z’n allen in Utrecht, toch zien en 
spreken we elkaar geregeld. Ik geniet van onze oude en nieuwe tradities: 
nieuwjaarsdiner, zomerbbq, boswandeling, etc. En ik vind het heel fijn dat we ook 
bij moeilijkere momenten er voor elkaar zijn. Zo bijzonder dat we elkaar al meer 
dan 20 jaar kennen! En wat fijn dat jullie erbij zijn om dit bijzondere moment met 
mij te delen! Ik zeg: “champagne en koeler!” 
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Lieve Mia, Joop, Wendela, Marnix, Elise, Sanno, Rosanne, Justus en Robin: Van 
begin af aan hoorde ik erbij. Ook al wonen we niet altijd even dicht bij elkaar, we 
zijn er voor elkaar als dat nodig is. En Mia: bedankt dat je bijspringt voor de kids 
(en tuin!) indien nodig. Het is jammer dat Peter er niet meer bij kan zijn. 
 
Lieve Ingrid, Cees, Eline, Victor en Jan Pieter: Wat is het altijd heerlijk ontspannen 
in Ravels. Dank voor jullie goede zorgen en altijd warme interesse voor ons. Het is 
fijn om zo’n familie te hebben! 
 
Lieve Jos en Pieter, Danielle en Jinne: Broertjes, wat fijn dat we zo’n goede band 
hebben en er voor elkaar zijn. Ik hou van jullie. Jasper en Rimke: heerlijk om jullie 
tante te zijn! 
 
Lieve papa en mama: In jullie warme nest ben ik opgegroeid en jullie hebben mij 
gemaakt tot wie ik nu ben. Ik ben trots op jullie en heel dankbaar voor alle 
mogelijkheden die we van jullie gekregen hebben. Ik hou van jullie. En mam, je 
mag nu best een traantje wegpinken! 
 
Liefste Luc en Thijs: Jullie zijn mijn kanjers! Jullie hebben mijn leven zo enorm 
verrijkt! Ik ben apetrots op jullie en geniet iedere dag van jullie! Kusknuf! 
 
En dan als laatste, allerliefste Remco: Wat zijn wij al jaren een topteam! Ik ben je 
dankbaar voor alles wat je voor mij doet. Ik hou superveel van je!!! 
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